<SEC-DOCUMENT>0001214659-22-000010.txt : 20220103
<SEC-HEADER>0001214659-22-000010.hdr.sgml : 20220103
<ACCEPTANCE-DATETIME>20220103063826
ACCESSION NUMBER:		0001214659-22-000010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20220103
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220103
DATE AS OF CHANGE:		20220103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BitNile Holdings, Inc.
		CENTRAL INDEX KEY:			0000896493
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				941721931
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12711
		FILM NUMBER:		22500284

	BUSINESS ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141
		BUSINESS PHONE:		(949) 444-5464 3679

	MAIL ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ault Global Holdings, Inc.
		DATE OF NAME CHANGE:	20210119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DPW Holdings, Inc.
		DATE OF NAME CHANGE:	20171229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIGITAL POWER CORP
		DATE OF NAME CHANGE:	19960823
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bn123121128k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:NILE="http://NILE/20220103">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_NILE_NILE_20220103 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20220103_20220103 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000896493 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityCentralIndexKey">0000896493</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nile-20220103.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-03to2022-01-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000896493</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-03</xbrli:startDate>
        <xbrli:endDate>2022-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20220103__20220103_zsL6IieCS2K8"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">___________________________________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&#160;&#160;<span id="xdx_901_edei--DocumentPeriodEndDate_c20220103__20220103_zvIPx2TegEda"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January
3, 2022</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20220103__20220103_zut1F73wv73j"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityRegistrantName">BITNILE HOLDINGS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="text-decoration: underline"><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20220103__20220103_zXGbSfkxzN6i"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"><span style="text-decoration: underline"><span id="xdx_902_edei--EntityFileNumber_c20220103__20220103_zqq41RdZpTd4"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityFileNumber">001-12711</ix:nonNumeric></span></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 33%; text-align: center"><span style="text-decoration: underline"><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20220103__20220103_zvOhJP2Qjmn4"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityTaxIdentificationNumber">94-1721931</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction of <br />
incorporation or organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20220103__20220103_zPY2FDnaXSS3"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityAddressAddressLine1">11411 Southern Highlands Parkway</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20220103__20220103_zJDhXxm15lGc"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityAddressAddressLine2">Suite 240</ix:nonNumeric></span>,
<span id="xdx_908_edei--EntityAddressCityOrTown_c20220103__20220103_zJc638UjhHyk"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityAddressCityOrTown">Las Vegas</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20220103__20220103_z9hWLueggxyc"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityAddressStateOrProvince">NV</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20220103__20220103_zOjvbySmwsE9"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:EntityAddressPostalZipCode">89141</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline"><span id="xdx_90B_edei--CityAreaCode_c20220103__20220103_zaZ4rPYE1kJ3"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:CityAreaCode">(949)</ix:nonNumeric></span> <span id="xdx_901_edei--LocalPhoneNumber_c20220103__20220103_z4pOXMWkkIIf"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:LocalPhoneNumber">444-5464</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant's telephone number, including area
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_90B_edei--WrittenCommunications_c20220103__20220103_zx5c7w155B13"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:booleanfalse" name="dei:WrittenCommunications">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20220103__20220103_zloIeqr9XLt4"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:booleanfalse" name="dei:SolicitingMaterial">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementTenderOffer_c20220103__20220103_zixKpg7oE9c7"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20220103__20220103_zyzL455TEpW5"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 34%; text-align: center">Title of each class</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Trading</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Symbol(s)</p></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 49%; text-align: center">Name of each exchange on which registered</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20220103__20220103_zgG8XAoHoU9e"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20220103__20220103_zaK6TOcQjCe8"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" name="dei:TradingSymbol">NILE</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20220103__20220103_zeTQ5UigFtbk"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&#160;<span style="font-family: Wingdings"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20220103__20220103_z7TrRvqokPce"><ix:nonNumeric contextRef="From2022-01-03to2022-01-03" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">o</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings">o</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 1.01</b></td><td><b>Entry into a Material Definitive Agreement</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 30, 2021
(the &#8220;<b>Closing Date</b>&#8221;), BitNile Holdings, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;) entered into
a Securities Purchase Agreement (the &#8220;<b>SPA</b>&#8221;) with certain sophisticated investors (the &#8220;<b>Investors</b>&#8221;)
providing for the issuance of (i) Secured Promissory Notes (individually, a &#8220;<b>Note</b>&#8221; and collectively, the &#8220;<b>Notes</b>&#8221;)
with an aggregate principal face amount of approximately $66,000,000; (ii) five-year warrants to purchase an aggregate of 14,095,350 shares
of Class A Common Stock, par value $0.001 per share (the &#8220;<b>Common Stock</b>&#8221;) of the Company (the &#8220;<b>Class A Warrant
Shares</b>&#8221;) at an exercise price of $2.50, subject to adjustment (the &#8220;<b>Class A Warrants</b>&#8221;); and (iii) five-year
warrants to purchase an aggregate of 1,942,508 shares of Common Stock (the &#8220;<b>Class B Warrant Shares</b>&#8221; and with the Class
A Warrant Shares, the &#8220;<b>Warrant Shares</b>&#8221;) at an exercise price of $2.50 per share, subject to adjustment (the &#8220;<b>Class
B Warrants</b>&#8221; and together with the Class A Warrants, the &#8220;<b>Warrants</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the SPA, the Company
shall repay sixty-five percent (65%) of the proceeds it may receive, while the Notes remain outstanding, from (i) any financing conducted
and (ii) the sale of any Bitcoin from its mining operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the SPA,
the Company agreed to file a registration statement on Form S-3 to register the Warrant Shares and certain other shares underlying previously
issued warrants to one of the Investors within ten (10) days of the Closing Date. The Warrant Shares will not be exercisable until the
Company shall have obtained approval of the NYSE American, LLC (the &#8220;<b>Exchange</b>&#8221;) for the foregoing issuances (the &#8220;<b>Exchange
Approval</b>&#8221;). Pursuant to the SPA and if required by the Exchange, the Company agreed to file a proxy statement to obtain stockholder
approval for the foregoing issuances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the SPA,
the Company and certain of its subsidiaries (the &#8220;<b>Subsidiaries</b>&#8221;) and Esousa Holdings, LLC, as the collateral agent
on behalf of the Investors (the &#8220;<b>Agent</b>&#8221;) entered into a security agreement (the &#8220;<b>Security Agreement</b>&#8221;),
pursuant to which the Company (i) pledged the equity interests in substantially all of its U.S. based subsidiaries and (ii) granted to
the Investors a security interest in, among other items, substantially all of the Company&#8217;s deposit accounts, securities accounts,
chattel paper, documents, equipment, general intangibles, instruments and inventory, and all proceeds therefrom (the &#8220;<b>Assets</b>&#8221;),
as set forth in the Security Agreement. In addition, pursuant to the Security Agreement, the Subsidiaries granted to the Investors a security
interest in its Assets and, pursuant to a Subsidiary Guaranty (the &#8220;<b>Subsidiary Guaranty</b>&#8221;), jointly and severally agreed
to guarantee and act as surety for the Company&#8217;s obligation to repay the Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Notes are further
secured by a guaranty (the &#8220;<b>A&amp;C Guaranty</b>&#8221;) provided by Ault &amp; Company, Inc. (&#8220;<b>A&amp;C</b>&#8221;),
an affiliate of the Company, as well as by Milton C. Ault, the Company&#8217;s Executive Chairman and the Chief Executive Officer of A&amp;C,
and his spouse.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Description of the Secured Promissory Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Notes have a principal
face amount of approximately $66,000,000 and bear interest at 8% per annum. The maturity date of the Notes is March 31, 2022. The Notes
contain standard and customary events of default including, but not limited to, failure to make payments when due under the Note, failure
to comply with certain covenants contained in the Note, or bankruptcy or insolvency of the Company. The Company may prepay the full outstanding
principal and accrued and unpaid interest at any time without penalty. The purchase price for the Notes was $60 million, of which approximately
$38.2 million was from the exchange of bridge notes sold by the Company in December 2021 in the principal amount of $37.2 million, plus
accrued interest and fees, and the remaining approximately $21.8 million was received by the Company in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Description of the
Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Warrants entitle
the holders to purchase shares of the Company&#8217;s common stock for a period of five years subject to certain beneficial ownership
limitations. The Warrants are exercisable immediately once the Company obtains Exchange Approval. The Warrants may be exercised on a cashless
basis prior to registration of the underlying Common Stock and for cash subsequent to registration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants entitle the Investor to purchase
an aggregate of 16,037,858 Warrant Shares for a period of five years, subject to certain beneficial ownership limitations. The exercise
price of each Warrant is subject to adjustment for customary stock splits, stock dividends, combinations or similar events. In addition,
if the trading price of the Common Stock is less than $2.50 per share 90 days after the Closing Date, the exercise price of the Class
A Warrants will be reduced to 110% of the closing price of the Common Stock on that date, subject to a floor price of $1.00 per share.
Notwithstanding anything therein to the contrary, the Warrants may be exercised via cashless exercise at the option of the Investor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Class A Warrant</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Investors elect to exercise their Class
A Warrants on a cashless basis, they will receive a number of shares of Common Stock (the &#8220;<b>Class A Net Number</b>&#8221;) derived
from the following formula:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence -->-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Class A Net Number = Y (A-B)/A</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">where:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">Y = &#160;&#160;&#160;&#160;&#160;&#160;&#160;the
number of Warrant Shares with respect to which this Warrant is being exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">A = &#160;&#160;&#160;&#160;&#160;&#160;&#160;the
Fair Market Value (as set forth in the Class A Warrant) of the Common Stock, provided, however, that in no event shall the Fair Market
Value used for the purposes of calculating the Class A Net Number be less than $1.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">B = &#160;&#160;&#160;&#160;&#160;&#160;&#160;the
Exercise Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Class B Warrant</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Investors elect to exercise their Class
B Warrants on a cashless basis, they will receive a number of shares of Common Stock (the &#8220;<b>Class B Net Number</b>&#8221;) derived
from the following formula:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Class B Net Number = (A x B)/C</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><br />
For purposes of the foregoing formula:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A= the total number of shares with respect to
which this Warrant is then being exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><br />
B= Black Scholes Value (as set forth in the Class B Warrant).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><br />
C= the Closing Bid Price of the Common Stock as of two (2) Trading Days (as defined in the Class B Warrant) prior to the time of such
exercise, provided, however, that in no event shall the Closing Bid Price used for the purposes of calculating the Class B Net Number
be less than $1.25 per share.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum shares of Common Stock issuable upon
the exercise of the Class B Warrants on a cashless basis is 3,403,212.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the Note, the Class
A Warrants, the Class B Warrants, the SPA, the Security Agreement, the A&amp;C Guaranty and the Subsidiary Guaranty do not purport to
be complete and are qualified in their entirety by reference to their respective forms which are annexed hereto as&#160;<b><span style="text-decoration: underline">Exhibits
4.1, 4.2, 4.3,&#160; 10.1, 10.2</span></b> and <b><span style="text-decoration: underline">10.3</span></b>, respectively, to this Current Report on Form 8-K and are incorporated
herein by reference.&#160;&#160;The foregoing does not purport to be a complete description of the rights and obligations of the parties
thereunder and such descriptions are qualified in their entirety by reference to such exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 2.03</b></td><td style="text-align: justify"><b>Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of
a Registrant</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information contained in Item 1.01 of this Current Report on Form
8-K is incorporated herein by reference to this Item 2.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 3.02</b></td><td><b>Unregistered Sales of Equity Securities</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in Item 1.01 of this
Current Report on Form 8-K is incorporated herein by reference to this Item 3.02. The Notes, the Warrants and the Warrant Shares described
in this Current Report on Form 8-K were offered and sold to the Investors in reliance upon exemption from the registration requirements
under Section 4(a)(2) under the Securities Act of 1933.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 7.01</b></td><td><b>Regulation FD Disclosure </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 31, 2021,
the Company issued a press release announcing the sale of the Notes and Warrants. A copy of the press release is furnished herewith as&#160;<b><span style="text-decoration: underline">Exhibit
99.1</span></b>&#160;and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In accordance with General
Instruction B.2 of Form 8-K, the information under this item shall not be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, except as shall be expressly set forth by specific reference in such a filing. This report will not be deemed an admission
as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Securities and Exchange
Commission encourages registrants to disclose forward-looking information so that investors can better understand the future prospects
of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain these types of statements,
which are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, and which
involve risks, uncertainties and reflect the Registrant&#8217;s judgment as of the date of this Current Report on Form 8-K. Forward-looking
statements may relate to, among other things, operating results and are indicated by words or phrases such as &#8220;expects,&#8221; &#8220;should,&#8221;
&#8220;will,&#8221; and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual
results to differ materially from those anticipated at the date of this Current Report on Form 8-K. Investors are cautioned not to rely
unduly on forward-looking statements when evaluating the information presented within.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-3-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item&#160;9.01</b></td><td><b>Financial Statements and Exhibits</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>(d)</b></td><td><b>Exhibits:</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 101px"><b>Exhibit No.&#160;</b></td>
    <td style="white-space: nowrap; width: 34px">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap"><b>Description</b></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>4.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex4_1.htm">Form of Note</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>4.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex4_2.htm">Form of Class A Warrant</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>4.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex4_3.htm">Form of Class B Warrant</a> </td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>10.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_1.htm">Form of Securities Purchase Agreement</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>10.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_2.htm">Form of Security Agreement</a> </td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>10.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_3.htm">Form of A&amp;C Guaranty</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>10.4</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_4.htm">Form of Subsidiary Guaranty</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>99.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex99_1.htm">Press release issued by the Company on December 31, 2021</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>101</td>
    <td>&#160;</td>
    <td style="text-align: justify">Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;&#160;&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-4-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;<b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>BITNILE HOLDINGS, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 48%">Dated: January 3, 2022</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 22%">/s/ Henry Nisser</td>
    <td style="white-space: nowrap; width: 30%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td colspan="2" style="white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Henry Nisser</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President and General Counsel</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">-5-</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 2px solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>




</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZS03jz6I7LVrEKlJE3AY7SrDNlEn8O5K3NLaIw8AwvPe9J8RA5LQ0NTIc52UBe2zaWnuEEs/IaE8YHNlqnUK4JV6M86yt794fmFFgMDCTOJE6CJ31bhxWKchkKEdDpUBOUzWG2UZEXz0jezYVWm90DdpWsGNq2aDX/OoT9vpJlppXV3VAdoZsCkkse/kNSiYKtnTXD+Krg6LIRDToJhI506391tycpwYWNTahy/Xof6MPCj5JMg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4_1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS NOTE HAS NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BITNILE HOLDINGS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">10% Original
Issuance Discount<BR>
Senior Secured Promissory Note<BR>
due March 31, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 59%; text-align: left; font-size: 10pt; font-weight: bold"><FONT STYLE="font-weight: normal">Note No. 12-29-2021-NoteE1</FONT></TD>
    <TD STYLE="width: 41%; text-align: right; font-size: 10pt; font-weight: bold"><FONT STYLE="font-weight: normal">Face Amount: $66,000,000.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt; font-weight: bold"><FONT STYLE="font-weight: normal">Dated: &nbsp;December 29, 2021 (the &ldquo;</FONT>Issuance Date<FONT STYLE="font-weight: normal">&rdquo;)</FONT></TD>
    <TD STYLE="text-align: right; font-size: 10pt; font-weight: bold"><FONT STYLE="font-weight: normal">Purchase Price: $60,000,000.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For value received, BITNILE
HOLDINGS, INC., a Delaware corporation (the &ldquo;<B>Maker</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;), hereby promises to pay to
the order of _____________ (the &ldquo;<B>Holder</B>&rdquo;), in accordance with the terms hereinafter provided, the principal amount
of Sixty-Six Million Dollars ($66,000,000.00) (the &ldquo;<B>Principal Amount</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All payments under or pursuant
to this 10% Original Issuance Discount Senior Secured Promissory Note (this &ldquo;<B>Note</B>&rdquo;) shall be made in United States
Dollars in immediately available funds to the Holder at the address of the Holder set forth in the Purchase Agreement (as hereinafter
defined) or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer of funds to
the Holder&rsquo;s account, instructions for which are attached hereto as <U>Exhibit A</U>. The Company shall be obligated to make weekly
payments to the Investor as provided herein. The Outstanding Principal balance of this Note shall be due and payable on March 31, 2022
(the &ldquo;<B>Maturity Date</B>&rdquo;) or at such earlier time as provided herein; provided, that the Holder, in its sole discretion,
may extend the Maturity Date to any date after the original Maturity Date. In the event that the Maturity Date shall fall on Saturday
or Sunday, such Maturity Date shall be the next succeeding Business Day. All calculations made pursuant to this Note shall be rounded
down to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
Agreement</U>. This Note has been executed and delivered pursuant to the Securities Purchase Agreement, dated as of December 29, 2021
(as the same may be amended from time to time, the &ldquo;<B>Purchase Agreement</B>&rdquo;), by and between the Maker, the Holder and
the other signatories thereto. Capitalized terms used and not otherwise defined herein shall have the meanings set forth for such terms
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Interest</U>.
This Note shall bear simple interest on the Outstanding Principal Amount at the rate of eight percent (8%) per annum, based on a 365-day
year. Interest shall commence with the date hereof and shall continue on the Outstanding Principal until paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prepayment.</U>
At any time after the Issuance Date, the Maker may repay all (but not less than all) of the Outstanding Principal Amount upon at
least ten (10) days&rsquo; written notice of the Holder (the &ldquo;<B>Prepayment Notice</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delisting from a
Trading Market</U>. If at any time the Class A Common Stock ceases to be listed on a Trading Market, (i) the Holder may deliver a demand
for payment to the Company and, if such a demand is delivered, the Company shall, within three (3) Business Days following receipt of
the demand for payment from the Holder, pay all of the Outstanding Principal Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
on Non-Business Days</U>. Whenever any payment to be made shall be due on a day which is not a Business Day, such payment may be due on
the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer</U>.
This Note may be transferred or sold, subject to the provisions of Section 4.9 of this Note, or pledged, hypothecated or otherwise granted
as security by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement</U>.
Upon receipt of a duly executed and notarized written statement from the Holder with respect to the loss, theft or destruction of this
Note (or any replacement hereof), or, in the case of a mutilation of this Note, upon surrender and cancellation of such Note, the Maker
shall issue a new Note, of like tenor and amount, in lieu of such lost, stolen, destroyed or mutilated Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Use
of Proceeds</U>. The Maker shall use the proceeds of this Note as set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Status
of Note and Security Interest</U>. The Maker shall not, and shall not permit any of its Subsidiaries to incur, Indebtedness other than
Permitted Indebtedness without the prior written consent of the Holder. Upon any Liquidation Event (as hereinafter defined), the Holder
will be entitled to receive, before any distribution or payment is made upon, or set apart with respect to, any Indebtedness of the Maker,
any Subsidiary or any class of capital stock of the Maker or such Subsidiary, an amount equal to the Outstanding Principal Amount plus
all accrued interest thereon (if any), provided, that the Holder shall be treated on a <I>pari passu</I> basis with any other signatories
to the Purchase Agreement. For purposes of this Note, &ldquo;<B>Liquidation Event</B>&rdquo; means a liquidation pursuant to a filing
of a petition for bankruptcy under applicable law or any other insolvency or debtor&rsquo;s relief, an assignment for the benefit of creditors,
or a voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Maker or any Subsidiary thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Secured
Note</U>. The full amount of this Note is secured by the Collateral (as defined in the respective Security Documents) identified and described
as security therefor in the Security Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">1.11.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
payments by the Maker to the Holder hereunder will be made free and clear of and without deduction for any and all present or future taxes
in respect of such payments and any deemed payments under applicable laws in respect of this Note. If any taxes are required by law to
be deducted by the Maker from or in respect of any amounts payable to the Holder hereunder (i) the sum payable by the Maker will be increased
as necessary so that, after making all required deductions for such Taxes (including deductions applicable to additional sums payable
under this Section 1.11), the Holder will receive an amount equal to the sum it would have received if such deduction had not been made;
(ii) the Maker will make such deductions; and (iii) the Maker will pay the full amount deducted to the relevant taxing authority in accordance
with applicable law and if the Holder so requires, the Maker will promptly furnish to the Holder such written proof of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">1.11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Maker
fails to pay any Taxes when due to the appropriate taxing authority or fails to increase the sum payable as prescribed in Section 1.11.1,
the Maker will indemnify the Holder for any incremental taxes, interest or penalties that may become payable by the Holder as a result
of any such failure. This Section 1.11 shall survive the termination of this Note and the payment of the Principal Amount and all other
obligations payable herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Events
of Default</U>. An &ldquo;<B><U>Event of Default</U></B>&rdquo; under this Note shall mean the occurrence of any of the events defined
in the Purchase Agreement, and any of the additional events described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
default in the payment of (i) the Principal Amount hereunder when due; or (ii)&nbsp;liquidated damages in respect of this Note as and
when the same shall become due and payable (whether on the Maturity Date or by acceleration or otherwise) and any such default is not
remedied within three (3) Business Days from the Event of Default occurring by the Company&rsquo;s failure to comply with this Section
2.1(a);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker or any Subsidiary shall fail to observe or perform any other covenant, condition or agreement contained in this Note or any Transaction
Document unless cured, if subject to cure, within ten (10) Business Days from the Event of Default, <U>provided</U>, <U>however</U>, that
it shall not be an Event of Default hereunder if the Company fails to comply with the registration rights provisions contained in Sections
9.1(a) or 9.1(c) of the Purchase Agreement; and <U>provided</U>, <U>further</U>, that the nothing in this Section 2.1(b) shall prohibit,
restrict or otherwise limit the Investor&rsquo;s rights, and the Company&rsquo;s obligations, with regard to the Effectiveness Penalty
pursuant to Section 9.1(c) of the Purchase Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;default
shall be made in the performance or observance of any material covenant, condition or agreement contained in the Purchase Agreement or
any other Transaction Document that is not covered by any other provisions of this <U>Section 2.1</U> unless cured, if subject to cure,
within ten (10) Business Days from the Event of Default, <U>provided</U>, <U>however</U>, that it shall not be an Event of Default hereunder
if the Company fails to comply with the registration rights provisions contained in Sections 9.1(a) or 9.1(c) of the Purchase Agreement;
and <U>provided</U>, <U>further</U>, that the nothing in this Section 2.1(c) shall prohibit, restrict or otherwise limit the Investor&rsquo;s
rights, and the Company&rsquo;s obligations, with regard to the Effectiveness Penalty pursuant to Section 9.1(c) of the Purchase Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
representation or warranty made by the Maker or any of its Subsidiaries herein or in the Purchase Agreement, the Warrant or any other
Transaction Document shall prove to have been false or incorrect or breached in a material respect on the date as of which made unless
cured, if subject to cure, within ten (10) Business Days from the Event of Default;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unless
otherwise approved in writing in advance by the Holder, the Maker shall announce an intention to pursue or consummate a Change of Control
pursuant to that definition contained in the Purchase Agreement, or the Maker shall enter into any agreement, understanding or arrangement
with respect to any Change of Control;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker or any of its Subsidiaries shall (A) default in any payment of any amount or amounts of principal of or interest (if any) on any
Indebtedness (other than the Indebtedness hereunder), the aggregate principal amount of which Indebtedness is in excess of $100,000 that
will permit the holder or holders of such Indebtedness to become due prior to its stated maturity or (B) default in the observance or
performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument or agreement evidencing,
securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition
is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such Indebtedness to cause with the giving of notice
if required, such Indebtedness to become due prior to its stated maturity and any such default is not remedied within ten (10) Business
Days from the Event of Default occurring by the Company&rsquo;s failure to comply with this Section 2.1(i);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker or any of its Subsidiaries shall: (i) apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian,
trustee or liquidator of itself or of all or a substantial part of its property or assets; (ii) make a general assignment for the benefit
of its creditors; (iii) commence a voluntary case under the United States Bankruptcy Code (as now or hereafter in effect) or under the
comparable laws of any jurisdiction (foreign or domestic); (iv) file a petition seeking to take advantage of any bankruptcy, insolvency,
moratorium, reorganization or other similar law affecting the enforcement of creditors&rsquo; rights generally; (v) acquiesce in writing
to any petition filed against it in an involuntary case under the United States Bankruptcy Code (as now or hereafter in effect) or under
the comparable laws of any jurisdiction (foreign or domestic); (vi) issue a notice of bankruptcy or winding down of its operations or
issue a press release regarding same; or (vii)&nbsp;take any action under the laws of any jurisdiction (foreign or domestic) analogous
to any of the foregoing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
proceeding or case shall be commenced in respect of the Maker or any of its Subsidiaries, without its application or consent, in any court
of competent jurisdiction, seeking: (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or readjustment
of its debts; (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial part of
its assets in connection with the liquidation or dissolution of the Maker or any of its Subsidiaries; or (iii) similar relief in respect
of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii) shall continue
undismissed, or unstayed and in effect, for a period of forty-five (45) days or any order for relief shall be entered in an involuntary
case under the United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign
or domestic) against the Maker or any of its Subsidiaries or action under the laws of any jurisdiction (foreign or domestic) analogous
to any of the foregoing shall be taken with respect to the Maker or any of its Subsidiaries and shall continue undismissed, or unstayed
and in effect for a period of forty-five (45) days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;one
or more final judgments or orders for the payment of money aggregating in excess of $200,000 (or its equivalent in the relevant currency
of payment) are rendered against one or more of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
failure of the Maker to instruct its transfer agent to remove any legends from the Warrant Shares and issue such unlegended certificates
to the Holder within three (3) Trading Days of the Holder&rsquo;s request so long as the Holder has provided confirmation, such as through
a valid Seller&rsquo;s Representation Letter, to the Maker that such Warrant Shares can be sold pursuant to Rule 144 or any other applicable
exemption;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker&rsquo;s Class A Common Stock are no longer publicly traded or cease to be listed on the Trading Market or, after the six month anniversary
of the Issuance Date, any Warrant Shares may not be immediately resold under Rule 144 without restriction on the number of shares to be
sold or manner of sale, unless such Warrant Shares have been registered for resale under the 1933 Act and may be sold without restriction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company ceases to be a &ldquo;reporting issuer&rdquo; under the Exchange Act, or applies to do so, in either case without the prior written
consent of the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall be any SEC or judicial stop trade order or trading suspension stop-order or management cease trade order or any restriction (collectively,
a &ldquo;<B>Restriction</B>&rdquo;) in place with the transfer agent for the Class A Common Stock restricting the trading of such Class
A Common Stock and such Restriction shall not have been lifted within ten (10) Business Days of its imposition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Class A Common Stock are no longer tradeable through the Depository Trust Company Fast Automated Securities Transfer program;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company&rsquo;s Market Capitalization is below $75 million for ten (10) consecutive days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
occurrence of a Material Adverse Effect in respect of the Maker, or the Maker and its Subsidiaries taken as a whole and any such occurrence
is not remedied within ten (10) Business Days from the Event of Default occurring by the Company&rsquo;s failure to comply with this Section
2.1(p);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
the extent required, the Company fails to obtain Shareholder Approval prior to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company fails to cause the Warrant Shares to be approved for listing on the Principal Market prior to any exercise of the Warrants thereof;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Company fails to maintain the listing of the Warrant Shares on the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies
Upon an Event of Default</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence of any Event of Default, interest will be payable on the Note at a rate equal to the greater of: (i) eighteen percent (18%)
per annum; and (ii) the maximum rate permitted by applicable law (&ldquo;<B>Interest Upon Default Amount</B>&rdquo;). Such interest will
accrue from the first date of the Event of Default on the Outstanding Principal Amount, for as long as the Event of Default will not have
been remedied. The Maker must pay this amount of interest on the Outstanding Principal Amount to the Investor on a monthly basis in arrears
on the last day of each calendar month following Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence of any Event of Default, the Maker shall, as promptly as possible but in any event within one (1) Business Day of such
Event of Default, notify the Holder of the occurrence of such Event of Default, describing the event or factual situation giving rise
to the Event of Default and specifying the relevant subsection or subsections of <U>Section 2.1</U> hereof under which such Event of Default
has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence and during the continuance of an Event of Default<U>,</U> the Holder may at any time at its option (1) declare that the
Interest Upon Default Amount has become applicable, without presentment, demand, protest or notice, all of which are hereby expressly
unconditionally and irrevocably waived by the Maker and (2) exercise all other rights and remedies available to it under the Transaction
Documents; <I>provided, however</I>, that upon the occurrence of an Event of Default described above, the Holder, in its sole and absolute
discretion, may exercise or otherwise enforce any one or more of the Holder&rsquo;s rights, powers, privileges, remedies and interests
under this Note, the Purchase Agreement, the other Transaction Documents or applicable law. No course of delay on the part of the Holder
shall operate as a waiver thereof or otherwise prejudice the rights of the Holder. No remedy conferred hereby shall be exclusive of any
other remedy referred to herein or now or hereafter available at law, in equity, by statute or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants</U>.
For so long as any Note is outstanding, without the prior written consent of the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Transaction Documents</U>. The Maker shall, and shall cause its Subsidiaries to, comply with its obligations under this Note and
the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Taxes, Etc</U>. The Maker shall, and shall cause each of its Subsidiaries to, promptly pay and discharge, or cause to be paid and discharged,
when due and payable, all lawful taxes, assessments and governmental charges or levies imposed upon the income, profits, property or business
of the Maker and the Subsidiaries, except for such failures to pay that, individually or in the aggregate, have not had and would not
reasonably be expected to have a Material Adverse Effect; provided, however, that any such tax, assessment, charge or levy need not be
paid if the validity thereof shall currently be contested in good faith by appropriate proceedings and if the Maker or such Subsidiaries
shall have set aside on its books adequate reserves with respect thereto, and provided, further, that the Maker and such Subsidiaries
will pay all such taxes, assessments, charges or levies forthwith upon the commencement of proceedings to foreclose any lien which may
have attached as security therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate
Existence</U>. The Maker shall, and shall cause each of its Subsidiaries to, maintain in full force and effect its corporate existence,
rights and franchises and all licenses and other rights to use property owned or possessed by it and reasonably deemed to be necessary
to the conduct of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Company Act</U>. The Maker shall conduct its businesses in a manner so that it will not become subject to, or required to be registered
under, the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale
of Collateral; Liens</U>. From the date hereof until the full release of the security interest in the Collateral, (i) the Maker and its
Subsidiaries shall not sell, lease, transfer or otherwise dispose of any of the Collateral, or attempt or contract to do so, other than
sales of inventory in the ordinary course of business consistent with past practices; and (ii) the Maker and its Subsidiaries shall not,
directly or indirectly, create, permit or suffer to exist, and shall defend the Collateral against and take such other action as is necessary
to remove, any lien, security interest or other encumbrance on the Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Repayment
of This Note</U>. The Company shall make weekly payments to the Investors on a <I>pari passu</I> basis equal to the gross proceeds generated
from the Sale or Issuance of Bitcoin, as provided in Section 3.1(g) below. Other than as set forth on <U>Schedule 5.7</U> of the Purchase
Agreement, neither the Company nor any Subsidiary has any outstanding Indebtedness (all such Indebtedness set forth on Schedule 5.7 of
the Purchase Agreement is hereinafter referred to as the &ldquo;Existing Debt&rdquo; and is collectively referred to herein as the &ldquo;Permitted
Indebtedness&rdquo;). The Company shall not make any voluntary cash prepayments on any Indebtedness at any time while any amounts are
owing under the Note other than with respect to the Existing Debt or cash payments the Company is required to make pursuant to the express
terms thereof existing on the date hereof. Neither the Company nor any Subsidiary shall incur any Indebtedness without the express written
consent of the Investor. If the Company or any Subsidiary issues any Indebtedness other than the Permitted Indebtedness, after obtaining
the written consent of the Investor pursuant to Section 1.9 of this Note, including any subordinated Indebtedness or convertible Indebtedness,
other than Exempted Securities, then unless otherwise waived in writing by and at the discretion of the Investor, the Company will immediately
utilize no less than sixty-five percent (65%) of the proceeds of such issuance (or cause such Subsidiary to immediately utilize the proceeds
of such issuance) to repay the Note. If the Company issues any Equity Interests, other than Exempted Securities, or mines or sells any
Bitcoin, unless otherwise waived in writing by and at the discretion of the Investor, the Company will direct sixty-five percent (65%)
of the proceeds from such issuance or sale of Bitcoin to repay the Note on a <I>pari passu</I> basis. Additionally, in the event that
an Investor exercises some or all of its Warrants for cash (&ldquo;<B>Exercise Proceeds</B>&rdquo;), then the Company shall direct all
such Exercise Proceeds to the repayment of the Note. Any such repayments of the Note as provided herein shall be made to the Investors
on a <I>pro rata</I> basis in proportion to their investment and shall be without premium or penalty to the Company. Moreover, each Investor
may, in its sole discretion and acting solely on behalf of itself, require that the Company apply some or all amounts owing under the
Note to the payment of any cash exercises of the Warrants by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale
or Issuance of Bitcoin</U>. The Company shall be obligated to sell or issue no less than sixty-five percent (65%) of the Bitcoin it mines.
The gross proceeds from the Sale or Issuance of Bitcoin shall be used by the Company to repay the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Set-Off</U>.
This Note shall be subject to the set-off provisions set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via email
at the email address specified in this Section prior to 5:00 p.m. (New York time) on a Business Day, (b) the next Business Day after the
date of transmission, if such notice or communication is delivered via email at the email address specified in this Section on a day that
is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New York time) on such date, (c)
the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. The addresses for notice shall be as set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, without reference to
principles of conflict of laws or choice of laws. This Note shall not be interpreted or construed with any presumption against the party
causing this Note to be drafted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
Article and section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a
part of this Note for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Note shall be cumulative and in
addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific performance
and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to
such remedy and nothing herein shall limit the Holder&rsquo;s right to pursue actual damages for any failure by the Maker to comply with
the terms of this Note. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation
thereof) shall be the amounts to be received by the holder thereof and shall not, except as expressly provided herein, be subject to any
other obligation of the Maker (or the performance thereof). The Maker acknowledges that a breach by it of its obligations hereunder will
cause irreparable and material harm to the Holder and that the remedy at law for any such breach would be inadequate. Therefore, the Maker
agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available rights
and remedies, at law or in equity, to equitable relief, including but not limited to an injunction restraining any such breach or threatened
breach, without the necessity of showing economic loss and without any bond or other security being required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Enforcement
Expenses</U>. The Maker agrees to pay all costs and expenses of enforcement of this Note, including, without limitation, reasonable attorneys&rsquo;
fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Binding
Effect</U>. The obligations of the Maker and the Holder set forth herein shall be binding upon the successors and assigns of each such
party, whether or not such successors or assigns are permitted by the terms herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments;
Waivers</U>. No provision of this Note may be waived or amended except in a written instrument signed by the Company and the Holder. No
waiver of any default with respect to any provision, condition or requirement of this Note shall be deemed to be a continuing waiver in
the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Securities Laws</U>. The Holder of this Note acknowledges that this Note is being acquired solely for the Holder&rsquo;s own account
and not as a nominee for any other party, and for investment, and that the Holder shall not offer, sell or otherwise dispose of this Note
in violation of securities laws. This Note and any note issued in substitution or replacement therefor shall be stamped or imprinted with
a legend in substantially the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&ldquo;THIS NOTE HAS NOT BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Jurisdiction;
Venue</U>. Any action, proceeding or claim arising out of, or relating in any way to this Agreement shall be brought and enforced in the
New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York. The Company
and the Holder irrevocably submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive any objection
to such exclusive jurisdiction or that such courts represent an inconvenient forum. The prevailing party in any such action shall be entitled
to recover its reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses relating to such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Parties
in Interest</U>. This Note shall be binding upon, inure to the benefit of and be enforceable by the Maker, the Holder and their respective
successors and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Failure
or Indulgence Not Waiver</U>. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Maker
Waivers</U>. Except as otherwise specifically provided herein, the Maker and all others that may become liable for all or any part of
the obligations evidenced by this Note hereby waive presentment, demand, notice of nonpayment, protest and all other demands and notices
in connection with the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals
of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such persons
and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting
the liability of the other persons, firms or Maker liable for the payment of this Note, AND DO HEREBY WAIVE TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto, shall operate
as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights on any one
occasion be deemed a waiver of the same right or rights on any future occasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE
MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE
LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS
MAY DESIRE TO USE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
Capitalized terms used herein and not defined shall have the meanings set forth in the Purchase Agreement. For the purposes hereof, the
following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;<U>Indebtedness</U>&rdquo; means: (a) all obligations for borrowed money; (b) all obligations evidenced by bonds, debentures, notes,
or other similar instruments and all reimbursement or other obligations in respect of letters of credit, bankers acceptances, current
swap agreements, interest rate hedging agreements, interest rate swaps, or other financial products; (c) all capital lease obligations
that exceed $150,000 in the aggregate in any fiscal year; (d) all obligations or liabilities secured by a lien or encumbrance on any asset
of the Maker or any Subsidiary, irrespective of whether such obligation or liability is assumed; (e) all obligations for the deferred
purchase price of assets, together with trade debt and other accounts payable that exceed $150,000 in the aggregate in any fiscal year;
(f) all synthetic leases; and (g) any obligation guaranteeing or intended to guarantee (whether directly or indirectly guaranteed, endorsed,
co-made, discounted or sold with recourse) any of the foregoing obligations of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Market
Capitalization</U>&rdquo; means, as of any date of determination, the product of (a) the number of issued and outstanding Common Shares
as of such date (exclusive of any Common Shares issuable upon the exercise of options or warrants or conversion of any convertible securities),
multiplied by (b) the closing price of the Common Shares on the Trading Market on the date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Outstanding
Principal Amount</U>&rdquo; means, at the time of determination, the Principal Amount outstanding after giving effect to any conversions
or prepayments pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Pages Follow]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Maker has caused
this Note to be duly executed by its duly authorized officer as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-weight: bold">BITNILE HOLDINGS, INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>William B. Horne</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: center"><B>EXHIBIT A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: center"><B>WIRE INSTRUCTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 5%">Name of Bank: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 95%">[Name]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify">[Address]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">Routing #:</TD>
    <TD STYLE="white-space: nowrap">[###]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">For credit to:</TD>
    <TD STYLE="white-space: nowrap">[Name]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">Account #:</TD>
    <TD STYLE="white-space: nowrap">[###]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4_2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BITNILE HOLDINGS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Class A Warrant To Purchase Shares
Of Class A Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant No.:&nbsp;&nbsp;&nbsp;&nbsp;12-29-2021-CLASS A WARRANT<BR>
Date of Issuance: December 29, 2021 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BitNile Holdings, Inc., a
Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, ________________, the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;),
is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Class A Warrant to Purchase Class A Common Stock (including any Warrants to Purchase Class A Common Stock issued
in exchange, transfer or replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Issuance Date, but
not after 11:59 p.m., New York time, on the Expiration Date (as defined below), _______ (subject to adjustment as provided herein), fully
paid and non-assessable shares of Class A Common Stock (as defined below) (the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise
defined herein, capitalized terms in this Warrant shall have the meanings set forth in that certain Securities Purchase Agreement, dated
as of December 29, 2021, by and among the Company, the Holder and the other signatories thereto, relating to the offer and sale of the
Note and Warrants (the &ldquo;<B>Purchase Agreement</B>&rdquo;) and in particular that for purposes of this Warrant, &ldquo;<B>Exchange
Approval</B>&rdquo; shall mean approval of the issuance of Common Stock contemplated by this Agreement by the NYSE American, which approval
shall be obtained as promptly as practicable after the Issuance Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)),
this Warrant may, subject to the Company&rsquo;s receipt of Exchange Approval, which date is referred to herein as the &ldquo;<B>Effective
Date</B>,&rdquo; be exercised by the Holder on any day on or after the Issuance Date in whole or in part, by delivery (whether via facsimile
or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;),
of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid,
the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied
by the number of Warrant Shares as to which this Warrant was so exercised (in respect of such specific exercise, the &ldquo;<B>Aggregate
Exercise Price</B>&rdquo;) in cash or via wire transfer of immediately available funds. The Holder shall not be required to deliver the
original of this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than
all of the Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate and issuance of a new
Warrant certificate evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice
for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate after
delivery of the Warrant Shares in accordance with the terms hereof. On or before the first (1<SUP>st</SUP>) Trading Day following the
date on which the Company has received an Exercise Notice, the Company shall transmit by facsimile an acknowledgment of confirmation of
receipt of such Exercise Notice, in the form attached hereto as <B><U>Exhibit B</U></B>, to the Holder and the Company&rsquo;s transfer
agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). On or before the second (2<SUP>nd</SUP>) Trading Day following the date on which the
Company has received such Exercise Notice, the Company shall credit such aggregate number of shares of Common Stock to which the Holder
is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
(&ldquo;<B>DTC</B>&rdquo;) through its Deposit/ Withdrawal at Custodian system. Upon delivery of an Exercise Notice, the Holder shall
be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has
been exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account. If this Warrant is submitted
in connection with any exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for
exercise is greater than the number of Warrant Shares being acquired upon an exercise, then, at the request of the Holder and upon surrender
hereof by the Holder at the principal office of the Company, the Company shall as soon as practicable and in no event later than three
(3) Business Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance
with Section 7(d)) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under
this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional shares of Common Stock
are to be issued upon the exercise of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to
the nearest whole number. The Company shall pay any and all taxes and fees which may be payable with respect to the issuance and delivery
of Warrant Shares upon exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any provision
contained herein to the contrary, the Holder may, in its sole discretion and acting solely on behalf of itself, require that the Company
apply some or all amounts owing under the Note to the payment of any cash exercises of the Warrants by the Holder (&ldquo;<B>Note Exercise</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whensoever mentioned in this
Warrant, the term &ldquo;exercise&rdquo; shall be deemed to mean &ldquo;exercise or exchange&rdquo; unless any such interpretation would
result in manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $2.50, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. To the extent permitted by law, the Company&rsquo;s obligations to issue and deliver the shares
of Common Stock upon exercise of the Warrant in accordance with the terms hereof are absolute and unconditional, irrespective of any action
or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach
or alleged breach by the Holder or any other person of any obligation to the Company or any violation or alleged violation of law by the
Holder or any other person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the
Holder in connection with the issuance of the shares of Common Stock. Nothing herein shall limit the Holder&rsquo;s right to pursue any
other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief with respect to the Company&rsquo;s failure to timely deliver the shares of Common Stock issuable upon exercise of this Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless
Exercise.</U> The aggregate Exercise Price for the number of Warrant Shares being purchased may also, in the sole discretion of the Holder,
be paid in full or in part on a &ldquo;cashless basis&rdquo; at the election of the Holder in the form of Warrant Shares withheld by the
Company from the Warrant Shares otherwise to be received upon exercise of this Warrant having an aggregate Fair Market Value on the date
of exercise equal to the aggregate Exercise Price of the Warrant Shares being purchased by the Holder; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this Warrant, the term &ldquo;<B>Fair
Market Value</B>&rdquo; means with respect to a particular date, the average closing price of the Common Stock for the five (5) trading
days immediately preceding the applicable exercise herein as officially reported by the Principal Market on which the Common Stock is
then listed or admitted to trading, or, if the Common Stock is not listed or admitted to trading on any securities exchange as determined
in good faith by resolution of the Board of Directors of the Company, based on the best information available to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of illustration of a cashless exercise
of this Warrant under Section 1(d), the calculation of such exercise shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">X = Y (A-B)/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">X = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of Warrant Shares to be issued to the Holder (rounded to the nearest whole share) (the &ldquo;<B>Net Number</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">Y = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of Warrant Shares with respect to which this Warrant is being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">A = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Fair Market Value of the Common Stock, provided, however, that in no event shall the Fair Market Value used for the purposes of calculating
the Net Number be less than $1.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">B = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of Rule 144, it is intended, understood,
and acknowledged that the Warrant Shares issuable upon exercise of this Warrant in a cashless exercise transaction as described in Section
1(d) above shall be deemed to have been acquired at the time this Warrant was issued. Moreover, it is intended, understood, and acknowledged
that the holding period for the Warrant Shares issuable upon exercise of this Warrant in a cashless exercise transaction as described
in Section 1(d) above shall be deemed to have commenced on the date this Warrant was issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to
be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed,
provided that following such issuance to Holder such dispute shall be resolved in accordance with Section 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations
on Exercises and Exchanges</U>. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable
or exchangeable by the Holder hereof to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially
own in excess of 9.99% of the number of shares of Common Stock outstanding after giving effect to the issuance of shares of Common Stock
issuable upon exercise of the Warrants calculated in accordance with Section 13(d) of the Exchange Act (the &ldquo;<B>Maximum Percentage</B>&rdquo;).
To the extent the above limitation applies, the determination of whether this Warrant shall be exercisable or exchangeable (vis-&agrave;-vis
other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and of which such securities shall
be exercisable or exchangeable (as among all such securities owned by the Holder) shall, subject to such Maximum Percentage limitation,
be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior
inability to exercise or exchange this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability or exchangeability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder.
The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Maximum Percentage beneficial
ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such Maximum
Percentage limitation. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant. The holders of shares
of Common Stock shall be third party beneficiaries of this paragraph and the Company may not waive this paragraph without the consent
of holders of a majority of its shares of Common Stock. For any reason at any time, upon the written or oral request of the Holder, the
Company shall within two (2) Business Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding,
including by virtue of any prior conversion or exercise or exchange of convertible or exercisable or exchangeable securities into shares
of Common Stock, including, without limitation, pursuant to this Warrant or securities issued pursuant to the Purchase Agreement, including
that certain Class B Warrant to Purchase Class A Common Stock, which was issued in conjunction with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reservation
of Shares; Insufficient Authorized Shares</U>. The Company shall initially reserve out of its authorized and unissued shares of Common
Stock a number of shares of Common Stock equal to 100% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s
obligations to issue shares of Common Stock hereunder, and the Company shall at all times keep reserved for issuance under this Warrant
a number of shares of Common Stock equal to 100% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s obligation
to issue shares of Common Stock hereunder. If, notwithstanding the foregoing, and not in limitation thereof, at any time while this Warrant
remains outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation
to reserve for issuance upon exercise or exchange of this Warrant at least a number of shares of Common Stock equal to the number of shares
of Common Stock as shall from time to time be necessary to effect the exercise or exchange this Warrant or the portion of this Warrant
then outstanding (the &ldquo;<B>Required Reserve Amount</B>&rdquo;) (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company
shall immediately take all action necessary to increase the Company&rsquo;s authorized shares of Common Stock to an amount sufficient
to allow the Company to reserve the Required Reserve Amount for this Warrant then outstanding. Without limiting the generality of the
foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than
ninety (90) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its shareholders for the approval
of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each shareholder
with a proxy statement and shall use its reasonable efforts to solicit its shareholders&rsquo; approval of such increase in authorized
shares of Common Stock and to cause its board of directors to recommend to the shareholders that they approve such proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant
are subject to adjustment from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Price
Reset.</U> In the event that the closing price of the Common Stock is less than the Exercise Price on the ninetieth (90<SUP>th</SUP>)
day following the Closing Date (the &ldquo;<B>Reset Date</B>&rdquo;), then the Exercise Price shall be reduced to one hundred and ten
percent (110%) of the closing price of the Common Stock on the Reset Date; provided, however, that any new Exercise Price determined pursuant
to the Price Reset contained this Section 2(a) shall not be below $1.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Dividends and Splits</U>. Without limiting any provision of Section 4, if the Company, at any time on or after the Effective Date, (i)
pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution on any class
of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise)
one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines (by combination, reverse
stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller number of shares, then in
each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock
outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date
for the determination of shareholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or
(iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any event requiring
an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then the calculation of such
Exercise Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 2, the number of Warrant Shares
that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the
aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price
in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculations</U>.
All calculations under this Section 2 shall be made by rounding to the nearest 1/10000<SUP>th</SUP> of cent and the nearest 1/100<SUP>th</SUP>
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Events</U>. In the event that the Company shall take any action to which the provisions hereof are not strictly applicable, or, if applicable,
would not operate to protect the Holder from dilution or if any event occurs of the type contemplated by the provisions of this Section
2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom
stock rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good faith determine and implement
an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder,
provided that no such adjustment pursuant to this Section 2(e) will increase the Exercise Price or decrease the number of Warrant Shares
as otherwise determined pursuant to this Section 2, provided further that if the Holder does not accept such adjustments as appropriately
protecting its interests hereunder against such dilution, then the Company&rsquo;s board of directors and the Holder shall agree, in good
faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose determination
shall be final and binding and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, indebtedness, property or
options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction,
other than a distribution of shares of Common Stock covered by Section 2(a)) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum Percentage) immediately
before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder&rsquo;s
right to participate in any such Distributions would result in the Holder exceeding the Maximum Percentage, then the Holder shall not
be entitled to participate in such Distribution to such extent (or the beneficial ownership of any such shares of Common Stock as a result
of such Distribution to such extent) and such Distribution to such extent shall be held in abeyance for the benefit of the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
Rights</U>. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options,
Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class
of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in any such
Purchase Right would result in the Holder exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes in writing
all of the obligations of the Company under this Warrant and the other Transaction Documents related to this Warrant in accordance with
the provisions of this Section 4(b) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder prior to such Fundamental Transaction, including agreements confirming the obligations of the Successor Entity as set forth
in this paragraph (b) and (c) and elsewhere in this Warrant and an obligation to deliver to the Holder in exchange for this Warrant a
security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including,
without limitation, which is exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of
capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction). Notwithstanding the foregoing,
at the election of the Holder upon exercise of this Warrant following a Fundamental Transaction, the Successor Entity shall deliver to
the Holder, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items still issuable
under Sections 3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of this Warrant prior to
the applicable Fundamental Transaction, such shares of common stock (or its equivalent) of the Successor Entity (including its Parent
Entity), or other securities, cash, assets or other property, which the Holder would have been entitled to receive upon the happening
of the applicable Fundamental Transaction had this Warrant been exercised immediately prior to the applicable Fundamental Transaction;
provided, however, that such amount of reserved shares of Common Stock shall be limited by the Maximum Percentage of shares of Common
Stock as set forth in Section 1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Application</U>.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and shall be applied as if this
Warrant (and any such subsequent warrants issued hereunder) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied however with
respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NON-CIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times
in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder.
Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable
upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this
Warrant, and (iii) shall, so long as this Warrant is outstanding, take all action necessary to reserve and keep available out of its authorized
and unissued shares of Common Stock, solely for the purpose of effecting the exercise of this Warrant, the maximum number of shares of
Common Stock as shall from time to time be necessary to effect the exercise of this Warrant; provided, however, that such amount of reserved
shares of Common Stock shall be limited by the Maximum Percentage of shares of Common Stock as set forth in Section 1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>WARRANT
HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the
Holder with copies of the same notices and other information given to the shareholders of the Company generally, contemporaneously with
the giving thereof to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REISSUANCE
OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer
of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may
request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number
of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing
the right to purchase the number of Warrant Shares not being transferred. If, at the time of the surrender of this Warrant in connection
with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration
statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or
manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of
allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, provide to the Company an opinion of counsel
selected by the Holder and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lost,
Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence),
and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchangeable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall
be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the
Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the
Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued
in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance
date, as indicated on the face of such new Warrant which is the same as the Effective Date, and (iv) shall have the same rights and conditions
as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REGISTRATION
RIGHTS.</U> The Holder has been granted certain registration rights relating to the Warrant Shares, as more fully detailed in Section
9 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 10.2 of the Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant
to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting the generality
of the foregoing, the Company will give written notice to the Holder (i) as soon as practicable upon each adjustment of the Exercise Price
and the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s) and (ii) at
least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or
distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities
or rights to purchase stock, warrants, securities, indebtedness, or other property pro rata to holders of shares of Common Stock or (C)
for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such
information (to the extent it constitutes, or contains, material, non-public information regarding the Company shall be made known to
the public prior to or in conjunction with such notice being provided to the Holder and (iii) at least ten (10) Trading Days prior to
the consummation of any Fundamental Transaction. To the extent that any notice provided hereunder (whether under this Section 8 or otherwise)
constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with
the SEC pursuant to a Current Report on Form 8-K. It is expressly understood and agreed that the time of execution specified by the Holder
in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(e)) may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holder. The Holder shall be entitled, at its option, to the benefit of any amendment of any other similar warrant
issued under the Purchase Agreement. No waiver shall be effective unless it is in writing and signed by an authorized representative of
the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEVERABILITY</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>GOVERNING
LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company
in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder or to enforce a judgment or other court ruling in
favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CONSTRUCTION;
HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any
Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>DISPUTE
RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price or fair market value or the arithmetic calculation
of the Warrant Shares (as the case may be), the Company or the Holder (as the case may be) shall submit the disputed determinations or
arithmetic calculations (as the case may be) via facsimile (i) within two (2) Business Days after receipt of the applicable notice giving
rise to such dispute to the Company or the Holder (as the case may be) or (ii) if no notice gave rise to such dispute, at any time after
the Holder or the Company (as the case may be) learned of the circumstances giving rise to such dispute. If the Holder and the Company
are unable to agree upon such determination or calculation (as the case may be) of the Exercise Price or fair market value or the number
of Warrant Shares (as the case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted
to the Company or the Holder (as the case may be), then the Company shall, within two (2) Business Days submit via facsimile (a) the disputed
arithmetic calculation of the Warrant Shares, the disputed determination of the Exercise Price or fair market value (as the case may be)
to an independent, reputable investment bank selected by the Holder or (b) if acceptable to the Holder, the disputed arithmetic calculation
of the Warrant Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense the investment bank
or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify the Company and the
Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations or calculations (as
the case may be). Such investment bank&rsquo;s or accountant&rsquo;s determination or calculation (as the case may be) shall be binding
upon all parties absent demonstrable error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages
for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly
provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.
The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled,
in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and
without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested
by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Warrant (including,
without limitation, compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby upon
the exercise of this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other costs in respect
thereof, provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the
issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>TRANSFER</U>.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Common
Stock</B>&rdquo; means (i) the Company&rsquo;s Class A common stock, $0.001 par value per share, and (ii) any capital stock into which
such common stock of the Company shall have been changed or any share capital resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Eligible
Market</B>&rdquo; means the Principal Market, New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the
Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Expiration
Date</B>&rdquo; means the date that is December 20, 2026 or, if such date falls on a day other than a Business Day or on which trading
does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Fundamental
Transaction</B>&rdquo; means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving entity) any other Person unless the shareholders of the Company immediately
prior to such consolidation or merger continue to hold more than 50% of the outstanding shares of Voting Stock after such consolidation
or merger, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or
assets to any other Person, or (3) allow any other Person to make a purchase, tender or exchange offer that is accepted by the holders
of more than 50% of the outstanding shares of Voting Stock of the Company (not including any shares of Voting Stock of the Company held
by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or
exchange offer), or (4) consummate a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off or scheme of arrangement) with any other Person whereby such other Person acquires more than
50% of the outstanding shares of Voting Stock of the Company (not including any shares of Voting Stock of the Company held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination), or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo; (as these terms are used for
purposes of Sections 13(d) and 14(d) of the 1934 Act and the rules and regulations promulgated thereunder) is or shall become the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented
by issued and outstanding Voting Stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent
equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Successor
Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Voting
Stock</B>&rdquo; of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof have the
general voting power to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of
such Person (irrespective of whether or not at the time capital stock of any other class or classes shall have or might have voting power
by reason of the happening of any contingency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[signature page follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF, </B>the
Company has caused this Warrant to Purchase Common Stock (Warrant A) to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-weight: bold">BITNILE HOLDINGS, INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>William B. Horne</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXERCISE NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TO BE EXECUTED BY THE REGISTERED HOLDER TO
EXERCISE THIS<BR>
CLASS A WARRANT TO PURCHASE COMMON STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BITNILE HOLDINGS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned holder hereby exercises the right to purchase _________________
of the shares of Common Stock (&ldquo;Warrant Shares&rdquo;) of BitNile Holdings, Inc., a Delaware corporation (the &ldquo;Company&rdquo;),
evidenced by Class A Warrant to Purchase Common Stock No. 12-__-2021 (the &ldquo;Warrant&rdquo;). Capitalized terms used herein and not
otherwise defined shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form of Exercise Price.
The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">a &ldquo;Cash Exercise&rdquo; with respect to ____________
Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">a &ldquo;Note Exercise&rdquo; with respect to ____________
Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">a &ldquo;Cashless Exercise&rdquo; with respect to
________ Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event that the Holder has elected a Cashless Exercise with respect
to some or all of the Warrant Shares, the Holder represents and warrants that __________ shares of Common Stock are to be delivered pursuant
to such Cashless Exercise, as further specified in Annex A to this Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of Exercise Price. In the event that the Holder has elected
a Cash Exercise or Note Exercise with respect to some or all of the Warrant Shares, the Holder shall pay the Aggregate Exercise Price
in the sum of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to the Company in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delivery of Warrant Shares and Net Number of shares of Common
Stock. The Company shall deliver to Holder, or its designee or agent as specified below, shares of Common Stock in respect of the
exercise contemplated hereby. Delivery shall be made to Holder, or for its benefit, to the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: _______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Registered Holder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: 0.5in">(if electronic book entry transfer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">Transaction Code Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: 0.5in">(if electronic book entry transfer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNEX A TO EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CASHLESS EXERCISE EXCHANGE CALCULATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TO BE FILLED IN BY THE REGISTERED HOLDER TO EXCHANGE THE CLASS A WARRANT
TO PURCHASE COMMON STOCK FOR COMMON STOCK IN A CASHLESS EXERCISE PURSUANT TO SECTION 1(d) OF THE WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Capitalized terms used herein and not otherwise defined shall have
the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of illustration of a cashless exercise
of this Warrant under Section 1(d), the calculation of such exercise shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">X = Y (A-B)/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">X = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of Warrant Shares to be issued to the Holder (rounded to the nearest whole share) (the &ldquo;<B>Net Number</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">Y = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of Warrant Shares with respect to which this Warrant is being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">A = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Fair Market Value of the Common Stock, provided, however, that in no event shall the Fair Market Value used for the purposes of calculating
the Net Number be less than $1.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">B = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&nbsp;&nbsp;__________ ___, 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Registered Holder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ACKNOWLEDGMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby
acknowledges this Exercise Notice and hereby directs _______________ to issue the above indicated number of shares of Common
Stock in accordance with the Transfer Agent Instructions dated ______________, 20__, from the Company and acknowledged and agreed to by _____________________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-weight: bold">BITNILE HOLDINGS, INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ex4_3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>BITNILE
Holdings, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Class
B Warrant To Purchase Shares of Class A Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant No.: 12-29-2021 CLASS B WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date of Issuance: December 29, 2021 (&ldquo;<B>Issuance
Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BitNile Holdings, Inc., a
Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, _______________, the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;),
is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Class B Warrant to Purchase Class A Common Stock (including any Warrants to Purchase Common Stock issued in exchange,
transfer or replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Effective Date, but not after
11:59 p.m., New York time, on the Expiration Date (as defined below), _______ (subject to adjustment as provided herein), fully paid and
non-assessable shares of Common Stock (as defined below) (the &ldquo;<B>Warrant Shares</B>&rdquo;). For purposes of this Warrant, &ldquo;<B>Exchange
Approval</B>&rdquo; shall mean approval of the issuance of Common Stock contemplated by this Agreement by the NYSE American, which approval
shall be obtained as promptly as practicable after the Issuance Date. Except as otherwise defined herein, capitalized terms in this Warrant
shall have the meanings set forth in that certain Securities Purchase Agreement, dated as of December 29, 2021, by and among the Company,
the Holder and the other signatories thereto relating to the offer and sale of the Note and Warrants (the &ldquo;<B>Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mechanics
of Exercise. </U>Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)),
this Warrant may, subject to the Company&rsquo;s receipt of Exchange Approval, which date is referred to herein as the &ldquo;<B>Effective
Date</B>,&rdquo; be exercised or exchanged by the Holder on any day on or after the Effective Date in whole or in part, by delivery (whether
via facsimile or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;),
of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid,
the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied
by the number of Warrant Shares as to which this Warrant was so exercised (in respect of such specific exercise, the &ldquo;<B>Aggregate
Exercise Price</B>&rdquo;) in cash or via wire transfer of immediately available funds provided, however, that if the Holder has elected
to exercise all or part of this Warrant on a cashless basis, it shall surrender the Warrant, in whole or in part (as applicable), rather
than deliver a cash payment to the Company. The Holder shall not be required to deliver the original of this Warrant in order to effect
an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Warrant Shares shall have the
same effect as cancellation of the original of this Warrant certificate and issuance of a new Warrant certificate evidencing the right
to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Warrant
Shares shall have the same effect as cancellation of the original of this Warrant certificate after delivery of the Warrant Shares in
accordance with the terms hereof. On or before the first (1<SUP>st</SUP>) Trading Day following the date on which the Company has received
an Exercise Notice, the Company shall transmit by facsimile an acknowledgment of confirmation of receipt of such Exercise Notice, in the
form attached hereto as <B><U>Exhibit B</U></B>, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;).
On or before the first (1<SUP>st</SUP>) Trading Day following the date on which the Company has received such Exercise Notice, the Company
shall credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit/Withdrawal at
Custodian system. Upon delivery of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are
credited to the Holder&rsquo;s DTC account. If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a)
and the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being
acquired upon an exercise, then, at the request of the Holder and upon surrender hereof by the Holder at the principal office of the Company,
the Company shall as soon as practicable and in no event later than three (3) Business Days after any exercise and at its own expense,
issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section 8(d)) representing the right to purchase the
number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect
to which this Warrant is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather
the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all taxes
and fees which may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any provision
contained herein to the contrary, the Holder may, in its sole discretion and acting solely on behalf of itself, require that the Company
apply some or all amounts owing under the Note to the payment of any cash exercises of the Warrants by the Holder (&ldquo;<B>Note Exercise</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whensoever mentioned in this
Warrant, the term &ldquo;exercise&rdquo; shall be deemed to mean &ldquo;exercise or exchange&rdquo; unless any such interpretation would
result in manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price. </U>For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $2.50<B>,</B> subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company&rsquo;s
Failure to Timely Deliver Securities. </U>To the extent permitted by law, the Company&rsquo;s obligations to issue and deliver the shares
of Common Stock upon exercise of the Warrant in accordance with the terms hereof are absolute and unconditional, irrespective of any action
or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach
or alleged breach by the Holder or any other person of any obligation to the Company or any violation or alleged violation of law by the
Holder or any other person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the
Holder in connection with the issuance of the shares of Common Stock. Nothing herein shall limit the Holder&rsquo;s right to pursue any
other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief with respect to the Company&rsquo;s failure to timely deliver the shares of Common Stock issuable upon exercise of this Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless
Exercise.</U> Notwithstanding anything contained herein to the contrary, the Holder may in its sole discretion (and without limiting the
Holder&rsquo;s rights and remedies contained herein), exercise this Warrant in whole or in part and, in lieu of making the cash payment
otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate Exercise Price, elect instead to receive
upon such exercise the &ldquo;<B>Net Number</B>&rdquo; of shares of Common Stock determined according to the following formula (a &ldquo;<B>Cashless
Exercise</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net Number = (A x B)/C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A= the total number of shares with respect to
which this Warrant is then being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
B= Black Scholes Value (as defined in Section 18).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
C= the Closing Bid Price of the Common Stock as of two (2) Trading Days prior to the time of such exercise, provided, however, that in
no event shall the Closing Bid Price used for the purposes of calculating the Net Number be less than $1.25 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><U>In the event that: (i) Closing
Bid Price </U>used for the purposes of calculating the Net Number <U>is below $1.25 per share; or (ii) the Holder is not able to exercise
all or any portion of this Warrant, then, in either case, the Company shall, at the Holder&rsquo;s election, within five (5) calendar
days following receipt of a written notice from the Holder (the &ldquo;Alternate Issuance Notice&rdquo;) be required, with respect to
all or any portion of the Warrant, as applicable, that cannot be exercised, to pay to the Holder an amount of cash equal to the Black
Scholes Value (as defined below) of this entire Warrant, or that portion of this Warrant that is not exercisable pursuant to Section 1(d)
on the date of such Alternate Issuance Notice.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disputes.
</U>In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares
(including, without limitation, the Net Number) to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder
the number of Warrant Shares that are not disputed, provided that following such issuance to Holder such dispute shall be resolved in
accordance with Section 15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations
on Exercises and Exchanges</U>. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable
or exchangeable by the Holder hereof to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially
own in excess of&nbsp;9.99% of the number of shares of Common Stock outstanding after giving effect to the issuance of shares of Common
Stock issuable upon exercise of the Warrants calculated in accordance with Section 13(d) of the Exchange Act (the &ldquo;<B>Maximum Percentage</B>&rdquo;).
To the extent the above limitation applies, the determination of whether this Warrant shall be exercisable or exchangeable (vis-&agrave;-vis
other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and of which such securities shall
be exercisable or exchangeable (as among all such securities owned by the Holder) shall, subject to such Maximum Percentage limitation,
be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior
inability to exercise or exchange this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph&nbsp;with respect to any subsequent determination of exercisability or exchangeability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder.
The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Maximum Percentage beneficial
ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such Maximum
Percentage limitation. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant. The holders of shares
of Common Stock shall be third party beneficiaries of this paragraph and the Company may not waive this paragraph without the consent
of holders of a majority of its shares of Common Stock. For any reason at any time, upon the written or oral request of the Holder, the
Company shall within two (2) Business Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding,
including by virtue of any prior conversion or exercise or exchange of convertible or exercisable or exchangeable securities into shares
of Common Stock, including, without limitation, pursuant to this Warrant or securities issued pursuant to the Purchase Agreement, including
that certain Class A Warrant to Purchase Class A Common Stock, which was issued in conjunction with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reservation
of Shares; Insufficient Authorized Shares. </U>The Company shall initially reserve out of its authorized and unissued shares of Common
Stock a number of shares of Common Stock equal to 200% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s
obligations to issue shares of Common Stock hereunder, and the Company shall at all times keep reserved for issuance under this Warrant
a number of shares of Common Stock equal to 200% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s obligation
to issue shares of Common Stock hereunder. If, notwithstanding the foregoing, and not in limitation thereof, at any time while this Warrant
remains outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation
to reserve for issuance upon exercise or exchange of this Warrant at least a number of shares of Common Stock equal to the number of shares
of Common Stock as shall from time to time be necessary to effect the exercise or exchange this Warrant or the portion of this Warrant
then outstanding (the &ldquo;<B>Required Reserve Amount</B>&rdquo;) (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company
shall immediately take all action necessary to increase the Company&rsquo;s authorized shares of Common Stock to an amount sufficient
to allow the Company to reserve the Required Reserve Amount for this Warrant then outstanding. Without limiting the generality of the
foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than
ninety (90) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its shareholders for the approval
of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each shareholder
with a proxy statement and shall use its reasonable efforts to solicit its shareholders&rsquo; approval of such increase in authorized
shares of Common Stock and to cause its board of directors to recommend to the shareholders that they approve such proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant
are subject to adjustment from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Dividends and Splits. </U>Without limiting any provision of Section 4, if the Company, at any time on or after the Effective Date, (i)
pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution on any class
of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise)
one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines (by combination, reverse
stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller number of shares, then in
each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock
outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date
for the determination of shareholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or
(iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any event requiring
an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then the calculation of such
Exercise Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Number
of Warrant Shares. </U>Simultaneously with any adjustment to the Exercise Price pursuant to this Section 2, the number of Warrant Shares
that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the
aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price
in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculations.
</U>All calculations under this Section 2 shall be made by rounding to the nearest 1/10000<SUP>th</SUP> of cent and the nearest 1/100<SUP>th</SUP>
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Events. </U>In the event that the Company shall take any action to which the provisions hereof are not strictly applicable, or, if applicable,
would not operate to protect the Holder from dilution or if any event occurs of the type contemplated by the provisions of this Section
2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom
stock rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good faith determine and implement
an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder,
provided that no such adjustment pursuant to this Section 2(d) will increase the Exercise Price or decrease the number of Warrant Shares
as otherwise determined pursuant to this Section 2, provided further that if the Holder does not accept such adjustments as appropriately
protecting its interests hereunder against such dilution, then the Company&rsquo;s board of directors and the Holder shall agree, in good
faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose determination
shall be final and binding and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, indebtedness, property or
options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction,
other than a distribution of shares of Common Stock covered by Section 2(a)) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum Percentage) immediately
before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder&rsquo;s
right to participate in any such Distributions would result in the Holder exceeding the Maximum Percentage, then the Holder shall not
be entitled to participate in such Distribution to such extent (or the beneficial ownership of any such shares of Common Stock as a result
of such Distribution to such extent) and such Distribution to such extent shall be held in abeyance for the benefit of the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
Rights. </U>In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options,
Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class
of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in any such
Purchase Right would result in the Holder exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transactions. </U>The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes in writing
all of the obligations of the Company under this Warrant and the other Transaction Documents related to this Warrant in accordance with
the provisions of this Section 4(b) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder prior to such Fundamental Transaction, including agreements confirming the obligations of the Successor Entity as set forth
in this paragraph (b) and (c) and elsewhere in this Warrant and an obligation to deliver to the Holder in exchange for this Warrant a
security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including,
without limitation, which is exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of
capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction). Notwithstanding the foregoing,
at the election of the Holder upon exercise of this Warrant following a Fundamental Transaction, the Successor Entity shall deliver to
the Holder, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items still issuable
under Sections 3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of this Warrant prior to
the applicable Fundamental Transaction, such shares of common stock (or its equivalent) of the Successor Entity (including its Parent
Entity), or other securities, cash, assets or other property, which the Holder would have been entitled to receive upon the happening
of the applicable Fundamental Transaction had this Warrant been exercised immediately prior to the applicable Fundamental Transaction;
provided, however, that such amount of reserved shares of Common Stock shall be limited by the Maximum Percentage of shares of Common
Stock as set forth in Section 1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Application</U>.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and shall be applied as if this
Warrant (and any such subsequent warrants issued hereunder) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied however with
respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>REGISTRATION
RIGHTS</U>. The Holder has been granted certain registration rights relating to the Warrant Shares, as more fully detailed in Section
9 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times
in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder.
Without limiting the generality of the foregoing, the Company (i)&nbsp;shall not increase the par value of any shares of Common Stock
receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii)&nbsp;shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock
upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is outstanding, take all action necessary to reserve and keep
available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of this Warrant,
the maximum number of shares of Common Stock as shall from time to time be necessary to effect the exercise of this Warrant; provided,
however, that such amount of reserved shares of Common Stock shall be limited by the Maximum Percentage of shares of Common Stock as set
forth in Section 1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>WARRANT
HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 7, the Company shall provide the
Holder with copies of the same notices and other information given to the shareholders of the Company generally, contemporaneously with
the giving thereof to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>REISSUANCE
OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer
of Warrant. </U>If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 8(d)), registered as the Holder may
request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number
of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 8(d)) to the Holder representing
the right to purchase the number of Warrant Shares not being transferred. If, at the time of the surrender of this Warrant in connection
with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration
statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or
manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of
allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, provide to the Company an opinion of counsel
selected by the Holder and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lost,
Stolen or Mutilated Warrant. </U>Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence),
and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 8(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchangeable
for Multiple Warrants. </U>This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 8(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall
be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of New Warrants. </U>Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the
Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 8(a) or Section 8(c), the
Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued
in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance
date, as indicated on the face of such new Warrant which is the same as the Effective Date, and (iv) shall have the same rights and conditions
as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>INTENTIONALLY
DELETED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>NOTICES</U>.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Warrant must be in writing
and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); (iii) upon confirmation
of transmission, when sent by email; or (iv) one business day after deposit with an overnight courier service, in each case properly addressed
to the party to receive the same. The addresses and facsimile numbers for such communications shall be (A) if to the Company, at the address
set forth on its signature page attached hereto or (B) if to the Holder, to 211 East 43rd Street, Suite 402, New York, NY 10017 or to
such other address and/or facsimile number and/or to the attention of such other Person as the recipient party has specified by written
notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (x) given by
the recipient of such notice, consent, waiver or other communication, (y) mechanically or electronically generated by the sender&rsquo;s
facsimile machine containing the time, date, recipient facsimile number and an image of the first page of such transmission or (z) provided
by an overnight courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from an overnight courier
service in accordance with clause (i), (ii), (iii) or (iv) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company shall provide the
Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail a description of such
action and the reason therefor. Without limiting the generality of the foregoing, the Company will give written notice to the Holder (i)
as soon as practicable upon each adjustment of the Exercise Price and the number of Warrant Shares, setting forth in reasonable detail,
and certifying, the calculation of such adjustment(s) and (ii) at least fifteen (15) days prior to the date on which the Company closes
its books or takes a record (A) with respect to any dividend or distribution upon the shares of Common Stock, (B) with respect to any
grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants, securities, indebtedness, or
other property pro rata to holders of shares of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction,
dissolution or liquidation, provided in each case that such information (to the extent it constitutes, or contains, material, non-public
information regarding the Company shall be made known to the public prior to or in conjunction with such notice being provided to the
Holder and (iii) at least ten (10) Trading Days prior to the consummation of any Fundamental Transaction. To the extent that any notice
provided hereunder (whether under this Section 10 or otherwise) constitutes, or contains, material, non-public information regarding the
Company, the Company shall simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K. It is expressly understood
and agreed that the time of execution specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(e)) may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative of
the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>SEVERABILITY</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>GOVERNING
LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company
in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder or to enforce a judgment or other court ruling in
favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>CONSTRUCTION;
HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any
Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>DISPUTE
RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price or fair market value or the arithmetic calculation
of the Warrant Shares (as the case may be), the Company or the Holder (as the case may be) shall submit the disputed determinations or
arithmetic calculations (as the case may be) via facsimile (i) within two (2) Business Days after receipt of the applicable notice giving
rise to such dispute to the Company or the Holder (as the case may be) or (ii) if no notice gave rise to such dispute, at any time after
the Holder or the Company (as the case may be) learned of the circumstances giving rise to such dispute. If the Holder and the Company
are unable to agree upon such determination or calculation (as the case may be) of the Exercise Price or fair market value or the number
of Warrant Shares (as the case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted
to the Company or the Holder (as the case may be), then the Company shall, within two (2) Business Days submit via facsimile (a) the disputed
arithmetic calculation of the Warrant Shares, the disputed determination of the Exercise Price or fair market value (as the case may be)
to an independent, reputable investment bank selected by the Holder or (b) if acceptable to the Holder, the disputed arithmetic calculation
of the Warrant Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense the investment bank
or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify the Company and the
Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations or calculations (as
the case may be). Such investment bank&rsquo;s or accountant&rsquo;s determination or calculation (as the case may be) shall be binding
upon all parties absent demonstrable error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages
for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly
provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.
The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled,
in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and
without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested
by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Warrant (including,
without limitation, compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby upon
the exercise of this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other costs in respect
thereof, provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the
issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>TRANSFER</U>.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Black
Scholes Value</B>&rdquo; means the Black Scholes value of an option for one share of Common Stock at the date of the applicable Cashless
Exercise, as such Black Scholes value is determined, calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share equal to the Exercise Price on the Closing Date of $2.50 per share,
(ii) a risk-free interest rate corresponding to the U.S. Treasury rate, (iii) a strike price equal to the Exercise Price in effect at
the time of the applicable Cashless Exercise, (iv) an expected volatility equal to 135%, and (v) a deemed remaining term of the Warrant
of five (5) years (regardless of the actual remaining term of the Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Common
Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s Class A common stock, $0.001 par value per share, and (ii) any capital stock into
which such common stock of the Company shall have been changed or any share capital resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Closing
Bid Price</B>&rdquo; means, for any security as of any date, the last closing bid price and the last closing trade price, respectively,
for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours
basis and does not designate the closing bid price or the closing trade price (as the case may be) then the last bid price of such security
prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or
trading market for such security, the last closing bid price or last trade price, respectively, of such security on the principal securities
exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the average
of the bid prices, or the ask prices, respectively, of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the Closing Bid Price cannot be calculated for a security on a particular date
on any of the foregoing bases, the Closing Bid Price of such security on such date shall be the fair market value as mutually determined
by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such
dispute shall be resolved in accordance with the procedures in Section 15. All such determinations shall be appropriately adjusted for
any stock dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Eligible
Market</B>&rdquo; means the Principal Market, New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the
Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Expiration
Date</B>&rdquo; means five (5) years from the Issuance Date or, if such date falls on a day other than a Business Day or on which trading
does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Fundamental
Transaction</B>&rdquo; means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving entity) any other Person unless the shareholders of the Company immediately
prior to such consolidation or merger continue to hold more than 50% of the outstanding shares of Voting Stock after such consolidation
or merger, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or
assets to any other Person, or (3) allow any other Person to make a purchase, tender or exchange offer that is accepted by the holders
of more than 50% of the outstanding shares of Voting Stock of the Company (not including any shares of Voting Stock of the Company held
by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or
exchange offer), or (4) consummate a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off or scheme of arrangement) with any other Person whereby such other Person acquires more than
50% of the outstanding shares of Voting Stock of the Company (not including any shares of Voting Stock of the Company held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination), or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo; (as these terms are used for
purposes of Sections 13(d) and 14(d) of the 1934 Act and the rules and regulations promulgated thereunder) is or shall become the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented
by issued and outstanding Voting Stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent
equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Successor
Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Voting
Stock</B>&rdquo; of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof have the
general voting power to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of
such Person (irrespective of whether or not at the time capital stock of any other class or classes shall have or might have voting power
by reason of the happening of any contingency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Company has caused this Warrant to Purchase Common Stock (Warrant B) to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BITNILE HOLDINGS, INC.</B>&nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>William B. Horne</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><B>Address</B>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 45%">11411 Southern Highlands Parkway, Suite 240</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Las Vegas, &nbsp;NV 89141</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLASS B WARRANT TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>BITNILE
Holdings, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
exercises the right to purchase _________________ of the shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of BitNile Holdings,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), evidenced by Warrant to Purchase Common Stock No. 12-20-2021 WARRANT
B (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth
in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Form
of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">_________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a &ldquo;<B>Cash Exercise</B>&rdquo;
with respect to ____________ Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">_________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a &ldquo;<B>Note Exercise</B>&rdquo;
with respect to ____________ Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">_________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a &ldquo;<B>Cashless Exercise</B>&rdquo;
with respect to ________ Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Holder has elected a Cashless
Exercise with respect to some or all of the Warrant Shares, the Holder represents and warrants that __________ shares of Common Stock
are to be delivered pursuant to such Cashless Exercise, as further specified in <B><U>Annex A</U></B> to this Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Exercise Price</U>. In the
event that the Holder has elected a Cash Exercise or Note Exercise with respect to some or all of the Warrant Shares, the Holder shall
pay the Aggregate Exercise Price in the sum of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to the Company in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Warrant Shares and Net Number of shares of Common Stock</U>. The Company shall deliver to Holder, or its designee or agent as specified
below, shares of Common Stock in respect of the exercise contemplated hereby. Delivery shall be made to Holder, or for its benefit, to
the following address:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 80%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date:&nbsp;&nbsp;_______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 10%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 90%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">Name of Registered Holder</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 5%; text-align: justify">By:</TD>
    <TD STYLE="white-space: nowrap; width: 20%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 75%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify">Name:</TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify">Title:</TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%">Account Number:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 94%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0; padding-left: 15pt">(if electronic book entry transfer)</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%">Transaction Code Number:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 94%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0; padding-left: 15pt">(if electronic book entry transfer)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>ANNEX A TO EXERCISE NOTICE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CASHLESS EXERCISE EXCHANGE CALCULATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE FILLED IN BY THE REGISTERED HOLDER TO
EXCHANGE THE CLASS B WARRANT TO PURCHASE COMMON STOCK FOR COMMON STOCK IN A CASHLESS EXERCISE PURSUANT TO SECTION 1(d) OF THE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used herein and not otherwise
defined shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net Number = (A x B)/C = shares
of Common Stock For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A= the total number of shares with respect
to which the Warrant is then being exercised </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">B= Black Scholes Value (as defined in
Section 18 of the Warrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">C= the Closing Bid Price of the Common
Stock as of two (2) Trading Days prior to the time of such exercise (as such Closing Bid Price is defined in Section 18 of the Warrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: &nbsp;&nbsp;__________ ___, 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Registered Holder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">By:</TD>
    <TD STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 80%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice (Warrant No. 12-20-2021 Class B Warrant) and hereby directs ______________ to issue the above indicated number of
shares of Common Stock in accordance with the Transfer Agent Instructions dated _________, 20__, from the Company and acknowledged and
agreed to by _______________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-weight: bold">BITNILE HOLDINGS, INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10_1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(as amended, supplemented, restated and/or modified from time to time, this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of December
29, 2021, by and among BitNile Holdings, Inc., a Delaware corporation (and, unless the context requires otherwise, collectively with the
&ldquo;<B>Subsidiaries</B>&rdquo; referred to below, the &ldquo;<B>Company</B>&rdquo;), and each investor indentified on the signature
page hereto (each, including its successors and assigns, the &ldquo;<B>Investor</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BACKGROUND</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board of directors (the &ldquo;<B>Board of Directors</B>&rdquo;) of the Company has authorized the issuance to Investor of the Note (as
defined below) and the Warrants (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Investor desires to purchase the Note (as defined below) and the Warrants (as defined below) on the terms and conditions set forth in
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with the execution of this Agreement, the Company, its Subsidiaries and the Investor will enter into certain security agreements and guarantees,
as listed in Exhibit A (the &ldquo;<B>Security Documents</B>&rdquo;), pursuant to which the Subsidiaries will guarantee all of the Company's
obligations under the Transaction Documents and the Company and its Subsidiaries will grant a first priority security interest in substantially
all of their respective assets to secure the Company&rsquo;s obligations hereunder and the Subsidiaries&rsquo; obligations under any such
guarantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Between
December 15, 2021 and December 28, 2021, the Company and certain investors entered into certain Purchase Agreements (collectively, the
&ldquo;<B>Note Purchase Agreement</B>&rdquo;) providing for, among other things, the offer and sale of those certain 10% Demand Secured
Promissory Notes (collectively, the &ldquo;<B>Bridge Notes</B>&rdquo;) in the aggregate principal face amount of approximately $38,162,000
MILLION DOLLARS (the &ldquo;<B>Bridge Financing</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use the proceeds from the sale of the Note (as defined below) to repay in full the investors in the Bridge Financing, as
more fully detailed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the foregoing recitals and the covenants and agreements set forth herein, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>1.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>DEFINITIONS</U>.
As used in this Agreement, the following terms shall have the following meanings specified or indicated below, and such meanings shall
be equally applicable to the singular and plural forms of such defined terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>1933 Act</B>&rdquo;
means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>1934 Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acquisition</B>&rdquo;
means the acquisition by the Company or any direct or indirect Subsidiary of the Company of a majority of the Equity Interests or substantially
all of the assets and business of any Person, whether by direct purchase of Equity Interests, asset purchase, merger, consolidation or
like combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Agreement</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Blue Sky Application</B>&rdquo;
has the meaning set forth in <U>Section 9.3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Board of Directors</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bridge Financing</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed in New York City.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the Common Stock and any other classes of shares in the capital of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means, with respect to the Company, on or after the date of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">a change in the composition of the Board of Directors of the Company at a single shareholder meeting where
a majority of the individuals that were directors of the Company immediately prior to the start of such shareholder meeting are no longer
directors at the conclusion of such meeting, without the prior written consent of a majority in interest of the Investors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: justify">a change, without the prior written consent of a majority in interest of the Investors, in the composition
of the Board of Directors of the Company prior to the termination of this Agreement where a majority of the individuals that were directors
as of the date of this Agreement cease to be directors of the Company prior to the termination of this Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: justify">other than a shareholder that holds such a position at the date of this Agreement, if a Person comes to
have beneficial ownership, control or direction over more than forty percent (40%) of the voting rights attached to any class of voting
securities of the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(d)</TD><TD STYLE="text-align: justify">the sale or other disposition by the Company or any of its Subsidiaries in a single transaction, or in
a series of transactions, of all or substantially all of their respective assets.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing</B>&rdquo;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Date</B>&rdquo;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Code</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Collateral Agent</B>&rdquo;
means Esousa Holdings LLC as detailed in that certain Security Agreement, executed and delivered on the date hereof and in connection
with the Agreement, by and between the Company and Esousa Holdings LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Class A Warrant</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Class B Warrant</B>&rdquo;
has the meaning set forth in <U>Section 2.1.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Class B Common Stock</B>&rdquo;
means the Class B Common Stock in the capital of the Company, each of which has $0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock</B>&rdquo;
means the Class A Common Stock in the capital of the Company, each of which has $0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Demand 10% Secured
Promissory Note</B>&rdquo; has the meaning set forth in the Note Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Effectiveness Period</B>&rdquo;
has the meaning set forth in <U>Section 9.2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Equity Interests</B>&rdquo;
means and includes capital stock, membership interests and other similar equity securities, and shall also include equity-linked securities
including, but not limited to, warrants or options to purchase capital stock, membership interests or other equity interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Event</B>&rdquo;
means any event, change, development, effect, condition, circumstance, matter, occurrence or state of facts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Event of Default</B>&rdquo;
has the meaning set forth in <U>Section 7.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange Approval</B>&rdquo;
means approval of the Principal Market to authorize the issuance of the Warrant Shares with full conversion and voting rights pursuant
to Rule 713(a)(ii) of the NYSE Company Guide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exempted Securities</B>&rdquo;
means (a) Common Stock or preferred shares or rights, warrants or options to purchase Common Stock or preferred shares issued in connection
with any Acquisition where the Company does not receive cash proceeds therefrom, (b) equity securities issued by reason of a dividend,
stock split, split-up or other distribution on Common Stock, (c)&nbsp;Common Stock or rights, warrants or options to purchase Common Stock
issued to employees or directors of, or consultants or advisors to, the Company or any of its Subsidiaries pursuant to a plan, agreement
or arrangement approved by the Board of Directors (&ldquo;<B>Equity Plans</B>&rdquo;), (d) Common Stock or rights, warrants or options
to purchase Common Stock issued to third parties in connection with strategic partnerships approved by the Board of Directors, (e) Common
Stock actually issued upon the exercise of options or warrants or Common Stock actually issued upon the conversion or exchange of any
securities convertible into Common Stock, in each case provided that such issuance is pursuant to the terms of the applicable option,
warrant or convertible security, or (f) Common Stock issued upon the exercise or conversion of options, warrants or convertible securities
outstanding on the date hereof where the Company does not receive cash proceeds therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Funding Amount</B>&rdquo;
means an amount equal to up to Sixty Million Dollars ($60,000,000).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Entity&rdquo;
</B>means any instrumentality, subdivision, court, administrative agency, department, body, bureau, division, board, committee, panel,
commission, official or other authority of any country, state, province, prefect, municipality, locality or other government or political
subdivision thereof, whether domestic or foreign, or any supranational or multinational organization or authority, or any quasi-governmental,
private body or arbitral body exercising any executive, legislative, judicial, quasi-judicial, regulatory, taxing, importing, administrative
or other governmental or quasi-governmental authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>HSR Act</B>&rdquo;
has the meaning set forth in <U>Section 5.15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indebtedness</B>&rdquo;
shall mean (a) all obligations for borrowed money; (b) all obligations evidenced by bonds, debentures, notes, or other similar instruments
and all reimbursement or other obligations in respect of letters of credit, bankers acceptances, current swap agreements, interest rate
hedging agreements, interest rate swaps, or other financial products; (c) all capital lease obligations that exceed $100,000 in the aggregate
in any fiscal year; (d) all obligations or liabilities secured by a lien or encumbrance on any asset of the Company or any Subsidiary,
irrespective of whether such obligation or liability is assumed; (e) all obligations for the deferred purchase price of assets, together
with trade debt and other accounts payable that exceed $100,000 in the aggregate in any fiscal year; (f) all synthetic leases; and (g)
any obligation guaranteeing or intended to guarantee (whether directly or indirectly guaranteed, endorsed, co-made, discounted or sold
with recourse) any of the foregoing obligations of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Group</B>&rdquo;
shall mean the Investor plus any other Person with which the Investor is considered to be part of a group under Section 13 of the 1934
Act or with which the Investor otherwise files reports under Sections 13 and/or 16 of the 1934 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Party</B>&rdquo;
has the meaning set forth in <U>Section 5.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Warrant
Shares</B>&rdquo; means the Warrant Shares plus all shares of Common Stock that are issuable to the Investor upon exercise of warrants
previously issued by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IP Rights</B>&rdquo;
has the meaning set forth in <U>Section 3.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Law</B>&rdquo; means
any law, rule, regulation, order, judgment or decree, including, without limitation, any federal, and state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Legend Removal Date&rdquo;</B>
has the meaning set forth in <U>Section 5.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Losses</B>&rdquo;
has the meaning set forth in <U>Section 5.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Adverse
Effect</B>&rdquo; means any material adverse effect on (i) the businesses, properties, assets, prospects, operations, results of operations
or financial condition of the Company, or the Company and the Subsidiaries, taken as a whole, or (ii) the ability of the Company to consummate
the transactions contemplated by this Agreement or to perform its obligations hereunder or under the Note or the Warrant; <I>provided,
however</I>, that none of the following shall be deemed either alone or in combination to constitute, and none of the following shall
be taken into account in determining whether there has been or would be, a Material Adverse Effect: (a)&nbsp;any adverse effect resulting
from or arising out of general economic or financial or capital markets or political conditions in the United States or in any other jurisdiction
in which the Company has operations or conducts business to the extent, and only to the extent, the effects do not disproportionately
affect the Company as compared to other participants in the industries in which the Company operates; (b) any adverse effect resulting
from or arising out of general conditions in the industries in which the Company and the Subsidiaries operate; (c) any adverse effect
resulting from any changes to applicable Law; or (d)&nbsp;any adverse effect resulting from or arising out of any natural disaster or
any acts of terrorism, sabotage, military action or war or any escalation or worsening thereof; <I>provided</I>, <I>further</I>, that
any event, occurrence, fact, condition or change referred to in clauses (a) through (d) immediately above shall be taken into account
in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event,
occurrence, fact, condition or change has a disproportionate effect on the Company and/or the Subsidiaries compared to other participants
in the industries in which the Company and the Subsidiaries operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Maximum Percentage</B>&rdquo;
means 9.99% of any class of Equity Interests in the Company that is registered under the 1934 Act (excluding any Equity Interests deemed
beneficially owned by virtue of the Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Money Laundering
Laws</B>&rdquo; has the meaning set forth in <U>Section 3.25</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>New Securities</B>&rdquo;
means, collectively, equity securities of the Company, whether or not currently authorized, as well as rights, options, or warrants to
purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable
for such equity securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Note</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Obligor</B>&rdquo;
means the Company and each of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>OFAC</B>&rdquo;
has the meaning set forth in <U>Section 3.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offer Notice</B>&rdquo;
has the meaning set forth in <U>Section 10.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted Indebtedness</B>&rdquo;
shall have the meaning set forth in <U>Section 5.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prepayment Right</B>&rdquo;
shall have the meaning set forth in <U>Section 2.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Principal Amount</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Principal Market</B>&rdquo;
means the NYSE American, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceedings</B>&rdquo;
has the meaning set forth in <U>Section 3.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prohibited Transaction</B>&rdquo;
means a transaction with a third party or third parties in which the Company issues or sells (or arranges or agrees to issue or sell):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
debt, equity or equity-linked securities (including options or warrants) that are convertible into, exchangeable or exercisable for, or
include the right to receive shares of the Company&rsquo;s Capital Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
a conversion, repayment, exercise or exchange rate or other price that is <U>based on</U>, <U>and/or varies with</U>, a discount to the
future trading prices of, or quotations for, Common Stock; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
a conversion, repayment, exercise or exchange rate or other price that is subject to being <U>reset at some future date</U> after the
initial issuance of such debt, equity or equity-linked security or upon the occurrence of specified or contingent events (other than warrants
that may be repriced by the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.1pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: justify">any securities in a capital or debt raising transaction or series of related transactions which grant
to an investor the right to receive additional securities based upon future transactions of the Company on terms more favorable than those
granted to such investor in such first transaction or series of related transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and are deemed to include transactions generally
referred to as at-the-market transactions (ATMs) or equity lines of credit and stand-by equity distribution agreements, and convertible
securities and loans having a similar effect. Notwithstanding the foregoing, and for the avoidance of doubt, rights issuances, shareholder
purchase plans, Equity Plans, convertible securities, or issuances of Equity Interests, based on the trading price of the Common Stock
on the Trading Market but each at a fixed price per share, shall not be deemed to be a Prohibited Transaction; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.1pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: justify">any other securities including, but not limited to, the issuance by the Company of non-convertible preferred
stock, in a capital or debt raising transaction or series of related transactions, with the exception of a transaction of this kind to
be entered into between the Company and a member of FINRA whose identity has been disclosed to the Collateral Agent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prospectus</B>&rdquo;
means the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement, with respect to
the terms of the offering of any portion of the Warrant Shares covered by such Registration Statement and by all other amendments and
supplements to the prospectus, including post-effective amendments and all material incorporated by reference in such prospectus, and
any &ldquo;free writing prospectus&rdquo; as defined in Rule 405 under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Public Record</B>&rdquo; has the meaning
set forth in Section 3.5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Register</B>,&rdquo;
&ldquo;<B>Registered</B>&rdquo; and &ldquo;<B>Registration</B>&rdquo; refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the 1933 Act (as defined below), and the declaration or ordering of effectiveness of
such Registration Statement or document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration Statement</B>&rdquo;
means any registration statement of the Company filed under the 1933 Act, including the Prospectus and amendments and supplements to such
Registration Statement, and including post-effective amendments, all exhibits and all material incorporated by reference in such Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Required Minimum</B>&rdquo;
means, as of any date, the maximum aggregate number of Common Stock then issued or potentially issuable in the future pursuant to the
Transaction Documents, including any Warrant Shares issuable upon exercise in full of all Warrants, ignoring any exercise limits set forth
therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Reverse Split</B>&rdquo;
has the meaning set forth in <U>Section 5.20</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC</B>&rdquo; means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Security Documents</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities</B>&rdquo;
means the Note, the Warrant and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Termination
Event</B>&rdquo; means either of the following has occurred:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;trading
in securities generally in the United States has been suspended or limited for a consecutive period of greater than three (3) Business
Days; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
banking moratorium has been declared by the United States or the New York State authorities and is continuing for a consecutive period
of greater than three (3) Business Days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Security Agreement</B>&rdquo;
means that certain security agreement, executed and delivered on the date hereof and in connection with the Agreement, by and between
the Company and Esousa Holdings LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Stockholder Approval</B>&rdquo;
shall mean the approval of the holders of a majority of the Company&rsquo;s outstanding voting Capital Stock: (a) if and to the extent
legally required, to amend the Company&rsquo;s certificate of incorporation to increase the number of authorized Common Stock by at least
the number of Common Stock equal to the number of Common Stock issuable hereunder, (b) to ratify and approve all of the transactions contemplated
by the Transaction Documents, including the issuance of all of the Warrant Shares (as such term is defined in each of such documents)
issuable to the Investor thereunder, all as may be required by the applicable rules and regulations of the Principal Market (or any successor
entity).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of
the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other
than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially owned, or
the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person.
Unless otherwise specified, all references herein to a &ldquo;Subsidiary&rdquo; or to &ldquo;Subsidiaries&rdquo; shall refer to a Subsidiary
or Subsidiaries of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax&rdquo;</B> or
&ldquo;<B>Taxes</B>&rdquo; means all federal United States and state, municipal, foreign and other taxes (including, without limitation,
income taxes, sales taxes, excise taxes, value added taxes, capital taxes, property taxes, withholding taxes, payroll taxes and contributions,
and production, severance and similar taxes and assessments) and includes all penalties, interest and fines with respect thereto and all
liabilities for the payment of such amounts as a transferee or successor or under any obligation to indemnify another Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Day</B>&rdquo;
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means whichever of the New York Stock Exchange, NYSE American, or the Nasdaq Stock Market (including the Nasdaq Capital Market), on which
the Common Stock is listed or quoted for trading on the date in question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Documents</B>&rdquo;
means this Agreement, the Note, the Warrants, the Security Documents, and any other documents or agreements executed or delivered by any
Obligor in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP&rdquo;</B>
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of one share of Common Stock trading in the ordinary course of
business on the applicable trading price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg
Financial L.P.; (b) if the Common Stock is not then listed on a Trading Market and if the Common Stock is traded in the over-the-counter
market, as reported by the OTCQX or OTCQB Markets, the volume weighted average price of one share of Common Stock for such date (or the
nearest preceding date) on the OTCQX or OTCQB Markets, as reported by Bloomberg Financial L.P.; (c) if the Common Stock is not then listed
or quoted on a Trading Market or on the OTCQX or OTCQB Markets and if prices for the Common Stock are then reported in the &ldquo;Pink
Sheets&rdquo; published by the OTC Markets Group (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price of one share of Common Stock so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases,
the fair market value of one share of Common Stock as determined by an independent appraiser selected in good faith by the majority in
interest of the Investors and reasonably acceptable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrants</B>&rdquo;
means Class A Warrant and Class B Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant Shares</B>&rdquo;
means the shares of Common Stock issuable upon exercise of the Warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>2</B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>PURCHASE
AND SALE OF THE NOTE AND THE WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Purchase
and Sale of the Note and the Warrants</U>. Subject to the terms and conditions set forth herein, at the Closing, the Company shall issue
and sell to the Investors, and the Investors shall purchase from the Company, (a) a 10% original issuance discount senior secured promissory
notes in the form attached hereto as <U>Exhibit B</U> (the &ldquo;<B>Notes</B>&rdquo;), in the aggregate principal amount of Sixty-Six
Million Dollars ($66,000,000), subject to adjustment as set forth in the Note (the &ldquo;<B>Principal Amount</B>&rdquo;); (b) a warrant
to purchase shares of Common Stock, in the form attached hereto as <U>Exhibit C</U>, registered in the name of the Investors, pursuant
to which the Investor shall have the right to acquire up to an aggregate of 14,834,700 Warrant Shares split among the Investors (the &ldquo;<B>Class
A Warrant</B>&rdquo;); and (c) a warrant to purchase shares of Common Stock, in the form attached hereto as <U>Exhibit D</U>, registered
in the name of the Investor, pursuant to which the Investors shall have the right to acquire, up to an aggregate of 2,042,914 Warrant
Shares split among the Investors (the &ldquo;<B>Class B Warrant</B>&rdquo;) in exchange for the Funding Amount. The Investor and the Company
agree that for U.S. federal income tax purposes and applicable state, municipal, local and non-U.S. tax purposes, the Funding Amount shall
be allocable between the Note and the Warrant based on the relative fair market values thereof. Neither the Investor nor the Company shall
take any contrary position on any tax return, or in any audit, claim, investigation, inquiry or proceeding in respect of Taxes, unless
otherwise required pursuant to a final determination within the meaning of Section&nbsp;1313 of the Internal Revenue Code of 1986, as
amended (the &ldquo;<B>Code</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Investor that has acquired
Bridge Notes shall have the ability to purchase the Notes, at its option and whether in full or partial payment therefor, for either (i)
cash, or (ii) the surrender of its Bridge Note, including accrued but unpaid interest as well as certain fees as provided for in such
Bridge Notes (such additional dollar amount of the Bridge Note, the &ldquo;<B>Bridge Amount</B>&rdquo;) for cancellation upon the Closing
Date, where the principal face amount of each such Bridge Amount shall be deemed to be equal to the amount in cash payable in consideration
for the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Closing</U>.
The closing hereunder, including payment for and delivery of the Note and the Warrants, shall take place remotely via the exchange of
documents and signatures, no later than ten (10) Business Days following the execution and delivery of this Agreement, subject to satisfaction
or waiver of the conditions set forth in <U>Section 6</U>, or at such other time and place as the Company and the Investor agree upon,
orally or in writing (the &ldquo;<B>Closing</B>,&rdquo; and the date of the Closing being the &ldquo;<B>Closing Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Repayment
of the Note and Prepayment Right.</U> As set forth in this Agreement and in the Note, the Company shall make weekly payments to the Investor
and shall make certain other payments to the Investor as detailed therein. Further, as set forth in the Note, in its sole discretion and
upon giving the prior written notice set forth in the Note, the Company will have the right to pre-pay the entire then-outstanding principal
amount of the Note at any time with no penalty or premium of any kind (the &ldquo;<B>Prepayment Right</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Senior
Obligation</U>. As an inducement for the Investors to enter into this Agreement and to purchase the Notes, all obligations of the Obligors
pursuant to the Transaction Documents shall be secured by a security interest in and lien upon all of the assets of the Obligors except
as set forth in the Security Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>3</B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY</U>. The Company represents and warrants to the Investor and covenants with the Investor that, except as
is set forth in the Disclosure Letter being delivered to the Investor as of the date hereof and as of the Closing Date, the following
representations and warranties are true and correct in all material respects:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.1</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Organization
and Qualification</U>. The Company is a corporation duly organized and validly existing in good standing under the Laws of the State
of Delaware and has the requisite corporate power and authority to own its properties and to carry on its business as now being conducted.
The Company is duly qualified to do business and is in good standing in every jurisdiction in which the ownership of its property or
the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified
or be in good standing would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.2</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authorization;
Enforcement; Compliance with Other Instruments</U>. The Company and each of its Subsidiaries (as applicable) has the requisite corporate
or limited liability company power, as the case may be, and authority to execute the Transaction Documents to which it is a party, to
issue and sell the Note and the Warrants pursuant hereto (in the case of the Company), and to perform its obligations under the Transaction
Documents to which it is a party, including issuing the Warrant Shares on the terms set forth in this Agreement upon receipt of Exchange
Approval. The execution and delivery of the Transaction Documents by the Company and its Subsidiaries and the issuance and sale of the
Securities by the Company pursuant hereto, including without limitation the reservation of the Warrant Shares for future issuance, have
been duly and validly authorized by the Company&rsquo;s Board of Directors and any similar governing body of a Subsidiary and no further
consent or authorization is required by the Company, its Subsidiaries, their respective Boards of Directors or other governing bodies,
the Company&rsquo;s stockholders or any other Person in connection therewith other than the Company&rsquo;s receipt of Exchange Approval,
which the Company expects to have within fourteen (14) days from the Closing Date. The Transaction Documents have been duly and validly
executed and delivered by the Company and its Subsidiaries party thereto and constitute valid and binding obligations of the Company
and its Subsidiaries (as applicable), enforceable against such parties in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
Laws relating to, or affecting generally, the enforcement of creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.3</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries (as applicable)
and the issuance and sale of the Note and the Warrants by the Company hereunder will not (a) conflict with or result in a violation of
the Company&rsquo;s or its Subsidiaries&rsquo; notice of articles, articles or any other constating documents, (b)&nbsp;conflict with,
or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any
right of termination, amendment, acceleration or cancellation of, any agreement to which the Company or any of the Subsidiaries is a
party, or require the Company or any Subsidiary to grant a lien or encumbrance on any of its property or assets under the terms of any
other agreement to which it is a party, or (c) subject to the making of the filings referred to in <U>Section&nbsp;5</U>, violate in
any material respect any Law or any rule or regulation of the Principal Market applicable to the Company or any of the Subsidiaries or
by which any of their properties or assets are bound or affected. Assuming the accuracy of the Investor&rsquo;s representations in <U>Section&nbsp;4
</U>and subject to the making of the filings referred to in <U>Section&nbsp;5</U>, (i) no approval or authorization will be required
from any governmental authority or agency, regulatory or self-regulatory agency or other third party (including the Principal Market)
in connection with the issuance of the Note and the Warrants and the other transactions contemplated by this Agreement (including the
issuance of the Warrant Shares upon exercise of the Warrants) and (ii)&nbsp;the issuance of the Note and the Warrants, and the issuance
of the Warrant Shares upon exercise of the Warrants will be exempt from the registration and qualification requirements under the 1933
Act and all applicable state securities Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.4</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Capitalization
and Subsidiaries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
authorized Capital Stock of the Company consists of Five Hundred Million shares of Class A Common Stock, Twenty-Five Million shares of
Class B Common Stock and Twenty-Five Million shares of Preferred Stock. As of the close of business on December 20, 2021, 84,331,047 shares
of Common Stock, no shares of Class B Common Stock and 132,040 shares of Preferred Stock were issued and outstanding. As of December 20,
2021, (x) an aggregate of 6,395,919 shares of Common Stock are issuable upon exercise of options granted under a stock option plan, of
which 938,401 are fully vested and exercisable; (y) an aggregate of 3,991,635 Common Stock are issuable upon exercise of outstanding warrants
granted by the Company, with exercise prices ranging from $0.88 to $2,000 per share and (Z) an aggregate of 2,810,000 restricted stock
grants are outstanding. The Company has duly reserved up to 11,925,000 shares of Common Stock for issuance upon exercise of the Warrant
A and has duly reserved up to 1,325,000 shares of Common Stock for issuance upon exercise of the Warrant B. The Warrant Shares, if and
when issued upon exercise of the Warrants in accordance with their respective terms, will be validly issued, fully paid and non-assessable
and free from all Taxes, liens and charges with respect to the issuance thereof. No shares of the Company&rsquo;s Capital Stock are subject
to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company. The Company&rsquo;s
certificate of incorporation and bylaws, each as amended, on file on the SEC&rsquo;s EDGAR website are true and correct copies of the
Company&rsquo;s constating documents as in effect as of the date hereof. The Company is not in violation of any provision of its certificate
of incorporation or bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Schedule
3.4(b)</U> lists each direct and indirect Subsidiary of the Company existing on the date hereof and indicates for each Subsidiary (i)
the authorized capital stock or other Equity Interests of such Subsidiary as of the date hereof, (ii) the number and kind of shares or
other ownership interests of such Subsidiary that are issued and outstanding as of the date hereof, and (iii) the owner of such shares
or other ownership interests. Other than as set forth on <U>Schedule 3.4(b)</U>, no Subsidiary has any outstanding stock options, warrants
or other instruments pursuant to which such Subsidiary may at any time or under any circumstances be obligated to issue any shares of
its capital stock or other Equity Interests. Each Subsidiary is duly organized and validly existing in good standing under the laws of
its jurisdiction of formation and has all requisite power and authority to own its properties and to carry on its business as now being
conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any Subsidiary is bound by any agreement or arrangement pursuant to which it is obligated to register the sale of any
securities under the 1933 Act other than Esousa Holdings, LLC. There are no outstanding securities of the Company or any of the Subsidiaries
which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem or purchase any security of the Company or any Subsidiary. There are no outstanding
securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Note, either Warrant
or the Warrant Shares. Neither the Company nor any Subsidiary has any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or
agreements or any similar plan or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
issuance and sale of any of the Securities on the Closing Date will not obligate the Company to issue shares of Common Stock or other
securities to any other Person and will not result in the adjustment of the exercise, conversion, exchange, or reset price of any outstanding
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of the date of this Agreement, the Company has capacity under the rules and regulations of the Principal Market to issue up to 16,866,209
shares of Common Stock (or securities exercisable for Common Stock) without obtaining Stockholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.5</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Public
Record; Financial Statements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of the date hereof, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it pursuant
to the reporting requirements of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits included therein and
financial statements and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &ldquo;Public
Record&rdquo;). As of their respective filing dates, all documents filed by the Company in the Public Record complied in all material
respects with the requirements of the 1934 Act, as applicable, and the rules and regulations thereunder, and none of the documents in
the Public Record, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of their respective dates, the financial statements of the Company included in the Public Record complied as to form in all material respects
with applicable accounting requirements and the published rules and regulations of the 1934 Act with respect thereto. Such financial statements
have been prepared in accordance with U.S. generally accepted accounting principals (&quot;<B>GAAP</B>&quot;), and audited by a firm that
is an independent registered public accounting firm subject to the public company accounting oversight board consistently applied, during
the periods involved (except as may be otherwise indicated in such financial statements or the notes thereto, or, in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material
respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations and
consolidated cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).
No other written information provided by or on behalf of the Company to the Investor in connection with the Investor&rsquo;s purchase
of the Note and the Warrants which is not included in the Public Record contains any untrue statement of a material fact or omits to state
any material fact necessary to make the statements therein, in the light of the circumstance under which they are or were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth on <U>Schedule 3.5(c)</U>, the Company and each of the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii) reasonable controls to safeguard assets are in place and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.6</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Litigation
and Regulatory Proceedings</U>. Other than as set forth on <U>Schedule 3.6</U>, there are no material actions, causes of action, suits,
claims, proceedings, inquiries or investigations (collectively, &ldquo;<B>Proceedings</B>&rdquo;) before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any
of the Subsidiaries, threatened against or affecting the Company or any of the Subsidiaries, the Common Stock or any other class of issued
and outstanding shares of the Company&rsquo;s Capital Stock, or any of the Company&rsquo;s or the Subsidiaries&rsquo; officers or directors
in their capacities as such and, to the knowledge of the Company, there is no reason to believe that there is any basis for any such
Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.7</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Undisclosed Events, Liabilities or Developments</U>. Other than as set forth on <U>Schedule 3.7</U> hereto, no event, development or
circumstance has occurred or exists, or to the knowledge of the Company, is reasonably anticipated to occur or exist that (a) would reasonably
be anticipated to have a Material Adverse Effect or (b) would be required to be disclosed by the Company under applicable securities
Laws on a Registration Statement relating to an issuance and sale by the Company of its Common Stock and which has not been publicly
announced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.8</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Compliance
with Law</U>. The Company and each of the Subsidiaries have conducted and are conducting their respective businesses in compliance in
all material respects with all applicable Laws and are in compliance in all material respects with the rules and regulations of the Trading
Market. The Company is not aware of any facts which could reasonably be anticipated to lead to a delisting of the Common Stock by the
Trading Market in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.9</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Employee
Relations</U>. Neither the Company nor any Subsidiary is involved in any union labor dispute nor, to the knowledge of the Company, is
any such dispute threatened. Neither the Company nor any Subsidiary is a party to any collective bargaining agreement. No executive officer
has notified the Company that such officer intends to leave the Company&rsquo;s employ or otherwise terminate such officer&rsquo;s employment
with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.10</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Intellectual
Property Rights</U>. The Company and each Subsidiary owns or possesses adequate rights or licenses to use all trademarks, trade names,
service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental
authorizations, trade secrets and other intellectual property rights (collectively, &ldquo;<B>IP Rights</B>&rdquo;) necessary to conduct
their respective businesses as now conducted. None of the material IP Rights of the Company or any of the Subsidiaries are expected to
expire or terminate within three (3) years from the date of this Agreement. Neither the Company nor any Subsidiary is infringing, misappropriating
or otherwise violating any IP Rights of any other Person. No claim has been asserted, and no Proceeding is pending, against the Company
or any Subsidiary alleging that the Company or any Subsidiary is infringing, misappropriating or otherwise violating the IP Rights of
any other Person, and, to the Company&rsquo;s knowledge, no such claim or Proceeding is threatened, and the Company is not aware of any
facts or circumstances which might give rise to any such claim or Proceeding. The Company and the Subsidiaries have taken commercially
reasonable security measures to protect the secrecy, confidentiality and value of all of their material IP Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.11</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Environmental
Laws</U>. Except, in each case, as would not be reasonably anticipated to have a Material Adverse Effect, the Company and the Subsidiaries
(a) are in compliance in all material respects with any and all applicable Laws relating to the protection of human health and safety,
the environment or hazardous or toxic substances or wastes, pollutants or contaminants, (b) have received and hold all permits, licenses
or other approvals required of them under all such Laws to conduct their respective businesses and (c) are in compliance in all material
respects with all terms and conditions of any such permit, license or approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.12</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title to all personal property owned by them which is material
to their respective businesses, in each case free and clear of all liens, encumbrances and defects except those set forth on <U>Schedule
3.12</U>. Any real property and facilities held under lease by the Company or any Subsidiary are held under valid, subsisting and enforceable
leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings
by the Company and the Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.13</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Insurance</U>.
The Company and each of the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company reasonably believes to be prudent and customary in the businesses in which the Company
and the Subsidiaries are engaged. Neither the Company nor any of the Subsidiaries has been refused any insurance coverage sought or applied
for, and the Company has no reason to believe that it will not be able to renew all existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.14</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Regulatory
Permits</U>. The Company and the Subsidiaries have in full force and effect all certificates, approvals, authorizations and permits from
all regulatory authorities and agencies necessary to own, lease or operate their respective properties and assets and conduct their respective
businesses, and neither the Company nor any Subsidiary has received any notice of Proceedings relating to the revocation or modification
of any such certificate, approval, authorization or permit, except for such certificates, approvals, authorizations or permits with respect
to which the failure to hold would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.15</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Materially Adverse Contracts, Etc</U>. Neither the Company nor any of the Subsidiaries is (a) subject to any charter, corporate or other
legal restriction, or any judgment, decree or order which in the judgment of the Company has or is expected in the future to have a Material
Adverse Effect or (b) a party to any contract or agreement which in the judgment of the Company has or would reasonably be anticipated
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.16</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Taxes</U>.
The Company and the Subsidiaries each has correctly prepared and duly and timely made or filed, or caused to be made or filed, all United
States federal, and applicable state, local and non-U.S. Tax returns, reports and declarations required by any jurisdiction to which
it is subject and has paid all Taxes and other governmental assessments and charges that are material in amount, required to be paid
by it, regardless of whether such amounts are shown or determined to be due on such returns, reports and declarations, except those being
contested in good faith by appropriate proceedings and for which it has set aside on its books provision reasonably adequate for the
payment of all Taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
Taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and, to the knowledge of the Company, there
is no basis for any such claim. Each of the Company and the Subsidiaries has collected, withheld and remitted all Taxes due and payable
to the property taxing or other governmental authority. There are no audits, assessments, reassessments, suits, proceedings, investigations
or claims pending against the Company or any of the Subsidiaries in respect of Taxes paid or payable, and there are no matters under
discussion with any taxing or governmental authority of any jurisdiction involving the Company or any Subsidiary with, or the subject
of any agreement with, any taxing or governmental authority relating to claims for additional Taxes. There are no agreements, waivers
or other arrangements providing for an extension of time with respect to the assessment or reassessment of any Tax owing by the Company
or any subsidiary, the filing of any tax returns by the Company or any Subsidiary or the payment of any Tax by the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Solvency</U>.
After giving effect to the receipt by the Company of the proceeds from the transactions contemplated by this Agreement (a) the Company&rsquo;s
fair saleable value of its assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing
debts and other liabilities (including known contingent liabilities) as they mature; and (b)&nbsp;the current cash flow of the Company,
together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated
uses of the cash, would be sufficient to pay all amounts on or in respect of its debt when such amounts are required to be paid. The Company
does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash
to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that
it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Investment
Company</U>. The Company is not, and is not an Affiliate of, an &ldquo;Investment Company&rdquo; within the meaning of the Investment
Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.19</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain
Transactions</U>. Other than employment or consultant agreements or as disclosed in the Public Record, there are no contracts, transactions,
arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any director, officer or employee
thereof on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.20</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
General Solicitation</U>. Neither the Company, nor any of its Affiliates, nor any person acting on its behalf, has engaged in any form
of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Note
or the Warrant pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.21</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Acknowledgment
Regarding the Investor&rsquo;s Purchase of the Note and the Warrants</U>. The Company&rsquo;s Board of Directors has approved the execution
of the Transaction Documents and the issuance and sale of the Note and the Warrants, based on its own independent evaluation and determination
that the terms of the Transaction Documents are reasonable and fair to the Company and in the best interests of the Company and its stockholders.
The Company and each of its Subsidiaries are entering into this Agreement and the Security Documents to which they are party, and the
Company is issuing and selling the Note and the Warrants, voluntarily and without economic duress. The Company has had the opportunity
to consider whether or not to retain independent legal counsel of its own choosing to review the Transaction Documents and advise the
Company with respect thereto but has determined not to retain any such independent legal counsel. The Company acknowledges and agrees
that the Investor is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Note and the Warrants and the
transactions contemplated hereby and that neither the Investor nor any person affiliated with the Investor is acting as a financial advisor
to, or a fiduciary of, the Company (or in any similar capacity) with respect to execution of the Transaction Documents or the issuance
of the Note and the Warrant or any other transaction contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>3.22</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Brokers&rsquo;, Finders&rsquo; or Other Advisory Fees or Commissions</U>. No brokers, finders or other similar advisory fees or commissions
will be payable by the Company or any Subsidiary or by any of their respective agents with respect to the issuance of the Note or any
of the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>OFAC</U>.
None of the Company nor any of the Subsidiaries nor, to the best knowledge of the Company, any director, officer, agent, employee, affiliate
or person acting on behalf of the Company and/or any Subsidiary has been or is currently subject to any United States sanctions administered
by the Office of Foreign Assets Control of the United States Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;); and the Company will
not directly or indirectly use any proceeds received from the Investor, or lend, contribute or otherwise make available such proceeds
to its Subsidiaries or to any affiliated entity, joint venture partner or other person or entity, to finance any investments in, or make
any payments to, any country or person currently subject to any of the sanctions of the United States administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>No
Foreign Corrupt Practices</U>. None of the Company or any of the Subsidiaries has, directly or indirectly: (a) made or authorized any
contribution, payment or gift of funds or property to any official, employee or agent of any governmental authority of any jurisdiction
except as otherwise permitted under applicable Law; or (b) made any contribution to any candidate for public office, in either case, where
either the payment or the purpose of such contribution, payment or gift was, is, or would be prohibited under the Foreign Corrupt Practices
Act or the rules and regulations promulgated thereunder or under any other legislation of any relevant jurisdiction covering a similar
subject matter applicable to the Company or its Subsidiaries and their respective operations and the Company has instituted and maintained
policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance with such legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Anti-Money
Laundering</U>. The operations of each of the Company and the Subsidiaries are and have been conducted at all times in compliance with
all applicable anti-money laundering laws, regulations, rules and guidelines in its jurisdiction of incorporation and in each other jurisdiction
in which such entity, as the case may be, conducts business (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;) and no action,
suit or proceeding by or before any court or governmental authority involving the Company or its Subsidiaries with respect to any of the
Money Laundering Laws is, to the best knowledge of the Company, pending, threatened or contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Disclosure</U>.
The Company confirms that neither it, nor to its knowledge, any other Person acting on its behalf has provided the Investor or its agents
or counsel with any information that the Company believes constitutes material, non-public information. The Company understands and confirms
that the Investor will rely on the foregoing representations and covenants in effecting transactions in securities of the Company. All
disclosures provided to the Investor regarding the Company, its business and the transactions contemplated hereby, furnished by or on
behalf of the Company (including the Company&rsquo;s representations and warranties set forth in this Agreement) are true and correct
in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements made therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>4.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>REPRESENTATIONS
AND WARRANTIES OF THE INVESTOR</U>. The Investor represents and warrants to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.1</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Organization
and Qualification</U>. The Investor, if an entity, is a validly existing corporation, limited partnership or limited liability company
and has all requisite corporate, partnership or limited liability company power and authority to invest in the Note and Warrants pursuant
to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.2</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authorization;
Enforcement; Compliance with Other Instruments</U>. The Investor has the requisite power and authority to enter into and to perform its
obligations under the Transaction Documents to which it is a party. The execution and delivery by the Investor of the Transaction Documents
to which it is a party have been duly and validly authorized by the Investor&rsquo;s governing body and no further consent or authorization
is required. The Transaction Documents to which it is a party have been duly and validly executed and delivered by the Investor and constitute
valid and binding obligations of the Investor, enforceable against the Investor in accordance with their terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.3</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Conflicts</U>. The execution, delivery and performance of the Transaction Documents to which it is a party by the Investor and the purchase
of the Note and the Warrants by the Investor will not (a) conflict with or result in a violation of the Investor&rsquo;s organizational
documents, (b) conflict with, or constitute a material default (or an event which, with notice or lapse of time or both, would become
a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement,
contract, indenture mortgage, indebtedness or instrument to which the Investor is a party, or (c) violate any Law applicable to the Investor
or by which any of the Investor&rsquo;s properties or assets are bound or affected. No approval or authorization will be required from
any governmental authority or agency, regulatory or self-regulatory agency or other third party in connection with the purchase of the
Note and the Warrant and the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.4</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Investment
Intent; Accredited Investor</U>. The Investor is purchasing the Note and the Warrants for its own account, for investment purposes, and
not with a view towards distribution. The Investor is an &ldquo;accredited investor&rdquo; as such term is defined in Rule 501(a) of
Regulation D of the 1933 Act. The Investor has, by reason of its business and financial experience, such knowledge, sophistication and
experience in financial and business matters and in making investment decisions of this type that it is capable of (a) evaluating the
merits and risks of an investment in the Note, the Warrants and the Warrant Shares and making an informed investment decision, (b) protecting
its own interests and (c) bearing the economic risk of such investment for an indefinite period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.5</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Opportunity
to Discuss</U>. The Investor has received all materials relating to the business, finance and operations of the Company and the Subsidiaries
as it has requested and has had an opportunity to discuss the business, management and financial affairs of the Company and the Subsidiaries
with the Company&rsquo;s management. In making its investment decision, the Investor has relied solely on its own due diligence performed
on the Company by its own representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>No
Governmental Review</U>. The Investor understands that no Government Entity has passed on or made any recommendation or endorsement of
the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the
merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.7</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Title
in and to the Bridge Notes</U>. If, and to the extent that, any Investor is surrendering for cancellation one or more BriedgeNotes, then
such Investor hereby warratns and represents to the Company that such Investor owns and holds, beneficially and of record, the entire
right, title, and interest in and to the Bridge Note free and clear of all rights and liens (other than pledges or security interests
arising by operation of applicable securities laws). The Investor has full power and authority to transfer and dispose of the Bridge
Note to the Company free and clear of any right or lien. Other than the transactions contemplated by this Agreement, there is no outstanding,
plan, pending proposal, or other right of any person or entity to acquire all or any part of the Bridge Notes and corresponding deduction
of the face amount of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>4.8</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Other Representations.</U>&nbsp;Except for the representations and warranties set forth in this Agreement and in other Transaction Documents,
the Investor makes no other representations or warranties to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>5.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>OTHER
AGREEMENTS OF THE PARTIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Legends,
etc</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities
may only be disposed of pursuant to an effective Registration Statement, to the Company or pursuant to an available exemption from or
in a transaction not subject to the registration requirements of the 1933 Act, and in compliance with any applicable state securities
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certificates
evidencing the Securities will contain the following legend, so long as is required by this <U>Section 5.2(b)</U> or <U>Section 5.2(c)</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">NEITHER THESE SECURITIES
NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED. THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. [THESE SECURITIES
AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES] [THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the Investor may from time to time pledge, and/or grant a security interest in some or all of the Securities, in accordance
with applicable securities laws, pursuant to a bona fide margin agreement in connection with a bona fide margin account and, if required
under the terms of such agreement or account, the Investor may transfer pledged or secured Securities to the pledgees or secured parties.
Such a pledge or transfer would not be subject to approval or consent of the Company and no legal opinion of legal counsel to the pledgee,
secured party or pledgor shall be required in connection with the pledge, but such legal opinion may be required in connection with a
subsequent transfer following default by the Investor transferee of the pledge. At the Company&rsquo;s expense, the Company will execute
and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge
or transfer of the Securities including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of the 1933
Act or other applicable provision of the 1933 Act to appropriately amend the list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certificates
evidencing the Warrant Shares shall not contain any legend: (i) while a Registration Statement covering the Warrant Shares is effective
under the 1933 Act, (ii) following any sale of such Warrant Shares pursuant to Rule 144, (iii) while such Investor Shares are eligible
for sale without restriction under Rule 144 and the Investor has taken all requisite steps to have such legend removed, or (iv) if such
legend is not required under applicable requirements of the 1933 Act (including judicial interpretations and pronouncements issued by
the staff of the SEC). The Company shall cause its counsel to issue any legal opinion or instruction required by the Company&rsquo;s transfer
agent to comply with the requirements set forth in this Section. At such time as a legend is no longer required for the Warrant Shares
under this <U>Section5.1(c)</U>, the Company will, no later than five (5) Business Days following the delivery by the Investor to the
Company or the Company&rsquo;s transfer agent of a certificate representing Warrant Shares containing a restrictive legend (such fifth
Business Day, the &ldquo;<B>Legend Removal Date</B>&rdquo;), deliver or cause to be delivered to the Investor a certificate representing
such Warrant Shares that is free from all restrictive and other legends. In addition to any other remedies available to the Investor,
the Company shall pay to the Investor, in cash, as partial liquidated damages and not as a penalty, for each $1,000.00 of Warrant Shares
(based on the VWAP of the Common Stock on the date such Warrant Shares are submitted to the Company or the Company&rsquo;s transfer agent)
delivered for removal of the restrictive or other legend, $5.00 per Trading Day for each Trading Day after the Legend Removal Date until
such Warrant Shares are delivered without a legend.&nbsp; The Company may not make any notation on its records or give instructions to
any transfer agent of the Company that enlarge the restrictions on transfer set forth in this Section except as it may reasonably determine
are necessary or appropriate to comply or to ensure compliance with those applicable laws that are enacted or modified after the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Furnishing
of Information</U>. As long as the Investor owns the Securities, the Company covenants to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the 1934 Act. As long as the Investor owns the Securities, if the Company is not required to file reports pursuant to such laws, it will
prepare and furnish to the Investor and make publicly available in accordance with Rule 144(c) such information as is required for the
Investor to sell the Warrant Shares under Rule 144. The Company further covenants that it will take such further action as any holder
of Securities may reasonably request, all to the extent required from time to time to enable such Person to sell such Warrant Shares without
registration under the 1933 Act within the limitation of the exemptions provided by Rule 144 or other applicable exemptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Integration</U>.
The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit
offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the 1933 Act) that will be integrated with
the offer or sale of the Securities in a manner that would require the registration under the 1933 Act of the sale of the Securities to
the Investor, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading
Market that would require, under the rules of the Trading Market, the Stockholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Notification
of Certain Events</U>. The Company shall give prompt written notice to the Investor of (a)&nbsp;the occurrence or non-occurrence of any
Event, the occurrence or non-occurrence of which would render any representation or warranty of the Company contained in this Agreement
or any other Transaction Document, if made on or immediately following the date of such Event, untrue or inaccurate in any material respect,
(b)&nbsp;the occurrence of any Event that, individually or in combination with any other Events, has had or could reasonably be expected
to have a Material Adverse Effect, (c)&nbsp;any failure of the Company to comply with or satisfy any covenant or agreement to be complied
with or satisfied by it hereunder or any Event that would otherwise result in the nonfulfillment of any of the conditions to the Investor&rsquo;s
obligations hereunder, (d)&nbsp;any notice or other communication from any Person alleging that the consent of such Person is or may be
required in connection with the consummation of the transactions contemplated by this Agreement or any other Transaction Document, or
(e)&nbsp;any Proceeding pending or, to the Company&rsquo;s knowledge, threatened against a party relating to the transactions contemplated
by this Agreement or any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>5.5</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Available
Stock</U>. The Company shall at all times keep authorized and reserved and available for issuance, free of preemptive rights, such number
of shares of Common Stock as are issuable upon exercise of the Warrants at any time, including any additional shares of Common Stock
that may be issued due to any adjustments, as more fully detailed in the Warrants. If the Company determines at any time that it does
not have a sufficient number of authorized Common Stock to reserve and keep available for issuance as described in this <U>Section 5.5</U>,
the Company shall use all commercially reasonable efforts to increase the number of authorized shares of Common Stock by seeking Stockholder
Approval for the authorization of such additional shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>5.6</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Use
of Proceeds</U>. The Company will use the proceeds from the sale of the Note and the Warrants as provided for herein for the repayment
of the Bridge Financing, and, thereafter, for the purchase and retention of bitcoin miners, certain acquisitions which have been disclosed
to the Investor and general working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Repayment
of Note</U>. The Company shall make weekly payments to the Investors on a <I>pari passu</I> basis equal to the gross proceeds generated
from the Sale or Issuance of Bitcoin, as provided in Section 5.8. Other than as set forth on <U>Schedule 5.7</U>, neither the Company
nor any Subsidiary has any outstanding Indebtedness (all such Indebtedness set forth on Schedule 5.7 is hereinafter referred to as the
&ldquo;<B>Existing Debt</B>&rdquo; and is collectively referred to herein as the &ldquo;<B>Permitted Indebtedness</B>&rdquo;). The Company
shall not make any voluntary cash prepayments on any Indebtedness at any time while any amounts are owing under the Note other than with
respect to the Existing Debt or cash payments the Company is required to make pursuant to the express terms thereof existing on the date
hereof. Neither the Company nor any Subsidiary shall incur any Indebtedness without the express written consent of the Investor. If the
Company or any Subsidiary issues any Indebtedness other than the Permitted Indebtedness, after obtaining the written consent of the Investor
pursuant to Section 1.9 of the Note, including any subordinated Indebtedness or convertible Indebtedness, other than Exempted Securities,
then unless otherwise waived in writing by and at the discretion of the Investor, the Company will immediately utilize no less than sixty-five
percent (65%) of the proceeds of such issuance (or cause such Subsidiary to immediately utilize the proceeds of such issuance) to repay
the Note. If the Company issues any Equity Interests, other than Exempted Securities, or mines or sells any Bitcoin, unless otherwise
waived in writing by and at the discretion of the Investor, the Company will direct sixty-five percent (65%) of the proceeds from such
issuance or sale of Bitcoin to repay the Note on a <I>pari passu</I> basis. Additionally, in the event that an Investor exercises some
or all of its Warrants for cash (&ldquo;<B>Exercise Proceeds</B>&rdquo;), then the Company shall direct all such Exercise Proceeds to
the repayment of the Note. Any such repayments of the Note as provided in this Section 5.7 shall be made to the Investors on a <I>pro
rata</I> basis in proportion to their investment and shall be without premium or penalty to the Company. Moreover, each Investor may,
in its sole discretion and acting solely on behalf of itself, require that the Company apply some or all amounts owing under the Note
to the payment of any cash exercises of the Warrants by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Sale
or Issuance of Bitcoin.</U> The Company shall be obligated to sell or issue no less than sixty-five percent (65%) of the Bitcoin it mines.
The gross proceeds from the Sale or Issuance of Bitcoin shall be used by the Company to repay the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Prohibited
Transactions</U>. The Company hereby covenants and agrees not to enter into any Prohibited Transactions without obtaining prior written
consent from the majority in interest of the Investors, until such time as the Note has been repaid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Securities
Laws Disclosure; Publicity</U>. The Company shall, by 9:00 a.m. (New York City time) on the Trading Day immediately following the date
hereof, issue a press release disclosing the material terms of the transactions contemplated hereby, and shall, within four (4) Business
Days following the date hereof, file a Current Report on Form 8-K disclosing the material terms of the transactions contemplated hereby
and file a copy of this Agreement on EDGAR. The Company shall not issue any press release nor otherwise make any such public statement
regarding the Investor or the Transaction Documents without the prior written consent of the Investor, except if such disclosure is required
by law, in which case the Company shall (a) ensure that such disclosure is restricted and limited in content and scope to the maximum
extent permitted by Law to meet the relevant disclosure requirement and (b) provide a copy of the proposed disclosure to the Investor
for review prior to release and the Company shall incorporate the Investor&rsquo;s reasonable comments. Notwithstanding anything herein
to the contrary, to comply with United States Treasury Regulations Section 1.6011-4(b)(3)(i), each of the Company and the Investor, and
each employee, representative or other agent of the Company or the Investor, may disclose to any and all persons, without limitation of
any kind, the U.S. federal and state income tax treatment, and the U.S. federal and state income tax structure, of the transactions contemplated
hereby and all materials of any kind (including opinions or other tax analyses) that are provided to such party relating to such tax treatment
and tax structure insofar as such treatment and/or structure relates to a U.S. federal or state income tax strategy provided to such recipient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Indemnification
of the Investor</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will indemnify and hold the Investor, its Affiliates and their respective directors, officers, managers, shareholders, members,
partners, employees and agents and permitted successors and assigns (each, an &ldquo;<B>Investor Party</B>&rdquo;) harmless from any and
all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation and defense (collectively, &ldquo;<B>Losses</B>&rdquo;) that
any such Investor Party may suffer or incur as a result of or relating to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
breach or inaccuracy of any representation, warranty, covenant or agreement made by the Company in any Transaction Document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
misrepresentation made by the Company in any Transaction Document or in any Public Record document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
omission to state any material fact necessary in order to make the statements made in any Public Record, in light of the circumstances
under which they were made, not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
proceeding before or by any court, public board, government agency, self-regulatory organization or body based upon, or resulting from
the execution, delivery, performance or enforcement of any of the Transaction Documents or the consummation of the transactions contemplated
thereby, and whether or not the Investor is party thereto by claim, counterclaim, crossclaim, as a defendant or otherwise, or if such
Proceeding is based upon, or results from, any of the items set forth in clauses (i) through (iii) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the indemnity contained herein, the Company will reimburse each Investor Party for its reasonable legal and other expenses
(including the cost of any investigation, preparation and travel in connection therewith) incurred in connection therewith, as such expenses
are incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of this <U>Section 5.11</U> shall survive the termination or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Non-Public
Information</U>. The Company covenants and agrees that neither it nor any other Person acting on its behalf will provide the Investor
or its agents or counsel with any information that the Company believes constitutes material, non-public information. To the extent the
Company does not comply with this covenant and provides the Investor with material, non-public information, the Company shall publicly
disclose such information within seventy two (72) hours of providing the information to the Investor; provided, however, in the event
that such material non-public information is provided to Investor pursuant to <U>Section 10</U>, the Company shall publicly disclose such
information within twenty (20) Business Days of providing the information to the Investor. The Company understands and confirms that the
Investor shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Stockholder
Approval</U>. The Company shall, if required to obtain Exchange Approval, hold a special meeting of stockholders on or before the 90th
calendar day following the date hereof for the purpose of obtaining the shareholder approval; provided, however, such ninety (90) calendar
days shall be increased to one hundred twenty (120) calendar days in the event the Company receives comments to its proxy statement from
the SEC, with the recommendation of the Board of Directors that such proposal be approved, and the Company shall solicit proxies from
its shareholders in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed
proxyholders shall vote their proxies in favor of such proposal. If the Company does not obtain Stockholder Approval at the first meeting,
the Company shall call a meeting every four months thereafter to seek Stockholder Approval until the date that Stockholder Approval is
obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Listing
of Securities</U>. The Company shall: (a) in the time and manner required by each Trading Market on which the shares of Common Stock are
listed, prepare and file with the Principal Market a Supplemental Listing Application covering the Warrant Shares in order to obtain Exchange
Approval, (b)&nbsp;take all steps necessary to cause such Common Stock to be approved for listing on the Principal Market on which the
shares of Common Stock are listed as soon as possible thereafter, (c) provide to the Investor confirmation of such listing, and (d) maintain
the listing of such shares on the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>
<U>Antitrust Notification</U>. If the Investor determines, in its sole judgment and upon the advice of counsel, that the issuance of the
Note, the Warrants or the Investor Shares pursuant to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the &ldquo;<B>HSR Act</B>&rdquo;), the Company shall file as soon as practicable after the date
on which the Company receives notice from the Investor of the applicability of the HSR Act and a request to so file with the United States
Federal Trade Commission and the United States Department of Justice the notification and report form required to be filed by it pursuant
to the HSR Act in connection with such issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Intentionally
Omitted.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Change
of Prime Broker, Custodian</U>. Each Investor has informed the Company of the names of its prime broker and its share custodian. Each
Investor shall notify the Company of any change in its prime broker or share custodian within three (3) Business Days of such change having
taken effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Share
Transfer Agent</U>. The transfer agent and represents and warrants that the transfer agent used bythe Company is Computershare Trust Company,
N.A., which participates in the Depository Trust Company Fast Automated Securities Transfer program. The Company shall not change its
share transfer agent without the prior written consent of the majority in interest of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Set-Off</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Investor may set off any of its obligations to the Company (whether or not due for payment), against any of the Company&rsquo;s obligations
to the Investor (whether or not due for payment) under this Agreement and/or any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Investor may do anything necessary to effect any set-off undertaken in accordance with this <U>Section 5.19</U> (including varying the
date for payment of any amount payable by the Investor to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>CLOSING
CONDITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Conditions
Precedent to the Obligations of the Investor</U>. The obligation of the Investor to fund the Note and acquire the Warrants at the Closing
is subject to the satisfaction or waiver by the Investor, at or before such Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Required
Documentation</U>. The Company must have delivered to the Investor copies of all resolutions duly adopted by the Board of Directors of
the Company, or any such other documentation of the Company approving the Agreement, the Transaction Documents and any of the transactions
contemplated hereby or thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Consents
and Permits</U>. The Company must have obtained and delivered to the Investor copies of all necessary permits, approvals, and registrations
necessary to effect this Agreement, the Transaction Documents and any of the transactions contemplated hereby or thereby, including pursuant
to <U>Section 3.14</U> of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Trading
Market Approval</U>. The Company must have delivered to the Investor copies of the Supplemental Listing Application through which Exchange
Approval will be sought for the issuance of the Warrant Shares upon exercise of the Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Event(s) of Default</U>. No Event of Default shall have occurred and no Event of Default would result from the execution of this Agreement
or any of the Transaction Documents or the transactions contemplated hereby or thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. The representations and warranties of the Company contained herein shall be true and correct in all material respects
as of the date when made and as of such Closing as though made on and as of such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance</U>.
The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by it at or prior to such Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Suspensions of Trading in Common Stock; Listing</U>. Trading in the Common Stock shall not have been suspended by the SEC or Principal
Market (except for any suspensions of trading of not more than one day on which the Principal Market is open solely to permit dissemination
of material information regarding the Company) at any time since the date of execution of this Agreement, and the Common Stock shall have
been at all times since such date listed for trading on a Trading Market;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC
Reporting.</U> The has, during the preceding twelve (12) months, filed with the SEC all reports and other materials required to be filed
by Section 13 or 15(d) of the 1934 Act, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
on Beneficial Ownership</U>. To the Company&rsquo;s knowledge, the issuance of the Warrants, in reliance of the &ldquo;blocker&rdquo;
provision therein, shall not cause the Investor Group to become, directly or indirectly, a &ldquo;beneficial owner&rdquo; (within the
meaning of Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder) of a number of Equity Interests of a class
that is registered under the 1934 Act which exceeds the Maximum Percentage of the Equity Interests of such class that are outstanding
at such time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Perfection
of Security Interest; Evidence of Lien Release</U>. The Investor shall have, to the extent possible, perfected certain security interest
granted in the assets and collateral of the Company and its Subsidiaries described in the Security Documents. To the extent that the Investor
has not perfected the security interest granted in the assets and collateral of the Company and its Subsidiaries as described in the Security
Agreement, then, at the expense of the Company, the Company and its Subsidiaries shall immediately take all steps necessary and required
to perfect the Investors&rsquo; security interest in the assets and collateral of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Post
Closing Matters Agreement.</U> The Company must have exected and delivered to the Investor the Post Closing Matters Agreement, substantially
in the form set out in <U>Exhibit E</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Funds
Flow Request</U>. The Company shall have delivered to the Investor a flow of funds request, substantially in the form set out in <U>Exhibit
F</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Conditions
Precedent to the Obligations of the Company</U>. The obligation of the Company to issue the Note and the Warrants at the Closing is subject
to the satisfaction or waiver by the Company, at or before such Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. The representations and warranties of the Investor contained herein shall be true and correct in all material respects
as of the date when made and as of such Closing Date as though made on and as of such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance</U>.
The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by the Investor at or prior to the Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>EVENTS
OF DEFAULT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Events
of Default</U>. The occurrence of any of the following events shall be an &ldquo;<B>Event of Default</B>&rdquo; under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
Event of Default under the Note;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
of the representations or warranties made by the Company, any Subsidiary or any of their agents, officers, directors, employees or representatives
in any Transaction Document or public filing being inaccurate, false or misleading in any material respect, as of the date as of which
it is made or deemed to be made, or any certificate or financial or other written statements furnished by or on behalf of the Company
or any Subsidiary to the Investor or any of its representatives, is inaccurate, false or misleading, in any material respect, as of the
date as of which it is made or deemed to be made, or on any Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
failure by the Company to comply with any of its covenants or agreements set forth in this Agreement, including but not limited to those
set forth in <U>Section 5.7</U>, <U>Section 5.13</U>, <U>Section 6(k)</U>, and <U>Section 10</U>; provided, however, that it shall not
be an Event of Default as provided hereunder if the Company fails to comply with the Registration Rights provisions contained in Sections
9.1(a) or 9.1(c) of this Agreement; further, provided, however, that the nothing in this Section 7 shall prohibit, restrict or otherwise
limit the Investor&rsquo;s rights, and the Company&rsquo;s obligations, with regard to the Effectiveness Penalty pursuant to Section 9.1(c);
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
default or breach, in any material respect, under the Post Closing Matters Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Investor
Right to Investigate an Event of Default</U>. If in the Investor&rsquo;s reasonable opinion, an Event of Default has occurred, or is or
may be continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Investor may notify the Company that it wishes to investigate such purported Event of Default;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall cooperate with the Investor in such investigation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall comply with all reasonable requests made by the Investor to the Company in connection with any investigation by the Investor
and shall (i) provide all information requested by the Investor in relation to the Event of Default to the Investor; provided that the
Investor agrees that any materially price sensitive information and/or non-public information will be subject to confidentiality, and
(ii) provide all such requested information within five (5) Business Days of such request; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall pay all reasonable costs incurred by the Investor in connection with any such investigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Remedies
Upon an Event of Default</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an Event of Default occurs pursuant to <U>Section 7.1(a)</U>, the Investor shall have such remedies as are set forth in the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an Event of Default occurs pursuant to <U>Section 7.1(b)</U> or <U>Section&nbsp;7.1(c)</U> and is not remedied within (i) three (3) Business
Days for an Event of Default occurring by the Company&rsquo;s or any Subsidiary&rsquo;s failure to comply with <U>Section 7.1(c)</U>,
or (ii) ten (10) Business Days for an Event of Default occurring pursuant to <U>Section 7.1(b)</U>, the Investor may declare, by notice
to the Company or the applicable Subsidiary, as applicable, effective immediately, all outstanding obligations by the Company or the applicable
Subsidiary, as applicable, under the Transaction Documents to be immediately due and payable in immediately available funds and the Investor
shall have no obligation to consummate any Closing under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
any Event of Default occurs and is not remedied within (i) three (3) Business Days for an Event of Default occurring by the Company&rsquo;s
failure to comply with <U>Section 7.1(c)</U>, or (ii) ten (10) Business Days for an Event of Default occurring pursuant to <U>Section
7.1(b)</U>, the Investor may, by written notice to the Company, terminate this Agreement effective as of the date set forth in the Investor&rsquo;s
notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>TERMINATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Events
of Termination</U>. This Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;may
be terminated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the majority in interest of the Investors on the occurrence or existence of a Securities Termination Event or a Change of Control pursuant
to subsection (c) or (d) contained in that definition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the mutual written consent of the Company and the majority in interest of the Investors, at any time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
either Party, by written notice to the other Parties, effective immediately, if the Closing has not occurred within fifteen (15) Business
Days of the date of this Agreement or such later date as the Company and the majority in interest of the Investors agree in writing, provided
that the right to terminate this Agreement under this <U>Section 8.1(a)(iii)</U> is not available to any party that is in material breach
of or material default under this Agreement or whose failure to fulfill any obligation under this Agreement has been the principal cause
of, or has resulted in the failure of the Closing to occur; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the majority in interest of the Investors, in accordance with <U>Section 7.3(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Automatic
Termination</U>. This Agreement will automatically terminate, without further action by the parties, at the time after the Closing that
the Principal Amount outstanding under the Note and any accrued but unpaid interest is reduced to zero (0), whether as a result of prepayment
or repayment by the Company in accordance with the terms of this Agreement and the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Effect
of Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to <U>Section 8.3(b)</U>, each Party&rsquo;s right of termination under <U>Section 8.1</U> is in addition to any other rights it may have
under this Agreement or otherwise, and the exercise of a right of termination will not be an election of remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Investor terminates this Agreement under <U>Section 8.1(a)(i)</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Investor may declare, by notice to the Company, all outstanding obligations by the Company under the Transaction Documents to be due and
payable (including, without limitation, the immediate repayment of any Principal Amount outstanding under the Note plus accrued but unpaid
interest) without presentment, demand, protest or any other notice of any kind, all of which are expressly waived by the Company, anything
to the contrary contained in this Agreement or in any other Transaction Document notwithstanding; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.6in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company must within five (5) Business Days of such notice being received, pay to the Investor in immediately available funds the outstanding
Principal Amount for the Note plus all accrued interest thereon (if any), unless the Investor terminates this Agreement as a result of
an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
in this Agreement will be deemed to release any party from any liability for any breach by such party of the terms and provisions of this
Agreement or to impair the right of any party to compel specific performance by any other Party of its obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>REGISTRATION
RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Statement</U>. Promptly, but in any event no later than ten (10) days following the Closing Date, the Company shall prepare and file with
the SEC a Registration Statement covering the resale of all of the Warrant Shares and any and all other shares of Common Stock owned by
the Investor, including any and all Common Stock that may issuable upon exercise of warrants. The foregoing Registration Statement shall
be filed on Form S-3 or any successor forms thereto. The Registration Statement (and each amendment or supplement thereto) shall be provided
to the Investor and its counsel at least five (5) Business Days prior to its filing or other submission and the Company shall incorporate
all reasonable comments, in the Company&rsquo;s judgment, provided by the Investor or its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>.
Except as otherwise expressly provided herein, the Company will pay all fees and expenses incident to the performance of or compliance
with this Section 9, including all fees and expenses associated with effecting the registration of the Warrant Shares, including all filing
and printing fees, the Company&rsquo;s counsel and accounting fees and expenses, costs associated with clearing the Warrant Shares for
sale under applicable state securities laws, listing fees, fees and expenses of one counsel to the Investor and the Investor&rsquo;s reasonable
expenses in connection with the registration, but excluding discounts, commissions, fees of underwriters, selling brokers, dealer managers
or similar securities industry professionals with respect to the Warrant Shares being sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness;
Penalty</U>. The Company shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as
practicable after filing thereof but in no event later than forty-five (45) days following the Closing Date (the &ldquo;<B>Effective Date</B>&rdquo;).
The Company shall notify the Investor by e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after the
Registration Statement is declared effective and shall simultaneously provide the Investor with copies of any related Prospectus to be
used in connection with the sale or other disposition of the securities covered thereby. In the event that the Registration Statement
is not declared effective by the Effective Date, then the Company shall pay to the Investors, for each month that the Registration Statement
is not declared effective after the Effective Date, a cash amount equal to one and one-half percent (1.5%) of the product obtained by
multiplying the Investor Warrant Shares by the then applicable exercise price provided for in the Warrants and other Company warrants
owned by the Investor (the &ldquo;<B>Effectiveness Penalty</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Piggyback
Registration Rights</U>. If the Company at any time determines to file a registration statement under the 1933 Act to register the offer
and sale, by the Company, of Common Stock (other than (x) on Form S-4 or Form S-8 under the 1933 Act or any successor forms thereto, (y)
an at-the-market offering, or (z) a registration of securities solely relating to an offering and sale to employees or directors of the
Company pursuant to any employee stock plan or other employee benefit plan arrangement), the Company shall, as soon as reasonably practicable,
give written notice to each Investor of its intention to so register the offer and sale of Common Stock and, upon the written request,
given within five (5) Business Days after delivery of any such notice by the Company, of an Investor to include in such registration its
Warrant Shares (which request must (a) be approved by the majority in interest of the Investors and (b) specify the number of Warrant
Shares proposed to be included in such registration), the Company shall cause all such Warrant Shares to be included in such registration
statement on the same terms and conditions as the Common Stock otherwise being sold pursuant to such registered offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Company
Obligations</U>. The Company will use its best efforts to effect the registration of the Warrant Shares in accordance with the terms hereof,
and pursuant thereto the Company will, as expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
its commercially reasonable efforts to cause the Registration Statement to become effective and to remain continuously effective for a
period that will terminate upon the first date on which all Warrant Shares are either covered by the Registration Statement or may be
sold without restriction, including volume or manner-of-sale restrictions, pursuant to Rule 144 or have been sold by the Investor (the
&ldquo;<B>Effectiveness Period</B>&rdquo;) and advise the Investor in writing when the Effectiveness Period has expired;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prepare
and file with the SEC such amendments and post-effective amendments and supplements to the Registration Statement and the Prospectus as
may be necessary to keep the Registration Statement effective for the Effectiveness Period and to comply with the provisions of the 1933
Act and the 1934 Act with respect to the distribution of all of the Warrant Shares covered thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provide
copies to and permit counsel designated by the Investor to review all amendments and supplements to the Registration Statement no fewer
than three (3) Business Days prior to its filing with the SEC and not file any document to which such counsel reasonably objects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;furnish
to the Investor and its legal counsel, without charge, (i) promptly after the same is prepared and publicly distributed, filed with the
SEC, or received by the Company (but not later than two (2) Business Days after the filing date, receipt date or sending date, as the
case may be) one copy of the Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus and each amendment
or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence
from the SEC or the staff of the SEC, in each case relating to the Registration Statement (other than any portion of any thereof which
contains information for which the Company has sought confidential treatment), and (ii) such number of copies of a Prospectus, including
a preliminary prospectus, and all amendments and supplements thereto and such other documents as the Investor may reasonably request in
order to facilitate the disposition of the Warrant Shares that are covered by the related Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;immediately
notify the Investor of any request by the SEC for the amending or supplementing of the Registration Statement or Prospectus or for additional
information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
its commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii) if such
order is issued, obtain the withdrawal of any such order at the earliest possible moment and notify the Company of the issuance of any
such order and the resolution thereof, or its receipt of notice of the initiation or threat of any proceeding for such purpose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prior
to any public offering of Warrant Shares, use its commercially reasonable efforts to register or qualify or cooperate with the Investor
and its counsel in connection with the registration or qualification of such Warrant Shares for offer and sale under the securities or
blue sky laws of such jurisdictions requested by the Investor and do any and all other commercially reasonable acts or things necessary
or advisable to enable the distribution in such jurisdictions of the Warrant Shares covered by the Registration Statement and the Company
shall promptly notify the Investor of any notification with respect to the suspension of the registration or qualification of any of such
Warrant Shares for sale under the securities or blue sky laws of such jurisdictions or its receipt of notice of the initiation or threat
of any proceeding for such purpose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;immediately
notify the Investor, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening of any event
as a result of which, the Registration Statement or Prospectus includes an untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein not misleading (in the case of the Prospectus, in light
of the circumstances in which they were made), and promptly prepare, file with the SEC and furnish to such holder a supplement to or an
amendment of such Registration Statement or Prospectus as may be necessary so that such Registration Statement or Prospectus shall not
include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading (in the case of such Prospectus, in light of the circumstances in which they were made);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;otherwise
use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the 1933 Act and the 1934
Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hold
in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i) disclosure of such
information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to complete
the Registration Statement or to avoid or correct a misstatement or omission in the Registration Statement, (iii) the release of such
information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction,
or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement or any
other agreement, and upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental
body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor&rsquo;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take
all other reasonable actions necessary to expedite and facilitate disposition by the Investor of all Warrant Shares pursuant to the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by the Company</U>. The Company will indemnify and hold harmless the Investors, from and against any Losses to which they may become subject
under the 1933 Act or otherwise, arising out of, relating to or based upon: (i) any untrue statement or alleged untrue statement of any
material fact contained in any Registration Statement, any preliminary prospectus, final Prospectus or other document, including any blue
sky application (as defined below), or any amendment or supplement thereof or any omission or alleged omission of a material fact required
to be stated therein or, in the case of the Registration Statement, necessary to make the statements therein not misleading or, in the
case of any preliminary prospectus, final Prospectus or other document, necessary to make the statements therein, in light of the circumstances
in which they were made, not misleading; (ii) any blue sky application or other document executed by the Company specifically for that
purpose or based upon written information furnished by the Company filed in any state or other jurisdiction in order to qualify any or
all of the Warrant Shares under the securities laws thereof (any such application, document or information herein called a &ldquo;<B>Blue
Sky Application</B>&rdquo;); (iii) any violation or alleged violation by the Company or its agents of the 1933 Act, the 1934 Act or any
similar federal or state law or any rule or regulation promulgated thereunder applicable to the Company or its agents and relating to
any action or inaction required of the Company in connection with the registration or the offer or sale of the Warrant Shares pursuant
to any Registration Statement; or (iv) any failure to register or qualify the Warrant Shares included in any such Registration Statement
in any state where the Company or its agents has affirmatively undertaken or agreed in writing that the Company will undertake such registration
or qualification on the Investor&rsquo;s behalf and will reimburse the indemnified Investor Parties for any legal or other expenses reasonably
incurred by them in connection with investigating, preparing or defending any such Losses; <U>provided</U>, <U>however</U>, that the Company
will not be liable in any such case if and to the extent, but only to the extent, that any such Losses arise out of or are based upon
an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by the
Investor or any such controlling Person in writing specifically for use in such Registration Statement or Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct
of Indemnification Proceedings</U>. Any Person entitled to indemnification hereunder shall (i) give prompt notice to the indemnifying
party of any claim, action, suit or proceeding with respect to which it seeks indemnification following such Person&rsquo;s receipt of,
or such Person otherwise becoming aware of, the commencement of such claim, action, suit or proceeding and (ii) permit such indemnifying
party to assume the defense of such claim, action, suit or proceeding with counsel reasonably satisfactory to the indemnified party; <U>provided</U>,
<U>however</U>, that any Person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate
in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless (A) the indemnifying
party has agreed to pay such fees or expenses, (B) the indemnifying party shall have failed to assume the defense of such claim and employ
counsel reasonably satisfactory to such Person or (C) in the reasonable judgment of any such Person, based upon written advice of its
counsel, a conflict of interest exists between such Person and the indemnifying party with respect to such claims (in which case, if the
Person notifies the indemnifying party in writing that such Person elects to employ separate counsel at the expense of the indemnifying
party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person); and <U>provided</U>,
<U>further</U>, that the failure or delay of any indemnified party to give notice as provided herein shall not relieve the indemnifying
party of its obligations hereunder, except to the extent that such failure or delay to give notice shall materially adversely affect the
indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection
with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for
all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, consent to entry of any judgment
or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect of such claim or litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>.
If for any reason the indemnification provided for in the preceding paragraph (a) is unavailable to an indemnified party or insufficient
to hold it harmless, other than as expressly specified therein, the indemnifying party shall contribute to the amount paid or payable
by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the indemnified
party and the indemnifying party, as well as any other relevant equitable considerations. No Person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the 1933 Act shall be entitled to contribution from any Person not guilty of such fraudulent misrepresentation.
The indemnity and contribution agreements contained in this Section are in addition to any other rights or remedies that any indemnified
party may have under applicable law, by separate agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>GENERAL
PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Fees
and Expenses</U>. At the Closing, the Company shall pay any additional reasonable fees and disbursements of McCarter &amp; English LLP
above the initial retainer (&ldquo;<B>Esousa Counsel</B>&rdquo;) in connection with the preparation of the Transaction Documents, it being
understood that Investor Counsel has not rendered any legal advice to the Company in connection with the transactions contemplated hereby
and that the Company has relied for such matters on the advice of its own counsel. All fees to be paid referenced above shall be offset
against the Funding Amount of the Investor and paid directly by the Investor to Investor Counsel. Following the Closing, the Company shall
reimburse the Investor for all reasonable fees and disbursements of Investor Counsel in connection with any additional agreements arising
pursuant to the transactions contemplated in this Agreement, including, but not limited to, intercreditor agreements relating to the Note
and any agreements or documentation required with respect to the Investor&rsquo;s exercise of any of its rights hereunder. Except as specified
above, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents. The
Company shall pay all stamp and other Taxes and duties levied in connection with the sale of the Note and the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Appointment
of Collateral Agent.</U> The Investor agrees to the appointment of Esousa Holdings LLC, an Investor in the Notes, to act as Collateral
Agent and further each Investor authorizes Esousa Holdings LLC to act as Collateral Agent in accordance with the terms and conditions
detailed in the Security Agreement, executed and delivered on the date hereof, by and between the Company and Esousa Holdings LLC. The
Collateral Agent shall receive a fee of $25,000, as more fully detailed in that certain Fee Letter executed and delivered in connection
with this Agreement and the Security Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
<U>Consultation with Counsel. </U> Each Investor has had the opportunity to seek independent counsel and to consult with counsel in order
to review the Transaction Documents and to advise the Company with respect thereto before executing this Agreement. Each Investor is executing
this Agreement without duress or coercion and without reliance on any representations, warranties or commitments other than those representations,
warranties, and commitments set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via email
at the email address specified in this Section prior to 5:00 p.m. (New York time) on a Business Day, (b) the next Business Day after the
date of transmission, if such notice or communication is delivered via email at the email address specified in this Section on a day that
is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New York time) on such date, (c)
the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. <FONT STYLE="background-color: white">Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by email or facsimile, or sent by
a nationally recognized overnight courier service addressed to each Investor at the email address, facsimile number, or address of the
Investor appearing on the books of the Company, or if no such email address, facsimile number, or address appears on the books of the
Company, at the principal place of business of such Investor set forth on the Investor&rsquo;s signature page attached hereto. </FONT>The
address for such notices and communications shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">William B. Horne</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">Chief executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">BitNile Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">11411 Southern Highlands Parkway, Suite
240</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">Las Vegas, Nevada 89141</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">Direct: (949) 444-5464</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">Email: Will@bitnile.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.4in">With a copy (which shall not constitute
notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">Henry Nisser</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">President and General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">BitNile Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">100 Park Avenue, 16th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">Suite 1658A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">Direct: (646) 650-5044</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 1.35in">Email: Henry@bitnile.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.5</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability</U>.
If any provision of this Agreement is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable,
such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the validity
and enforceability of the remaining provisions of this Agreement will not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.6</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, without reference to
principles of conflict of laws or choice of laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.7</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Jurisdiction
and Venue</U>. Any action, proceeding or claim arising out of, or relating in any way to this Agreement shall be brought and enforced
in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York. The
Company and the Investor irrevocably submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive
any objection to such exclusive jurisdiction or that such courts represent an inconvenient forum. The prevailing party in any such action
shall be entitled to recover its reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses relating to such action or
proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.8</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>WAIVER
OF RIGHT TO JURY TRIAL</U>. THE COMPANY AND THE INVESTOR HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Survival</U>.
The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.10</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Entire
Agreement</U>. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.11</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived or amended except in a written instrument signed by the Company and the Investor.
No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Construction</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed as if drafted
jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provisions of this Agreement or any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.13</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors
and Assigns</U>. This Agreement shall be binding upon, and inure to the benefit of and be enforceable by, the Company and the Investor
and their respective successors and assigns. The Company may not assign this Agreement or any rights or obligations hereunder without
the prior written consent of the Investor. The Investor may assign any or all of its rights under this Agreement to any Person to whom
the Investor assigns or transfers any Securities, provided such transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions hereof that apply to the &ldquo;Investor&rdquo; and such transferee is an accredited investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>No
Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.15</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Further
Assurances</U>. Each party hereto shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in
order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-size: 10pt"><B>10.16</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterparts</U>.
This Agreement may be executed in two identical counterparts, both of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party. Signature pages delivered by facsimile
or e-mail shall have the same force and effect as an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><U>Specific
Performance</U>. The Company acknowledges that monetary damages alone would not be adequate compensation to the Investor for a breach
by the Company of this Agreement and the Investor may seek an injunction or an order for specific performance from a court of competent
jurisdiction if (a) the Company fails to comply or threatens not to comply with this Agreement or (b) the Investor has reason to believe
that the Company will not comply with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have executed this Securities Purchase Agreement as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><B>COMPANY</B>:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">BITNILE HOLDINGS, INC.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 72%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify">William B. Horne</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><B>REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><B>[SIGNATURE
PAGE FOR THE INVESTORS FOLLOWS]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Company Signature Page of Securities Purchase
Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>INVESTOR SIGNATURE PAGES TO
BITNILE HOLDINGS, INC. SECURITIES PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">IN WITNESS
WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 15%; font-size: 10pt"><FONT STYLE="background-color: white">Name of Investor:&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 30%"><FONT STYLE="background-color: white">Signature of Authorized Signatory of Investor:&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 68%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="background-color: white">Name of Authorized Signatory: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; white-space: nowrap"><FONT STYLE="background-color: white">Title of Authorized Signatory:&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="background-color: white">Email Address of Authorized Signatory:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="background-color: white">Facsimile Number of Authorized Signatory:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="background-color: white">Address for Notice to Investor: </FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 58%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 20%"><FONT STYLE="background-color: white">Subscription Amount: </FONT></TD>
    <TD STYLE="width: 10%; border-bottom: Black 1pt solid"><FONT STYLE="background-color: white">$</FONT></TD>
    <TD STYLE="width: 70%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 10%"><FONT STYLE="background-color: white">EIN Number: </FONT></TD>
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%"><FONT STYLE="background-color: white">With a copy (which shall not constitute notice) to:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 68%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Investor Signature Page of Securities Purchase
Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SECURITY DOCUMENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM OF NOTE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[See attached]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM OF CLASS A WARRANT </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[See attached]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM OF CLASS B WARRANT </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>POST CLOSING MATTERS AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBT F</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FLOW OF FUNDS REQUEST</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BitNile Holdings Inc. &ndash; Securities Purchase
Agreement &ndash; Flow of Funds Request</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Securities Purchase Agreement,
dated December 29, 2021 (the &ldquo;<B>Agreement</B>&rdquo;) between BitNile Holdings Inc. (the &ldquo;<B>Company</B>&rdquo;) and ___________
(the &ldquo;<B>Investor</B>&rdquo;), the Company irrevocably authorizes the Investor to distribute such funds as set out below, in the
manner set out below, at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used but not otherwise defined
in this letter will have the meaning given to such terms in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 71%; border: Black 1pt solid"><B><I>Item</I></B></TD>
    <TD STYLE="width: 29%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><B><I>Amount</I></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">Closing&nbsp;&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">Fees and Expenses</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">Bridge Financing Repayment</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">Total</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please transfer the net amount of US $XX due at the Closing, to the
following bank account:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beneficiary Bank: [&bull;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Swift code:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ABA/Routing #:[&bull;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Account #: [&bull;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beneficiary name and address: [&bull;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>BITNILE HOLDINGS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 52%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name: </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title: </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex10_2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SECURITY AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This <B>PLEDGE AND SECURITY
AGREEMENT</B>, dated as of December 29, 2021 (this &ldquo;<B><U>Agreement</U></B>&rdquo;), is made by (i) <FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>BitNile
Holdings, Inc.</B></FONT>, a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo; or the &ldquo;<B><U>Grantor</U></B>&rdquo;,
and collectively with each subsidiary of the Company listed as a &ldquo;Guarantor&rdquo; on the signature pages hereto (together with
each other Person that executes a joinder agreement and becomes a &ldquo;Guarantor&rdquo; hereunder or otherwise guaranties all or any
part of the Secured Obligations, each a &ldquo;<B><U>Guarantor</U></B>&rdquo; and collectively, the &ldquo;<B><U>Guarantors</U></B>&rdquo;
or, together with the Company, the &ldquo;<B><U>Grantors</U></B>&rdquo;) and (ii) Digital Farms Management LLC, solely for purposes of
pledging its membership interests in Alliance Cloud Services, LLC, in favor of <FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Esousa
Holdings, LLC</B></FONT>, a New York limited liability company (&ldquo;<B><U>Esousa</U></B>&rdquo;), in its capacity as collateral agent
for the Secured Parties referred to below (in such capacity, together with its successors and assigns in such capacity, if any, the &ldquo;<B><U>Collateral
Agent</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RECITALS</U>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Securities Purchase Agreement, dated as of the date hereof (such agreement, as amended, restated, supplemented, modified or otherwise
changed from time to time, including any replacement agreement therefor, being herein referred to as the &ldquo;<B><U>Purchase Agreement</U></B>&rdquo;),
by and among the&nbsp;Company, the investors from time to time party thereto (each a &ldquo;<B><U>Investor</U></B>&rdquo; and collectively,
the&nbsp;&rdquo;<B><U>Investors</U></B>&rdquo;), and the Collateral Agent, the Investors have agreed to purchase certain Senior Secured
Promissory Notes dated on or about the date hereof (each a &ldquo;<B><U>Note</U></B>&rdquo; and collectively, the &ldquo;<B><U>Notes</U></B>&rdquo;)
and warrants (the &ldquo;<B><U>Warrants</U></B>&rdquo;), from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is a condition precedent to the Investors purchasing the Notes and Warrants from the Company pursuant to the Purchase Agreement that each
Grantor shall have executed and delivered to the Collateral Agent a pledge to the Collateral Agent, for the benefit of the Secured Parties,
and the granting to the Collateral Agent, for the benefit of the Secured Parties, a security interest in and lien on all of the Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Grantors are mutually dependent on each other in the conduct of their respective businesses as an integrated operation, with credit needed
from time to time by each Grantor often being provided through financing obtained by the other Grantors and the ability to obtain such
financing being dependent on the successful operations of all of the Grantors as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor has determined that the execution, delivery and performance of this Agreement directly benefit, and are in the best interest of,
such Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">NOW, THEREFORE, in consideration
of the premises and the agreements herein and in order to induce the Collateral Agent and the Investors to purchase the Notes and to provide
other financial accommodations to the Company pursuant to the Purchase Agreement, the Grantors hereby jointly and severally agree with
the Collateral Agent, for the benefit of the Secured Parties, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reference
is hereby made to the Purchase Agreement for a statement of the terms thereof. All capitalized terms used in this Agreement and the recitals
hereto which are defined in the Purchase Agreement or in Article 8 or 9 of the Uniform Commercial Code as in effect from time to time
in the State of New York (the &ldquo;<B><U>Code</U></B>&rdquo;) and which are not otherwise defined herein shall have the same meanings
herein as set forth therein; <U>provided</U> that terms used herein which are defined in the Code as in effect in the State of New York
on the date hereof shall continue to have the same meaning notwithstanding any replacement or amendment of such statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following terms shall have the respective meanings provided for in the Code: &ldquo;Accounts&rdquo;, &ldquo;Account Debtor&rdquo;, &ldquo;Cash
Proceeds&rdquo;, &ldquo;Certificate of Title&rdquo;, &ldquo;Chattel Paper&rdquo;, &ldquo;Commercial Tort Claim&rdquo;, &ldquo;Commodity
Account&rdquo;, &ldquo;Commodity Contracts&rdquo;, &ldquo;Deposit Account&rdquo;, &ldquo;Documents&rdquo;, &ldquo;Electronic Chattel Paper&rdquo;,
&ldquo;Equipment&rdquo;, &ldquo;Fixtures&rdquo;, &ldquo;General Intangibles&rdquo;, &ldquo;Goods&rdquo;, &ldquo;Instruments&rdquo;, &ldquo;Inventory&rdquo;,
&ldquo;Investment Property&rdquo;, &ldquo;Letter-of-Credit Rights&rdquo;, &ldquo;Noncash Proceeds&rdquo;, &ldquo;Payment Intangibles&rdquo;,
&ldquo;Proceeds&rdquo;, &ldquo;Promissory Notes&rdquo;, &ldquo;Record&rdquo;, &ldquo;Security Account&rdquo;, &ldquo;Software&rdquo;,
&ldquo;Supporting Obligations&rdquo; and &ldquo;Tangible Chattel Paper&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used in this Agreement, the following terms shall have the respective meanings indicated below, such meanings to be applicable equally
to both the singular and plural forms of such terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Additional Collateral</U></B>&rdquo;
has the meaning specified therefor in <U>Section 4(a)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Copyrights</U></B>&rdquo;
means any and all rights in any published and unpublished works of authorship, including (i) copyrights and moral rights, (ii) copyright
registrations and recordings thereof and all applications in connection therewith including those listed on <U>Schedule II</U> and all
renewals, extensions, restorations and reversions thereof, (iii) income, license fees, royalties, damages, and payments now and hereafter
due or payable under and with respect thereto, including payments under all licenses entered into in connection therewith and damages
and payments for past, present, or future infringements thereof, (iv) the right to sue for past, present, and future infringements thereof,
and (v) all of each Grantor&rsquo;s rights corresponding thereto throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Event of Default</U></B>&rdquo;
has the meaning given to such term in the Purchase Agreement and the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Existing Issuer</U></B>&rdquo;
has the meaning specified therefor in the definition of the term &ldquo;Pledged Shares&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Intellectual Property</U></B>&rdquo;
means any and all Patents, Copyrights, Trademarks, trade secrets, know-how, inventions (whether or not patentable), algorithms, software
programs (including source code and object code), processes, product designs, industrial designs, blueprints, drawings, data, customer
lists, URLs and domain names, specifications, documentations, reports, catalogs, literature, and any other forms of technology or proprietary
information of any kind, including all rights therein and all applications for registration or registrations thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Licenses</U></B>&rdquo;
means, with respect to any Person (the &ldquo;<B><U>Specified Party</U></B>&rdquo;), (i) any licenses or other similar rights provided
to the Specified Party in or with respect to Intellectual Property owned or controlled by any other Person, and (ii) any licenses or other
similar rights provided to any other Person in or with respect to Intellectual Property owned or controlled by the Specified Party, in
each case, including (A) any software license agreements (other than license agreements for commercially available off-the-shelf software
that is generally available to the public which have been licensed to a Grantor pursuant to end-user licenses), (B) the license agreements
listed on <U>Schedule III</U>, and (C) the right to use any of the licenses or other similar rights described in this definition in connection
with the enforcement of any of the Collateral Agent&rsquo;s and the Investors&rsquo; rights under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Lien</U></B>&rdquo;
means any lien, encumbrance, claim, charge, pledge, security interest, assignment, hypothecation, deed of trust, mortgage, lease, conditional
sale, retention of title or other preferential arrangement having substantially the same economic effect as any of the foregoing, whether
voluntary, involuntary or imposed by Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Patents</U></B>&rdquo;
means patents and patent applications, including (i) the patents and patent applications listed on <U>Schedule IV</U>, (ii) all continuations,
divisionals, continuations-in-part, re-examinations, reissues, and renewals thereof and improvements thereon, (iii) all income, royalties,
damages and payments now and hereafter due or payable under and with respect thereto, including payments under all licenses entered into
in connection therewith and damages and payments for past, present, or future infringements thereof, (iv) the right to sue for past, present,
and future infringements thereof, and (v) all of each Grantor&rsquo;s rights corresponding thereto throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Permitted Liens</U></B>&rdquo;
mean (1) Liens and security interests securing Indebtedness owed by a Grantor to any other Grantor, provided that such Indebtedness is
subordinate to the Secured Obligations and such Liens are second in priority to the Liens of the Agent; (2) liens for taxes, assessments,
or similar charges either not yet due or being contested in good faith; (3) liens of materialmen, mechanics, warehousemen, or carriers,
or other like liens arising in the ordinary course of business on an arms&rsquo; length basis and securing obligations which are not
yet delinquent; (4) purchase money liens or purchase money security interests upon or in any property acquired or held by a Grantor in
the ordinary course of business to secure Indebtedness outstanding on the date of this Agreement or permitted to be incurred under this
Agreement; (5) Liens which, as of the date of this Agreement, have been disclosed to and approved by the Agent on behalf of the Investors
in writing; and (6) those Liens which in the aggregate constitute an immaterial and insignificant monetary amount with respect to the
net value of the Grantors&rsquo; assets, taken as a whole, in any event not exceeding $25,000 in any single instance or $100,000 in the
aggregate outstanding at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Pledged Debt</U></B>&rdquo;
means the indebtedness described in <U>Schedule X</U> and all indebtedness from time to time owned or acquired by a Grantor, the promissory
notes and other Instruments evidencing any or all of such indebtedness, and all interest, cash, Instruments, Investment Property, financial
assets, securities, Equity Interests, other equity interests, stock options and commodity contracts, notes, debentures, bonds, promissory
notes or other evidences of indebtedness and all other property from time to time received, receivable or otherwise distributed in respect
of or in exchange for any or all of such indebtedness.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Pledged Interests</U></B>&rdquo;
means, collectively, (a) the Pledged Debt, (b) the Pledged Shares and (c) all security entitlements in any and all of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Pledged Issuer</U></B>&rdquo;
has the meaning specified therefor in the definition of the term &ldquo;Pledged Shares&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Pledged Shares</U></B>&rdquo;
means (a) the shares of Equity Interests described in <U>Schedule XI</U>, whether or not evidenced or represented by any stock certificate,
certificated security or other Instrument, issued by the Persons described in such <U>Schedule XI</U> (the &ldquo;<B><U>Existing Issuers</U></B>&rdquo;),
(b) the shares of Equity Interests at any time and from time to time acquired by a Grantor of any and all Persons now or hereafter existing
(such Persons, together with the Existing Issuers, being hereinafter referred to collectively as the &ldquo;<B><U>Pledged Issuers</U></B>&rdquo;
and each individually as a &ldquo;<B><U>Pledged Issuer</U></B>&rdquo;), whether or not evidenced or represented by any stock certificate,
certificated security or other Instrument, and (c) the certificates representing such shares of Equity Interests, all options and other
rights, contractual or otherwise, in respect thereof and all dividends, distributions, cash, Instruments, Investment Property, financial
assets, securities, Equity Interests, other equity interests, stock options and commodity contracts, notes, debentures, bonds, promissory
notes or other evidences of indebtedness and all other property (including without limitation, any stock dividend and any distribution
in connection with a stock split) from time to time received, receivable or otherwise distributed in respect of or in exchange for any
or all of such Equity Interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Post-Closing Agreement</U></B>&rdquo;
means the Post-Closing Agreement of even date herewith between the Agent and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Secured Obligations</U></B>&rdquo;
has the meaning specified therefor in <U>Section 3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Secured Parties</U></B>&rdquo;
means the Agent, for itself and on behalf of the Investors, and the Investors, and each of their successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Titled Collateral</U></B>&rdquo;
means all Collateral for which the title to such Collateral is governed by a Certificate of Title or certificate of ownership, including
without limitation, all motor vehicles (including without limitation, all trucks, trailers, tractors, service vehicles, automobiles and
other mobile equipment) for which the title to such motor vehicles is governed by a Certificate of Title or certificate of ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Trademarks</U></B>&rdquo;
means any and all trademarks, trade names, registered trademarks, trademark applications, service marks, registered service marks, brand
names, certification marks, collective marks, logos, symbols, trade dress, assumed names, fictitious names and service mark applications,
including (i) the trade names, registered trademarks, trademark applications, registered service marks and service mark applications listed
on <U>Schedule V</U>, (ii) all extensions, modifications and renewals thereof, (iii) all income, royalties, damages and payments now and
hereafter due or payable under and with respect thereto, including payments under all licenses entered into in connection therewith and
damages and payments for past or future infringements or dilutions thereof, (iv) the right to sue for past, present and future infringements
and dilutions thereof, (v) the goodwill of each Grantor&rsquo;s business symbolized by the foregoing or connected therewith, and (vi)
all of each Grantor&rsquo;s rights corresponding thereto throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Transaction Documents</U></B>&rdquo;
has the meaning given to such term in the Purchase Agreement and includes this Agreement and any Security Agreement Supplement, as any
of such documents may be amended, restated, supplemented, modified or otherwise changed from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
2.&nbsp;</FONT><U>Grant of Security Interest</U>. As collateral security for the payment, performance and observance of all of the Secured
Obligations, each Grantor hereby pledges and assigns to the Collateral Agent (and its agents and designees), and grants to the Collateral
Agent (and its agents and designees), for itself and the benefit of the other Secured Parties, a continuing security interest in all personal
property and Fixtures of such Grantor, wherever located and whether now or hereafter existing and whether now owned or hereafter acquired,
of every kind and description, tangible or intangible, including without limitation, the following (all being collectively referred to
herein as the &ldquo;<B><U>Collateral</U></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Accounts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Chattel Paper (whether tangible or electronic);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Commercial Tort Claims, including without limitation, those specified on <U>Schedule IX</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Deposit Accounts, all cash, and all other property from time to time deposited therein or otherwise credited thereto and the monies and
property in the possession or under the control of the Collateral Agent or any Investor or any Affiliate, representative, agent or correspondent
of the Collateral Agent or any Investor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
General Intangibles (including without limitation, all Payment Intangibles, Intellectual Property and Licenses);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Goods, including without limitation, all Equipment, Fixtures and Inventory;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Instruments (including without limitation, Promissory Notes);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Investment Property;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Letter-of-Credit Rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Pledged Interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Supporting Obligations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
other tangible and intangible personal property of such Grantor (whether or not subject to the Code), including without limitation, all
bank and other accounts and all cash and all investments therein, all proceeds, products, offspring, accessions, rents, profits, income,
benefits, substitutions and replacements of and to any of the property of such Grantor described in the preceding clauses of this <U>Section
2</U> (including without limitation, any proceeds of insurance thereon and all causes of action, claims and warranties now or hereafter
held by such Grantor in respect of any of the items listed above), and all books, correspondence, files and other Records, including without
limitation, all tapes, disks, cards, Software, data and computer programs in the possession or under the control of such Grantor or any
other Person from time to time acting for such Grantor that at any time evidence or contain information relating to any of the property
described in the preceding clauses of this <U>Section 2</U> or are otherwise necessary or helpful in the collection or realization thereof;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Proceeds, including all Cash Proceeds and Noncash Proceeds, and products of any and all of the foregoing Collateral;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in each case howsoever such Grantor&rsquo;s interest
therein may arise or appear (whether by ownership, security interest, claim or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Security for Secured Obligations</U>. The security interest created under this Agreement, including under <U>Section 2</U>,
in the Collateral constitutes continuing collateral security for all of the following obligations, whether now existing or hereafter incurred
(the &ldquo;<B><U>Secured Obligations</U></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
prompt payment by each Grantor, as and when due and payable (whether by scheduled maturity, required prepayment, acceleration, demand
or otherwise), of all amounts from time to time owing by it in respect of the Purchase Agreement, the Notes and any other Transaction
Documents (other than the Warrants), including without limitation, (i)&nbsp;all obligations of the Company to pay the &ldquo;Principal
Amount&rdquo; under the Notes and make and fulfill any other repayment obligations as to the principal thereunder, (ii)&nbsp;in the case
of a Guarantor, all amounts from time to time owing by such Grantor in respect of its guaranty made pursuant to this Agreement or under
any other guaranty to which it is a party, including without limitation, all obligations guaranteed by such Grantor and (iii)&nbsp;all
interest, fees, commissions, charges, expense reimbursements, indemnifications and all other amounts due or to become due under any Note
or other Transaction Document (other than the Warrants) (including without limitation, all interest, fees, commissions, charges, expense
reimbursements, indemnifications and other amounts that accrue after the commencement of any Insolvency Proceeding of any Grantor, whether
or not the payment of such interest, fees, commissions, charges, expense reimbursements, indemnifications and other amounts are unenforceable
or are not allowable, in whole or in part, due to the existence of such Insolvency Proceeding); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
due performance and observance by each Grantor of all of its other obligations from time to time existing in respect of the Purchase Agreement,
the Notes and any other Transaction Documents (other than the Warrants);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">provided that, when the Notes
have been indefeasibly paid in full pursuant to their terms, the term &ldquo;Secured Obligations&rdquo; shall not include any of the foregoing
obligations under the Purchase Agreement or any other Transaction Documents, and any remaining obligations under such Transaction Documents
shall no longer be secured hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Delivery of the Pledged Interests</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;All
promissory notes currently evidencing the Pledged Debt and all certificates currently representing the Pledged Shares shall be delivered
to the Collateral Agent, subject to the Post-Closing Agreement, on or prior to the execution and delivery of this Agreement. All other
promissory notes, certificates and Instruments constituting Pledged Interests from time to time required to be pledged to the Collateral
Agent pursuant to the terms of this Agreement or the Purchase Agreement (the &ldquo;<B><U>Additional Collateral</U></B>&rdquo;) shall
be delivered to the Collateral Agent promptly upon, but in any event within five days of, receipt thereof by or on behalf of any of the
Grantors. All such promissory notes, certificates and Instruments shall be held by or on behalf of the Collateral Agent pursuant hereto
and shall be delivered in suitable form for transfer by delivery or shall be accompanied by duly executed instruments of transfer or assignment
or undated stock powers executed in blank, all in form and substance reasonably satisfactory to the Collateral Agent. If any Pledged Interest
consists of uncertificated securities, unless the immediately following sentence is applicable thereto, such Grantor shall cause the Collateral
Agent (or its designated custodian or nominee) to become the registered holder thereof, or cause each issuer of such securities to agree,
so long as this Agreement is effective, that it will comply with instructions originated by the Collateral Agent with respect to such
securities without further consent by such Grantor. If any Pledged Interest consists of security entitlements, such Grantor shall transfer
such security entitlements to the Collateral Agent (or its custodian, nominee or other designee), or cause the applicable securities intermediary
to agree that it will comply with entitlement orders by the Collateral Agent without further consent by such Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
five days of the receipt by a Grantor of any Additional Collateral, a Pledge Amendment, duly executed by such Grantor, in substantially
the form of Exhibit A hereto (a &ldquo;<B><U>Pledge Amendment</U></B>&rdquo;), shall be delivered to the Collateral Agent, in respect
of the Additional Collateral that must be pledged pursuant to this Agreement and the Purchase Agreement. The Pledge Amendment shall from
and after delivery thereof constitute part of <U>Schedules X</U> and <U>XI</U>. Each Grantor hereby authorizes the Collateral Agent to
attach each Pledge Amendment to this Agreement and agrees that all promissory notes, certificates or Instruments listed on any Pledge
Amendment delivered to the Collateral Agent shall for all purposes hereunder constitute Pledged Interests and such Grantor shall be deemed
upon delivery thereof to have made the representations and warranties set forth in <U>Section 5</U> with respect to such Additional Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Grantor shall receive, by virtue of such Grantor&rsquo;s being or having been an owner of any Pledged Interests, any (i) stock certificate
(including without limitation, any certificate representing a stock dividend or distribution in connection with any increase or reduction
of capital, reclassification, merger, consolidation, sale of assets, combination of shares, stock split, spin-off or split-off), promissory
note or other Instrument, (ii) option or right, whether as an addition to, substitution for, or in exchange for, any Pledged Interests,
or otherwise, (iii) dividends payable in cash (except such dividends permitted to be retained by any such Grantor pursuant to <U>Section
7</U>) or in securities or other property or (iv) dividends, distributions, cash, Instruments, Investment Property and other property
in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or paid-in
surplus, such Grantor shall receive such stock certificate, promissory note, Instrument, option, right, payment or distribution in trust
for the benefit of the Collateral Agent, shall segregate it from such Grantor&rsquo;s other property and shall deliver it forthwith to
the Collateral Agent, in the exact form received, with any necessary indorsement and appropriate stock powers duly executed in blank,
to be held by the Collateral Agent as Pledged Interests and as further collateral security for the Secured Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations and Warranties</U>. Each Grantor represents and warrants as of the date of this Agreement or any applicable
Security Agreement Supplement to which it is a party as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule
I</U> sets forth (i) the exact legal name of each Grantor, (ii) the state or jurisdiction of organization of each Grantor, (iii) the type
of organization of each Grantor and (iv) the organizational identification number of each Grantor or states that no such organizational
identification number exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as disclosed in the Public Record, there is no pending or, to the knowledge of any Grantor, written notice threatening action, suit, proceeding
or claim before any court or other Governmental Entity or any arbitrator, or any order, judgment or award by any court or other Governmental
Entity or any arbitrator, that may adversely affect the grant by any Grantor, or the perfection, of the security interest purported to
be created hereby in the Collateral, or the exercise by the Collateral Agent of any of its rights or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Equipment, Fixtures, Inventory and other Goods now existing are, and all Equipment, Fixtures, Inventory and other Goods hereafter existing
will be, located at the addresses specified therefor in <U>Schedule VI</U> (as amended, supplemented or otherwise modified from time to
time in accordance with <U>Section 6(b)</U>). Each Grantor&rsquo;s chief place of business and chief executive office, the place where
such Grantor keeps its Records concerning Accounts and all originals of all Chattel Paper are located at the addresses specified therefor
in <U>Schedule VI</U> (as amended, supplemented or otherwise modified from time to time in accordance with the terms hereof). None of
the Accounts is evidenced by Promissory Notes or other Instruments. Set forth in <U>Schedule VII</U> is a complete and accurate list,
as of the date of this Agreement, of each Deposit Account, Securities Account and Commodities Account of each Grantor, together with the
name and address of each institution at which each such Account is maintained, the account number for each such Account and a description
of the purpose of each such Account. Set forth in <U>Schedule V</U> is (i) a complete and correct list of each trade name used by each
Grantor and (ii) the name of, and each trade name used by, each Person from which such Grantor has acquired any substantial part of the
Collateral within five years of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Date, (i) <U>Schedule II</U> provides a complete and correct list of all registered Copyrights owned by any Grantor,
all applications for registration of Copyrights owned by any Grantor, and all other Copyrights owned by any Grantor and material to the
conduct of the business of any Grantor; (ii) <U>Schedule III</U> provides a complete and correct list of all Licenses entered into by
any Grantor pursuant to which (A) any Grantor has provided any license or other rights in Intellectual Property owned or controlled by
such Grantor to any other Person other than non-exclusive software licenses granted in the ordinary course of business or (B) any Person
has granted to any Grantor any license or other rights in Intellectual Property owned or controlled by such Person that is material to
the business of such Grantor; (iii) <U>Schedule IV</U> provides a complete and correct list of all Patents owned by any Grantor and all
applications for Patents owned by any Grantor; and (iv) <U>Schedule V</U> provides a complete and correct list of all registered Trademarks
owned by any Grantor, all applications for registration of Trademarks owned by any Grantor, and all other Trademarks owned by any Grantor
and material to the conduct of the business of any Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
(A) Each Grantor owns, or holds licenses in, or otherwise possesses legally enforceable rights in, all Intellectual Property that is reasonably
necessary to the operation of its business as currently conducted, or (B) each Grantor is the sole and exclusive owner of Intellectual
Property (free and clear of any Liens) used by it and has sole and exclusive rights to the use and distribution therefor or the material
covered thereby in connection with the services or products in respect of which such Intellectual Property are currently being used, sold,
licensed or distributed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for those claims which could not reasonably be expected to result in a Material Adverse Effect and which the applicable Grantor is diligently
pursuing the remedy thereof, no claims with respect to the Intellectual Property rights of any Grantor are pending or, to the knowledge
of any Grantor, threatened against any Grantor or, to the knowledge of any Grantor, any other Person, (i)&nbsp;alleging that the manufacture,
sale, licensing or use of any Intellectual Property as now manufactured, sold, licensed or used by any Grantor or any third party infringes
on any intellectual property rights of any third party, (ii)&nbsp;against the use by any Grantor or any third party of any technology,
know-how or computer software used in any Grantor&rsquo;s business as currently conducted or (iii)&nbsp;challenging the ownership by any
Grantor, or the validity or effectiveness, of any such Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the knowledge of any Grantor, (i)&nbsp;no Grantor has infringed on any intellectual property rights of any third party and (ii)&nbsp;none
of the Intellectual Property rights of any Grantor infringes on any intellectual property rights of any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
registered Copyrights, registered Trademarks, and issued Patents that are owned by such Grantor and necessary in the conduct of its business
are valid, subsisting and enforceable and have at all times been in compliance with all laws, rules, regulations, and orders of any Governmental
Entity applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor has taken reasonable steps to maintain the confidentiality of and otherwise protect and enforce its rights in all trade secrets
owned by such Grantor that are necessary in the business of such Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than software which by the terms of its own license explicitly permits the licensee to distribute the software together with other commercial
programs with no restrictions on such Grantor&rsquo;s ability to charge fees for such distribution and with no restriction on such Grantor&rsquo;s
right to receive payments for transfer of its Intellectual Property, no open source or public library software, including any version
of any software licensed pursuant to any GNU public license, is, in whole or in part, embodied or incorporated, in any manner, in any
Grantor&rsquo;s software products that is licensed or distributed by any Grantor. No open source or public library software licensed pursuant
to any GNU public license which requires any Grantor to license such Grantor&rsquo;s software products to third parties, or any other
license which requires any Grantor to license such Grantor&rsquo;s software products to third parties, is embodied or incorporated, in
any manner, in any Grantor&rsquo;s source code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as noted on <U>Schedule XI</U>, the Existing Issuers set forth in <U>Schedule XI</U> identified as a Subsidiary of a Grantor are each
such Grantor&rsquo;s only Subsidiaries existing on the date hereof. The Pledged Shares have been duly authorized and validly issued and
are fully paid and nonassessable and the holders thereof are not entitled to any preemptive, first refusal or other similar rights. Except
as noted in <U>Schedule XI</U>, the Pledged Shares constitute 100% of the issued shares of Equity Interests of the Pledged Issuers as
of the date hereof. All other shares of Equity Interests constituting Pledged Interests will be duly authorized and validly issued, fully
paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
promissory notes currently evidencing the Pledged Debt have been, and all other promissory notes from time to time evidencing Pledged
Debt, when executed and delivered, will have been, duly authorized, executed and delivered by the respective makers thereof, and all such
promissory notes are or will be, as the case may be, legal, valid and binding obligations of such makers, enforceable against such makers
in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other similar Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Grantors are and will be at all times the sole and exclusive owners of, or otherwise have and will have adequate rights in, the Collateral
free and clear of any Lien, except for Permitted Liens. No effective financing statement or other instrument similar in effect covering
all or any part of the Collateral is on file in any recording or filing office, except such as are securing Permitted Liens as of the
date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exercise by the Collateral Agent of any of its rights and remedies hereunder will not contravene any Law or any contractual restriction
binding on or otherwise affecting any Grantor or any of its properties and will not result in, or require the creation of, any Lien upon
or with respect to any of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
authorization or approval or other action by, and no notice to or filing with, any Governmental Entity or any other Person (other than
those that have been obtained and are in full force and effect) is required for (i) the due execution, delivery and performance by any
Grantor of this Agreement, (ii)&nbsp;the grant by any Grantor of the security interest purported to be created hereby in the Collateral
or (iii)&nbsp;the exercise by the Collateral Agent of any of its rights and remedies hereunder, except, in the case of this clause (iii),
as may be required in connection with any sale of any Pledged Interests by Laws affecting the offering and sale of securities generally,
except for (A) the filing under the Uniform Commercial Code as in effect in the applicable jurisdiction of the financing statements described
in <U>Schedule VIII</U> and (B) such control account agreements required to perfect the Liens hereunder, as may be subject to Section
6(l) and the Post-Closing Agreement. No authorization or approval or other action by, and no notice to or filing with, any Governmental
Entity or any other Person, is required for the perfection of the security interest purported to be created hereby in the Collateral (other
than those that have been obtained and are in full force and effect), except (A)&nbsp;for the filing under the Uniform Commercial Code
as in effect in the applicable jurisdiction of the financing statements described in <U>Schedule VIII</U>, (B)&nbsp;such control account
agreements required to perfect the Liens hereunder, as may be subject to Section 6(l) and the Post-Closing Agreement, (C) with respect
to the perfection of the security interest created hereby in the United States Intellectual Property and Licenses, for the recording of
the appropriate Assignment for Security, substantially in the form of Exhibit B hereto in the United States Patent and Trademark Office
or the United States Copyright Office, as applicable, (D)&nbsp; with respect to the perfection of the security interest created hereby
in Titled Collateral, for the submission of an appropriate application requesting that the Lien of the Collateral Agent be noted on the
Certificate of Title or certificate of ownership, completed and authenticated by the applicable Grantor, together with the Certificate
of Title or certificate of ownership, with respect to such Titled Collateral, to the appropriate Governmental Entity, (E) with respect
to any action that may be necessary to obtain control of Collateral constituting Deposit Accounts, Electronic Chattel Paper, Investment
Property or Letter-of-Credit Rights, the taking of such actions, and (F) the Collateral Agent&rsquo;s having possession of all Documents,
Chattel Paper, Instruments and cash constituting Collateral (subclauses (A), (B), (C), (D), (E), and (F), each a &ldquo;<B><U>Perfection
Requirement</U></B>&rdquo; and collectively, the &ldquo;<B><U>Perfection Requirements</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement creates a legal, valid and enforceable security interest in favor of the Collateral Agent, for the benefit of the Secured Parties,
in the Collateral, as security for the Secured Obligations. The compliance with the Perfection Requirements result in the perfection of
such security interests. Such security interests are, or in the case of Collateral in which any Grantor obtains rights after the date
hereof, will be, perfected, first priority security interests subject only to Permitted Liens and the Perfection Requirements. Such Perfection
Requirements and all other action necessary or desirable to perfect and protect such security interest have been duly made or taken, except
for (i) the Collateral Agent&rsquo;s having possession of all Instruments, Documents, Chattel Paper and cash constituting Collateral after
the date hereof, (ii) the Collateral Agent&rsquo;s having control of all Deposit Accounts (subject to Section 6(l)), Electronic Chattel
Paper, Investment Property or Letter-of-Credit Rights constituting Collateral after the date hereof, and (iii) the other filings and recordations
and actions described in <U>Section 5(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date hereof, no Grantor holds any Commercial Tort Claims or is aware of any such pending claims, except for such claims described
in <U>Schedule IX</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to each Grantor and its Subsidiaries that is a partnership or a limited liability company, each such Person has irrevocably opted
into (and has caused each of its Subsidiaries that is a partnership or a limited liability company, and a Pledged Issuer to opt into)
Article 8 of the Uniform Commercial Code. Such interests are securities for purposes of Article 8 of any relevant Uniform Commercial Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Covenants as to the Collateral</U>. So long as any of the Secured Obligations (whether or not due) shall remain unpaid,
unless the Collateral Agent shall otherwise consent in writing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further
Assurances</U>. Each Grantor will at its expense, at any time and from time to time, promptly execute and deliver all further instruments
and documents and take all further action that may be necessary or desirable or that the Collateral Agent may request in order (i)&nbsp;to
perfect and protect, or maintain the perfection of, the security interest and Lien purported to be created hereby; (ii)&nbsp;to enable
the Collateral Agent to exercise and enforce its rights and remedies hereunder in respect of the Collateral; or (iii)&nbsp;otherwise to
effect the purposes of this Agreement, including without limitation: (A)&nbsp;marking conspicuously all Chattel Paper, Instruments and
Licenses and, at the request of the Collateral Agent, all of its Records pertaining to the Collateral with a legend, in form and substance
satisfactory to the Collateral Agent, indicating that such Chattel Paper, Instrument, License or Collateral is subject to the security
interest created hereby, (B)&nbsp;if any Account shall be evidenced by a Promissory Note or other Instrument or Chattel Paper, delivering
and pledging to the Collateral Agent such Promissory Note, other Instrument or Chattel Paper, duly endorsed and accompanied by executed
instruments of transfer or assignment, all in form and substance satisfactory to the Collateral Agent, (C)&nbsp;executing and filing (to
the extent, if any, that such Grantor&rsquo;s signature is required thereon) or authenticating the filing of, such financing or continuation
statements, or amendments thereto, (D) with respect to Intellectual Property hereafter existing and not covered by an appropriate security
interest grant, the executing and recording in the United States Patent and Trademark Office or the United States Copyright Office, as
applicable, appropriate instruments granting a security interest, as may be necessary or desirable or that the Collateral Agent may reasonably
request in order to perfect and preserve the security interest purported to be created hereby, (E) delivering to the Collateral Agent
irrevocable proxies in respect of the Pledged Interests, (F)&nbsp;furnishing to the Collateral Agent from time to time statements and
schedules further identifying and describing the Collateral and such other reports in connection with the Collateral as the Collateral
Agent may reasonably request, all in reasonable detail, (G)&nbsp;if at any time after the date hereof, any Grantor acquires or holds any
Commercial Tort Claim with a maximum potential value in excess of $100,000, promptly notifying the Collateral Agent in a writing signed
by such Grantor setting forth a brief description of such Commercial Tort Claim and granting to the Collateral Agent a security interest
therein and in the proceeds thereof, which writing shall incorporate the provisions hereof and shall be in form and substance satisfactory
to the Collateral Agent, (H)&nbsp;upon the acquisition after the date hereof by any Grantor of any Titled Collateral, promptly notifying
the Collateral Agent of such acquisition, setting forth a description of the Titled Collateral acquired and a good faith estimate of the
current value of such Titled Collateral, and if so requested by the Collateral Agent, promptly causing the Collateral Agent to be listed
as the lienholder on such Certificate of Title or certificate of ownership and delivering evidence of the same to the Collateral Agent,
and (I)&nbsp;taking all actions required by Law in any relevant Uniform Commercial Code jurisdiction, or by other Law as applicable in
any foreign jurisdiction. Except in accordance with this Agreement, no Grantor shall take or fail to take any action which would in any
manner impair the validity or enforceability of the Collateral Agent&rsquo;s security interest in and Lien on any Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Location
of Equipment and Inventory</U>. Each Grantor will keep the Equipment and Inventory (other than Equipment and Inventory sold in the ordinary
course of business in accordance with <U>Section 6(h)</U>) at the locations specified in <U>Schedule VI</U> or, upon not less than 30
days&rsquo; prior written notice to the Collateral Agent accompanied by a new <U>Schedule VI</U> indicating each new location of the Equipment
and Inventory, at such other locations in the continental United States as the Grantors may elect, <U>provided</U> that (i) all action
has been taken to grant to the Collateral Agent a perfected, first priority security interest in such Equipment and Inventory, and (ii)
the Collateral Agent&rsquo;s rights in such Equipment and Inventory, including without limitation, the existence, perfection and priority
of the security interest created hereby in such Equipment and Inventory, are not adversely affected thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Condition
of Equipment</U>. Each Grantor will maintain or cause the Equipment which is necessary or useful in the proper conduct of its business
to be maintained and preserved in good condition, repair and working order and in accordance with any manufacturer&rsquo;s manual, ordinary
wear and tear excepted, and will forthwith, or in the case of any loss or damage to any Equipment promptly after the occurrence thereof,
make or cause to be made all repairs, replacements and other improvements in connection therewith which are necessary or desirable, consistent
with past practice, or which the Collateral Agent may reasonably request to such end. Each Grantor will promptly furnish to the Collateral
Agent a statement describing in reasonable detail any loss or damage in excess of $50,000 to any Equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes,
Etc.</U> Each Grantor jointly and severally agrees to pay promptly when due all property and other taxes, assessments and governmental
charges or levies imposed upon, and all claims (including claims for labor, materials and supplies) against, the Equipment and Inventory,
except to the extent the validity thereof is being contested in good faith by proper proceedings which stay the imposition of any penalty,
fine or Lien resulting from the non-payment thereof and with respect to which adequate reserves in accordance with GAAP have been set
aside for the payment thereof, or otherwise provided in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
Each Grantor will, at its own expense, maintain insurance with respect to the Collateral in accordance with the terms of the Purchase
Agreement. Each Grantor will, if so requested by the Collateral Agent, deliver to the Collateral Agent original or duplicate insurance
policies and, as often as the Collateral Agent may reasonably request, a report of a reputable insurance broker with respect to such insurance.
Each Grantor will also, at the request of the Collateral Agent, execute and deliver instruments of assignment of such insurance policies
and cause the respective insurers to acknowledge notice of such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
Concerning the Accounts and the Licenses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor will, except as otherwise provided in this subsection&nbsp;(f), continue to collect, at its own expense, all amounts due or to
become due under the Accounts. In connection with such collections, each Grantor may (and, at the Collateral Agent&rsquo;s direction,
will) take such action as such Grantor (or, if applicable, the Collateral Agent) may deem necessary or advisable to enforce collection
or performance of the Accounts; <U>provided</U>, <U>however</U>, that the Collateral Agent shall have the right at any time, upon the
occurrence and during the continuance of an Event of Default, to notify the Account Debtors or obligors under any Accounts of the assignment
of such Accounts to the Collateral Agent and to direct such Account Debtors or obligors to make payment of all amounts due or to become
due to such Grantor thereunder directly to the Collateral Agent or its designated agent and, upon such notification and at the expense
of such Grantor and to the extent permitted by Law, to enforce collection of any such Accounts and to adjust, settle or compromise the
amount or payment thereof, in the same manner and to the same extent as such Grantor might have done. After receipt by any Grantor of
a notice from the Collateral Agent that the Collateral Agent has notified, intends to notify, or has enforced or intends to enforce a
Grantor&rsquo;s rights against the Account Debtors or obligors under any Accounts as referred to in the proviso to the immediately preceding
sentence, (A)&nbsp;all amounts and proceeds (including Instruments) received by such Grantor in respect of the Accounts shall be received
in trust for the benefit of the Collateral Agent hereunder, shall be segregated from other funds of such Grantor and shall be forthwith
paid over to the Collateral Agent or its designated agent in the same form as so received (with any necessary endorsement) to be held
as cash collateral and applied as specified in <U>Section 9(d)</U>, and (B) such Grantor will not adjust, settle or compromise the amount
or payment of any Account or release wholly or partly any Account Debtor or obligor thereof or allow any credit or discount thereon. In
addition, upon the occurrence and during the continuance of an Event of Default, the Collateral Agent may (in its sole and absolute discretion)
direct any or all of the banks and financial institutions with which any Grantor either maintains a Deposit Account or a lockbox or deposits
the proceeds of any Accounts to send promptly to the Collateral Agent or its designated agent by wire transfer (to such account as the
Collateral Agent shall specify, or in such other manner as the Collateral Agent shall direct) all or a portion of such securities, cash,
investments and other items held by such institution. Any such securities, cash, investments and other items so received by the Collateral
Agent or its designated agent shall (in the sole and absolute discretion of the Collateral Agent) be held as additional Collateral for
the Secured Obligations or distributed in accordance with <U>Section 9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence and during the continuance of any breach or default under any material License by any party thereto other than a Grantor,
(A) the relevant Grantor will, promptly after obtaining knowledge thereof, give the Collateral Agent written notice of the nature and
duration thereof, specifying what action, if any, it has taken and proposes to take with respect thereto, (B) no Grantor will, without
the prior written consent of the Collateral Agent, which consent shall not be unreasonably withheld, delayed or conditioned, declare or
waive any such breach or default or affirmatively consent to the cure thereof or exercise any of its remedies in respect thereof, and
(C) each Grantor will, upon written instructions from the Collateral Agent and at such Grantor&rsquo;s expense, take such action as the
Collateral Agent may reasonably deem necessary or advisable in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor will, at its expense, promptly deliver to the Collateral Agent a copy of each notice or other communication received by it by
which any other party to any material License (A) declares a breach or default by a Grantor of any material term thereunder, (B) terminates
such License or (C) purports to exercise any of its rights or affect any of its obligations thereunder, together with a copy of any reply
by such Grantor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor will exercise promptly and diligently each and every right which it may have under each material License (other than any right
of termination) and will duly perform and observe in all respects all of its obligations under each material License and will take all
action reasonably necessary to maintain the Licenses in full force and effect. No Grantor will, without the prior written consent of the
Collateral Agent, cancel, terminate, amend or otherwise modify in any respect, or waive any provision of, any material License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
Concerning the Pledged Interests</U>. Each Grantor will</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.85in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
the Grantors&rsquo; joint and several expense, promptly deliver to the Collateral Agent a copy of each notice or other communication received
by it in respect of the Pledged Interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
the Grantors&rsquo; joint and several expense, defend the Collateral Agent&rsquo;s right, title and security interest in and to the Pledged
Interests against the claims of any Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not
make or consent to any material amendment or other material modification or waiver with respect to any Pledged Interests or enter into
any agreement or permit to exist any restriction with respect to any Pledged Interests (other than as permitted under the Transaction
Documents); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not
permit the issuance of (A) any additional shares of any class of Equity Interests of any Pledged Issuer, (B) any securities convertible
voluntarily by the holder thereof or automatically upon the occurrence or non-occurrence of any event or condition into, or exchangeable
for, any such shares of Equity Interests or (C) any warrants, options, contracts or other commitments entitling any Person to purchase
or otherwise acquire any such shares of Equity Interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfers
and Other Liens</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor will sell, assign (by operation of Law or otherwise), lease, license, exchange or otherwise transfer or dispose of any of the
Collateral, without the prior written consent of the Collateral Agent, except for transactions conducted in the ordinary course of business
(which shall not include any real property), including the sale of unregistered securities the proceeds of which remain in a Deposit Account
or Security Account subject to a control account agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor will create, suffer to exist or grant any Lien upon or with respect to any Collateral, other than a Permitted Lien.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the request of the Collateral Agent, in order to facilitate filings with the United States Patent and Trademark Office and the United
States Copyright Office, each Grantor shall execute and deliver to the Collateral Agent one or more Copyright Security Agreements, Trademark
Security Agreements, or Patent Security Agreements to further evidence the Collateral Agent&rsquo;s Lien on such Grantor&rsquo;s Patents,
Trademarks, or Copyrights, and the General Intangibles of such Grantor relating thereto or represented thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall have the duty, with respect to Intellectual Property that is necessary in the conduct of such Grantor&rsquo;s business,
to protect and diligently enforce and defend at such Grantor&rsquo;s expense its Intellectual Property, including (A) to diligently enforce
and defend, including, where it is commercially reasonable to, promptly suing for infringement, misappropriation, or dilution and to recover
any and all damages for such infringement, misappropriation, or dilution, and filing for opposition, interference, and cancellation against
conflicting Intellectual Property rights of any Person, (B) to prosecute diligently any material trademark application or service mark
application that is part of the Trademarks pending as of the date hereof or hereafter until the termination of this Agreement, (C) to
prosecute diligently any material patent application that is part of the Patents pending as of the date hereof or hereafter until the
termination of this Agreement, (D) to take all reasonable and necessary action to preserve and maintain all of such Grantor&rsquo;s Trademarks,
Patents, Copyrights, Licenses, and its rights therein, including paying all maintenance fees and filing of applications for renewal, affidavits
of use, and affidavits of noncontestability, and (E) to require all employees, consultants, and contractors of each Grantor who were involved
in the creation or development of such Intellectual Property to sign agreements containing assignment of Intellectual Property rights
and obligations of confidentiality. Each Grantor further agrees not to abandon any Intellectual Property or Intellectual Property License
that is necessary in the conduct of such Grantor&rsquo;s business. Each Grantor hereby agrees to take the steps described in this <U>Section
6(i)(ii)</U> with respect to all new or acquired Intellectual Property to which it or any of its Subsidiaries is now or later becomes
entitled that is necessary in the conduct of such Grantor&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grantors
acknowledge and agree that the Secured Parties shall have no duties with respect to any Intellectual Property or Licenses of any Grantor.
Without limiting the generality of this <U>Section 6(i)(iii)</U>, Grantors acknowledge and agree that no Secured Party shall be under
any obligation to take any steps necessary to preserve rights in the Collateral consisting of Intellectual Property or Licenses against
any other Person, but any Secured Party may do so at its option from and after the occurrence and during the continuance of an Event of
Default, and all expenses incurred in connection therewith (including reasonable fees and expenses of attorneys and other professionals)
shall be for the sole account of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall promptly file an application with the United States Copyright Office for any Copyright that has not been registered with
the United States Copyright Office if such Copyright is necessary in connection with the conduct of such Grantor&rsquo;s business. Any
expenses incurred in connection with the foregoing shall be borne by the Grantors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall provide the Collateral Agent with a written report of all new Patents or Trademarks that are registered or the subject of
pending applications for registrations, and of all Licenses that are material to the conduct of such Grantor&rsquo;s business, in each
case, which were acquired, registered, or for which applications for registration were filed by any Grantor or entered into during the
prior period and any statement of use or amendment to allege use with respect to intent-to-use trademark applications. In the case of
such registrations or applications therefor, which were acquired by any Grantor, each such Grantor shall file the necessary documents
with the appropriate Governmental Entity identifying the applicable Grantor as the owner (or as a co-owner thereof, if such is the case)
of such Intellectual Property. In each of the foregoing cases, the applicable Grantor shall promptly cause to be prepared, executed, and
delivered to the Collateral Agent supplemental schedules to the applicable Transaction Documents to identify such Patent and Trademark
registrations and applications therefor (with the exception of Trademark applications filed on an intent-to-use basis for which no statement
of use or amendment to allege use has been filed) and Licenses as being subject to the security interests created thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything
to the contrary in this Agreement notwithstanding, in no event shall any Grantor, either itself or through any agent, employee, licensee,
or designee, file an application for the registration of any Copyright with the United States Copyright Office or any similar office or
agency in another country without giving the Collateral Agent written notice thereof at least three Business Days prior to such filing
and complying with <U>Section 6(i)(i)</U>. Upon receipt from the United States Copyright Office of notice of registration of any Copyright,
each Grantor shall promptly (but in no event later than three Business Days following such receipt) notify (but without duplication of
any notice required by <U>Section 6(i)(v)</U>) the Collateral Agent of such registration by delivering, or causing to be delivered, to
the Collateral Agent, documentation sufficient for the Collateral Agent to perfect the Collateral Agent&rsquo;s Liens on such Copyright.
If any Grantor acquires from any Person any Copyright registered with the United States Copyright Office or an application to register
any Copyright with the United States Copyright Office, such Grantor shall promptly (but in no event later than five Business Days following
such acquisition) notify the Collateral Agent of such acquisition and deliver, or cause to be delivered, to the Collateral Agent, documentation
sufficient for the Collateral Agent to perfect the Collateral Agent&rsquo;s Liens on such Copyright. In the case of such Copyright registrations
or applications therefor which were acquired by any Grantor, each such Grantor shall promptly (but in no event later than five Business
Days following such acquisition) file the necessary documents with the appropriate Governmental Entity identifying the applicable Grantor
as the owner (or as a co-owner thereof, if such is the case) of such Copyrights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall take reasonable steps to maintain the confidentiality of, and otherwise protect and enforce its rights in, the Intellectual
Property that is necessary in the conduct of such Grantor&rsquo;s business, including as applicable (A) protecting the secrecy and confidentiality
of its confidential information and trade secrets by having and enforcing a policy requiring all current employees, consultants, licensees,
vendors and contractors with access to such information to execute appropriate confidentiality agreements; (B) taking actions reasonably
necessary to ensure that no trade secret falls into the public domain; and (C) protecting the secrecy and confidentiality of the source
code of all software programs and applications of which it is the owner or licensee by having and enforcing a policy requiring any licensees
(or sublicensees) of such source code to enter into license agreements with commercially reasonable use and non-disclosure restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor shall enter into any Intellectual Property License to receive any license or rights in any Intellectual Property of any other
Person unless such Grantor has used commercially reasonable efforts to permit the assignment of or grant of a security interest in such
Intellectual Property License (and all rights of Grantor thereunder) to the Collateral Agent (and any transferees of the Collateral Agent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Deposit,
Commodities and Securities Accounts</U>. Each Grantor shall cause each bank and other financial institution with an account referred to
in <U>Schedule VII</U> to execute and deliver to the Collateral Agent (or its designee), subject to Section 6(l) and the Post-Closing
Agreement, a control agreement, in form and substance satisfactory to the Collateral Agent, duly executed by such Grantor and such bank
or financial institution, or enter into other arrangements in form and substance satisfactory to the Collateral Agent, pursuant to which
such institution shall irrevocably agree, among other things, that (i)&nbsp;it will comply at any time with the instructions originated
by the Collateral Agent (or its designee) to such bank or financial institution directing the disposition of cash, Commodity Contracts,
securities, Investment Property and other items from time to time credited to such account, without further consent of such Grantor, which
instructions the Collateral Agent (or its designee) will not give to such bank or other financial institution in the absence of a continuing
Event of Default and which the Collateral Agent (or its designee) will immediately withdraw if no Event of Default is continuing, (ii)&nbsp;all
cash, Commodity Contracts, securities, Investment Property and other items of such Grantor deposited with such institution shall be subject
to a perfected, first priority security interest in favor of the Collateral Agent (or its designee), (iii)&nbsp;any right of set off (other
than recoupment of standard fees), banker&rsquo;s Lien or other similar Lien, security interest or encumbrance shall be fully waived as
against the Collateral Agent (or its designee), and (iv)&nbsp;upon receipt of written notice from the Collateral Agent during the continuance
of an Event of Default, such bank or financial institution shall promptly send to the Collateral Agent (or its designee) by wire transfer
(to such account as the Collateral Agent (or its designee) shall specify, or in such other manner as the Collateral Agent (or its designee)
shall direct) all such cash, the value of any Commodity Contracts, securities, Investment Property and other items held by it, provided,
however, that arrangements will be made to allow any derivative contracts to be fulfilled. Without the prior written consent of the Collateral
Agent, no Grantor shall make or maintain any Deposit Account, Commodity Account or Securities Account except for the accounts set forth
in <U>Schedule VII</U>. The provisions of this <U>Section 6(j)</U> shall not apply to Excluded Accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Titled
Collateral</U>. At the request of the Collateral Agent, each Grantor shall (a) cause all Collateral, now owned or hereafter acquired by
any Grantor, which under applicable Law are required to be registered and has a value in excess of $25,000, to be properly registered
in the name of such Grantor, (b) cause all Titled Collateral with a value in excess of $25,000, to be properly titled in the name of such
Grantor, and if requested by the Collateral Agent, with the Collateral Agent&rsquo;s Lien noted thereon and (c) if requested by the Collateral
Agent, promptly deliver to the Collateral Agent (or its custodian) originals of all such Certificates of Title or certificates of ownership
for such Titled Collateral a value in excess of $25,000, with the Collateral Agent&rsquo;s Lien noted thereon, and take such other actions
as may be reasonably required by the Collateral Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Control</U>.
Each Grantor hereby agrees to take any or all action that may be necessary or desirable or that the Collateral Agent may request in order
for the Collateral Agent to obtain control in accordance with Sections 9-104, 9-105, 9-106, and 9-107 of the Code with respect to the
following Collateral: (i)&nbsp;Deposit Accounts, (ii) Securities Accounts, (iii) Electronic Chattel Paper, (iv) Investment Property and
(v) Letter-of-Credit Rights. Each Grantor hereby acknowledges and agrees that any agent or designee of the Collateral Agent shall be
deemed to be a &ldquo;secured party&rdquo; with respect to the Collateral under the control of such agent or designee for all purposes.
Notwithstanding anything in this Agreement to the contrary, so long as no Event of Default has occurred and is then continuing, the Grantors
shall not be required to maintain a control account agreement for the benefit of the Agent in respect of any Deposit Account that contains
$25,000 or less in cash at any time and in respect of any Security Account that contains $10,000 or less in securities and cash at any
time; provided that any Deposit Account may contain in excess of $25,000 for a period not to exceed two Business Days, and any Security
Account may contain in excess of $10,000 for a period not to exceed ten Business Days, so long as Grantors are making diligent efforts
to transfer such cash or securities to a Deposit Account or Security Account that is subject to a control account agreement, or obtain
a deposit account control agreement or securities account control agreement covering such Deposit Account or Security Account within
such applicable period.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Records;
Inspection and Reporting</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall keep adequate records concerning the Accounts, Chattel Paper and Pledged Interests. Each Grantor shall permit the Collateral
Agent, or any agents or representatives thereof or such professionals or other Persons as the Collateral Agent may designate (A)&nbsp;to
examine and make copies of and abstracts from such Grantor&rsquo;s books and records, (B) to visit and inspect its properties, (C)&nbsp;to
verify materials, leases, notes, Accounts, Inventory and other assets of such Grantor from time to time, (D)&nbsp;to conduct audits, appraisals
and valuations or examinations at the locations of such Grantor and (E) to discuss such Grantor&rsquo;s affairs, finances and accounts
with any of its directors, officers, managerial employees, independent accountants or any of its other representatives, and otherwise
as provided in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor shall, without the prior written consent of the Collateral Agent, which consent shall not be unreasonably withheld, delayed or
conditioned, change (A) its name, identity or organizational structure, (B) its jurisdiction of incorporation or organization as set forth
in <U>Schedule I</U> or (C) its chief executive office as set forth in <U>Schedule VI</U>. Each Grantor shall promptly notify the Collateral
Agent upon obtaining an organizational identification number, if on the date hereof such Grantor did not have such identification number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Voting Rights, Dividends, Etc. in Respect of the Pledged Interests</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So
long as no Event of Default shall have occurred and be continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
Grantor may exercise any and all voting and other consensual rights pertaining to any Pledged Interests for any purpose not inconsistent
with the terms of this Agreement, the Purchase Agreement, the Notes or the other Transaction Documents; <U>provided</U>, <U>however</U>,
that (A) each Grantor will give the Collateral Agent at least five Business Days&rsquo; notice of the manner in which it intends to exercise,
or the reasons for refraining from exercising, any such right that could reasonably be expected to adversely affect in any material respect
the value, liquidity or marketability of any Collateral or the creation, perfection and priority of the Collateral Agent&rsquo;s Lien;
and (B) none of the Grantors will exercise or refrain from exercising any such right, as the case may be, if the Collateral Agent gives
a Grantor notice that, in the Collateral Agent&rsquo;s reasonable judgment, such action (or inaction) could reasonably be expected to
adversely affect in any material respect the value, liquidity or marketability of any Collateral or the creation, perfection and priority
of the Collateral Agent&rsquo;s Lien; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
of the Grantors may receive and retain any and all dividends, interest or other distributions paid in respect of the Pledged Interests
to the extent permitted by the Transaction Documents; <U>provided</U>, <U>however</U>, that any and all (A) dividends and interest paid
or payable other than in cash in respect of, and Instruments and other property received, receivable or otherwise distributed in respect
of or in exchange for, any Pledged Interests and (B) cash paid, payable or otherwise distributed in redemption of, or in exchange for,
any Pledged Interests, together with any dividend, interest or other distribution or payment which at the time of such payment was not
permitted by the Transaction Documents, shall be, and shall forthwith be delivered to the Collateral Agent, to hold as, Pledged Interests
and shall, if received by any of the Grantors, be received in trust for the benefit of the Collateral Agent, shall be segregated from
the other property or funds of the Grantors, and shall be forthwith delivered to the Collateral Agent in the exact form received with
any necessary indorsement and appropriate stock powers duly executed in blank, to be held by the Collateral Agent as Pledged Interests
and as further collateral security for the Secured Obligations; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Collateral Agent will execute and deliver (or cause to be executed and delivered) to a Grantor all such proxies and other instruments
as such Grantor may reasonably request for the purpose of enabling such Grantor to exercise the voting and other rights which it is entitled
to exercise pursuant to <U>Section 7(a)(i)</U> and to receive the dividends, interest or other distributions which it is authorized to
receive and retain pursuant to <U>Section 7(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence and during the continuance of an Event of Default:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
rights of each Grantor to exercise the voting and other consensual rights which it would otherwise be entitled to exercise pursuant to
<U>Section 7(a)(i)</U>, and to receive the dividends, distributions, interest and other payments that it would otherwise be authorized
to receive and retain pursuant to <U>Section 7(a)(ii)</U>, shall cease, and all such rights shall thereupon become vested in the Collateral
Agent, which shall thereupon have the sole right to exercise such voting and other consensual rights and to receive and hold as Pledged
Interests such dividends, distributions and interest payments;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Collateral Agent is authorized to notify each debtor with respect to the Pledged Debt to make payment directly to the Collateral Agent
(or its designee) and may collect any and all moneys due or to become due to any Grantor in respect of the Pledged Debt, and each of the
Grantors hereby authorizes each such debtor to make such payment directly to the Collateral Agent (or its designee) without any duty of
inquiry;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;without
limiting the generality of the foregoing, the Collateral Agent may at its option exercise any and all rights of conversion, exchange,
subscription or any other rights, privileges or options pertaining to any of the Pledged Interests as if it were the absolute owner thereof,
including without limitation, the right to exchange, in its discretion, any and all of the Pledged Interests upon the merger, consolidation,
reorganization, recapitalization or other adjustment of any Pledged Issuer, or upon the exercise by any Pledged Issuer of any right, privilege
or option pertaining to any Pledged Interests, and, in connection therewith, to deposit and deliver any and all of the Pledged Interests
with any committee, depository, transfer agent, registrar or other designated agent upon such terms and conditions as it may determine;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
dividends, distributions, interest and other payments that are received by any of the Grantors contrary to the provisions of <U>Section
7(b)(i)</U> shall be received in trust for the benefit of the Collateral Agent, shall be segregated from other funds of the Grantors,
and shall be forthwith paid over to the Collateral Agent as Pledged Interests in the exact form received with any necessary indorsement
and appropriate stock powers duly executed in blank, to be held by the Collateral Agent as Pledged Interests and as further collateral
security for the Secured Obligations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Additional Provisions Concerning the Collateral</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the maximum extent permitted by applicable Law, and for the purpose of taking any action that the Collateral Agent may deem necessary
or advisable to accomplish the purposes of this Agreement, each Grantor hereby (i) authorizes the Collateral Agent to execute any such
agreements, instruments or other documents in such Grantor&rsquo;s name and to file such agreements, instruments or other documents in
such Grantor&rsquo;s name and in any appropriate filing office, (ii)&nbsp;authorizes the Collateral Agent at any time and from time to
time to file, one or more financing or continuation statements and amendments thereto, relating to the Collateral (including without limitation,
any such financing statements that (A) describe the Collateral as &ldquo;all assets&rdquo; or &ldquo;all personal property&rdquo; (or
words of similar effect) or that describe or identify the Collateral by type or in any other manner as the Collateral Agent may determine,
regardless of whether any particular asset of such Grantor falls within the scope of Article 9 of the Uniform Commercial Code or whether
any particular asset of such Grantor constitutes part of the Collateral, and (B) contain any other information required by Part 5 of Article
9 of the Code for the sufficiency or filing office acceptance of any financing statement, continuation statement or amendment, including
without limitation, whether such Grantor is an organization, the type of organization and any organizational identification number issued
to such Grantor) and (iii)&nbsp;ratifies such authorization to the extent that the Collateral Agent has filed any such financing statements,
continuation statements, or amendments thereto, prior to the date hereof. A photocopy or other reproduction of this Agreement or any financing
statement covering the Collateral or any part thereof shall be sufficient as a financing statement where permitted by Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor hereby irrevocably appoints the Collateral Agent as its attorney-in-fact and proxy, with full authority in the place and stead
of such Grantor and in the name of such Grantor or otherwise, from time to time in the Collateral Agent&rsquo;s discretion, to take any
action and to execute any instrument that the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement,
including without limitation, (i) to obtain and adjust insurance required to be paid to the Collateral Agent, (ii) to ask, demand, collect,
sue for, recover, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of any Collateral,
(iii) to receive, endorse, and collect any drafts or other Instruments, Documents and Chattel Paper in connection with clause (i) or (ii)
above, (iv) to receive, indorse and collect all Instruments made payable to such Grantor representing any dividend, interest payment or
other distribution in respect of any Pledged Interests and to give full discharge for the same, (v) to file any claims or take any action
or institute any proceedings which the Collateral Agent may deem necessary or desirable for the collection of any Collateral or otherwise
to enforce the rights of each Secured Party with respect to any Collateral, (vi) to execute assignments, licenses and other documents
to enforce the rights of each Secured Party with respect to any Collateral, (vii) to pay or discharge taxes or Liens levied or placed
upon or threatened against the Collateral, the legality or validity thereof and the amounts necessary to discharge the same to be determined
by the Collateral Agent in its sole discretion, and such payments made by the Collateral Agent to become Secured Obligations of such Grantor
to the Collateral Agent, due and payable immediately upon demand, and (viii) to sign and endorse any invoices, freight or express bills,
bills of lading, storage or warehouse receipts, assignments, verifications and notices in connection with Accounts, Chattel Paper and
other documents relating to the Collateral. This power is coupled with an interest and is irrevocable until the date on which all of the
Secured Obligations have been indefeasibly paid in full in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purpose of enabling the Collateral Agent to exercise rights and remedies hereunder, at such time as the Collateral Agent shall be
lawfully entitled to exercise such rights and remedies, and for no other purpose, each Grantor hereby (i) grants to the Collateral Agent
an irrevocable, non-exclusive license (exercisable without payment of royalty or other compensation to any Grantor) to use, assign, license
or sublicense any Intellectual Property now or hereafter owned by any Grantor, wherever the same may be located, including in such license
reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer programs used for the
compilation or printout thereof; and (ii) assigns to the Collateral Agent, to the extent assignable, all of its rights to any Intellectual
Property now or hereafter licensed or used by any Grantor. Notwithstanding anything contained herein to the contrary, but subject to the
provisions of the Purchase Agreement that limit the right of a Grantor to dispose of its property and <U>Section 6(i)</U>, so long as
no Event of Default shall have occurred and be continuing, each Grantor may exploit, use, enjoy, protect, license, sublicense, assign,
sell, dispose of or take other actions with respect to the Intellectual Property in the ordinary course of its business. In furtherance
of the foregoing, unless an Event of Default shall have occurred and be continuing, the Collateral Agent shall from time to time, upon
the request of a Grantor, execute and deliver any instruments, certificates or other documents, in the form so requested, which such Grantor
shall have certified are appropriate (in such Grantor&rsquo;s judgment) to allow it to take any action permitted above (including relinquishment
of the license provided pursuant to this clause (c) as to any Intellectual Property). Further, upon the date on which all of the Secured
Obligations have been indefeasibly paid in full in cash, the Collateral Agent (subject to <U>Section 14(e)</U>) shall release and reassign
to the Grantors all of the Collateral Agent&rsquo;s right, title and interest in and to the Intellectual Property, and the Licenses, all
without recourse, representation or warranty whatsoever and at the Grantors&rsquo; sole expense. The exercise of rights and remedies hereunder
by the Collateral Agent shall not terminate the rights of the holders of any licenses or sublicenses theretofore granted by any Grantor
in accordance with the second sentence of this clause (c). Each Grantor hereby releases the Collateral Agent from any claims, causes of
action and demands at any time arising out of or with respect to any actions taken or omitted to be taken by the Collateral Agent under
the powers of attorney granted herein other than actions taken or omitted to be taken through the Collateral Agent&rsquo;s gross negligence
or willful misconduct, as determined by a final determination of a court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Grantor fails to perform any agreement or obligation contained herein, the Collateral Agent may itself perform, or cause performance
of, such agreement or obligation, in the name of such Grantor or the Collateral Agent, and the expenses of the Collateral Agent incurred
in connection therewith shall be jointly and severally payable by the Grantors pursuant to <U>Section 10</U> and shall be secured by the
Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
powers conferred on the Collateral Agent hereunder are solely to protect its interest in the Collateral and shall not impose any duty
upon it to exercise any such powers. Other than the exercise of reasonable care to assure the safe custody of any Collateral in its possession
and the accounting for moneys actually received by it hereunder, the Collateral Agent shall have no duty as to any Collateral or as to
the taking of any necessary steps to preserve rights against other parties or any other rights pertaining to any Collateral and shall
be relieved of all responsibility for any Collateral in its possession upon surrendering it or tendering surrender of it to any of the
Grantors (or whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct). The Collateral
Agent shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral in its possession if such Collateral
is accorded treatment substantially equal to that which the Collateral Agent accords its own property, it being understood that the Collateral
Agent shall not have responsibility for ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders
or other matters relating to any Collateral, whether or not the Collateral Agent has or is deemed to have knowledge of such matters. The
Collateral Agent shall not be liable or responsible for any loss or damage to any of the Collateral, or for any diminution in the value
thereof, by reason of the act or omission of any warehouseman, carrier, forwarding agency, consignee or other agent or bailee selected
by the Collateral Agent in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything
herein to the contrary notwithstanding (i)&nbsp;each Grantor shall remain liable under the Licenses and otherwise in respect of the Collateral
to the extent set forth therein to perform all of its obligations thereunder to the same extent as if this Agreement had not been executed,
(ii)&nbsp;the exercise by the Collateral Agent of any of its rights hereunder shall not release any Grantor from any of its obligations
under the Licenses or otherwise in respect of the Collateral, and (iii)&nbsp;the Collateral Agent shall not have any obligation or liability
by reason of this Agreement under the Licenses or otherwise in respect of the Collateral, nor shall the Collateral Agent be obligated
to perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any claim for payment
assigned hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Collateral Agent may at any time in its discretion (i) without notice to any Grantor, transfer or register in the name of the Collateral
Agent or any of its nominees any or all of the Pledged Interests, and (ii) exchange certificates or Instruments constituting Pledged Interests
for certificates or Instruments of smaller or larger denominations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Remedies Upon Default</U>. If any Event of Default shall have occurred and be continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Collateral Agent may exercise in respect of the Collateral, in addition to any other rights and remedies provided for herein or otherwise
available to it, all of the rights and remedies of a secured party upon default under the Code (whether or not the Code applies to the
affected Collateral), and also may (i)&nbsp;take absolute control of the Collateral, including without limitation, transfer into the Collateral
Agent&rsquo;s name or into the name of its nominee or nominees (to the extent the Collateral Agent has not theretofore done so) and thereafter
receive, for the benefit of each Secured Party, all payments made thereon, give all consents, waivers and ratifications in respect thereof
and otherwise act with respect thereto as though it were the outright owner thereof, (ii)&nbsp;require each Grantor to, and each Grantor
hereby agrees that it will at its expense and upon request of the Collateral Agent forthwith, assemble all or part of the Collateral as
directed by the Collateral Agent and make it available to the Collateral Agent at a place or places to be designated by the Collateral
Agent that is reasonably convenient to both parties, and the Collateral Agent may enter into and occupy any premises owned or leased by
any Grantor where the Collateral or any part thereof is located or assembled for a reasonable period in order to effectuate the Collateral
Agent&rsquo;s rights and remedies hereunder or under Law, without obligation to any Grantor in respect of such occupation, and (iii)&nbsp;without
notice except as specified below and without any obligation to prepare or process the Collateral for sale, (A)&nbsp;sell the Collateral
or any part thereof in one or more parcels at public or private sale, at any of the Collateral Agent&rsquo;s offices, at any exchange
or broker&rsquo;s board or elsewhere, for cash, on credit or for future delivery, and at such price or prices and upon such other terms
as the Collateral Agent may deem commercially reasonable or (B)&nbsp;lease, license or otherwise dispose of the Collateral or any part
thereof upon such terms as the Collateral Agent may deem commercially reasonable. Each Grantor agrees that, to the extent notice of sale
or any other disposition of the Collateral shall be required by Law, at least ten (10) days&rsquo; prior notice to the applicable Grantor
of the time and place of any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">public sale or the time after which any private sale or other disposition of the Collateral is to be made
shall constitute reasonable notification. The Collateral Agent shall not be obligated to make any sale or other disposition of Collateral
regardless of notice of sale having been given. The Collateral Agent may adjourn any public or private sale from time to time by announcement
at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned.
Each Grantor hereby waives any claims against each Secured Party arising by reason of the fact that the price at which the Collateral
may have been sold at a private sale was less than the price which might have been obtained at a public sale or was less than the aggregate
amount of the Secured Obligations, even if the Collateral Agent accepts the first offer received and does not offer the Collateral to
more than one offeree, and waives all rights that such Grantor may have to require that all or any part of the Collateral be marshaled
upon any sale (public or private) thereof. Each Grantor hereby acknowledges that (i)&nbsp;any such sale of the Collateral by the Collateral
Agent shall be made without warranty, (ii)&nbsp;the Collateral Agent may specifically disclaim any warranties of title, possession, quiet
enjoyment or the like, (iii) the Collateral Agent may bid (which bid may be, in whole or in part, in the form of cancellation of indebtedness),
if permitted by Law, for the purchase, lease, license or other disposition of the Collateral or any portion thereof for the account of
the Collateral Agent (on behalf of itself and each Secured Party) and (iv)&nbsp;such actions set forth in clauses&nbsp;(i), (ii) and (iii)
above shall not adversely affect the commercial reasonableness of any such sale of the Collateral. In addition to the foregoing, (i)&nbsp;upon
written notice to any Grantor from the Collateral Agent after and during the continuance of an Event of Default, such Grantor shall cease
any use of the Intellectual Property or any trademark, patent or copyright similar thereto for any purpose described in such notice; (ii)
the Collateral Agent may, at any time and from time to time after and during the continuance of an Event of Default, upon ten (10) days&rsquo;
prior notice to any Grantor, license, whether general, special or otherwise, and whether on an exclusive or non-exclusive basis, any of
the Intellectual Property, throughout the universe for such term or terms, on such conditions, and in such manner, as the Collateral Agent
shall in its sole discretion determine; and (iii) the Collateral Agent may, at any time, pursuant to the authority granted in <U>Section
8</U> (such authority being effective upon the occurrence and during the continuance of an Event of Default), execute and deliver on behalf
of a Grantor, one or more instruments of assignment of the Intellectual Property (or any application or registration thereof), in form
suitable for filing, recording or registration in any country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the Collateral Agent determines to exercise its right to sell all or any part of the Pledged Interests pursuant to <U>Section
9(a)</U>, each Grantor will, at such Grantor&rsquo;s expense and upon request by the Collateral Agent: (i) execute and deliver, and cause
each issuer of such Pledged Interests and the directors and officers thereof to execute and deliver, all such instruments and documents,
and do or cause to be done all such other acts and things, as may be necessary or, in the opinion of the Collateral Agent, advisable to
register such Pledged Interests under the provisions of the Securities Act, and to cause the registration statement relating thereto to
become effective and to remain effective for such period as prospectuses are required by Law to be furnished, and to make all amendments
and supplements thereto and to the related prospectus which, in the reasonable opinion of the Collateral Agent, are necessary or advisable,
all in conformity with the requirements of the Securities Act and the rules and regulations of the SEC applicable thereto, (ii) cause
each issuer of such Pledged Interests to qualify such Pledged Interests under the state securities or &ldquo;Blue Sky&rdquo; Laws of each
jurisdiction, provided, that, such issuer shall not be required to qualify generally to do business in any jurisdiction where it is not
then so qualified, subject the issuer to any material tax in any such jurisdiction where it is not then so subject or file a general consent
to service of process in any such jurisdiction; and to use commercially reasonable efforts to obtain all necessary governmental approvals
for the sale of the Pledged Interests, as reasonably requested by the Collateral Agent, (iii) cause each Pledged Issuer to make available
to its securityholders, as soon as practicable, an earnings statement which will satisfy the provisions of Section 11(a) of the Securities
Act, and (iv) do or cause to be done all such other acts and things as may be reasonably necessary to make such sale of such Pledged Interests
valid and binding and in compliance with applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the provisions of <U>Section 9(b)</U>, each Grantor recognizes that the Collateral Agent may deem it impracticable to effect a public
sale of all or any part of the Pledged Shares or any other securities constituting Pledged Interests and that the Collateral Agent may,
therefore, determine to make one or more private sales of any such securities to a restricted group of purchasers who will be obligated
to agree, among other things, to acquire such securities for their own account, for investment and not with a view to the distribution
or resale thereof. Each Grantor acknowledges that any such private sale may be at prices and on terms less favorable to the seller than
the prices and other terms which might have been obtained at a public sale and, notwithstanding the foregoing, agrees that if such private
sales are made in a commercially reasonable manner, then the Collateral Agent shall have no obligation to delay the sale of any such securities
for the period of time necessary to permit the issuer of such securities to register such securities for public sale under the Securities
Act. Each Grantor further acknowledges and agrees that any offer to sell such securities which has been (i) publicly advertised on a bona
fide basis in a newspaper or other publication of general circulation in the financial community of New York, New York (to the extent
that such an offer may be so advertised without prior registration under the Securities Act) or (ii) made privately in the manner described
above to not less than fifteen <U>bona fide</U> offerees shall be deemed to involve a &ldquo;public disposition&rdquo; for the purposes
of Section 9-610(c) of the Code (or any successor or similar, applicable statutory provision) as then in effect in the State of New York,
notwithstanding that such sale may not constitute a &ldquo;public offering&rdquo; under the Securities Act, and that the Collateral Agent
may, in such event, bid for the purchase of such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
cash held by the Collateral Agent (or its agent or designee) as Collateral and all Cash Proceeds received by the Collateral Agent (or
its agent or designee) in respect of any sale of or collection from, or other realization upon, all or any part of the Collateral may,
in the discretion of the Collateral Agent, be held by the Collateral Agent (or its agent or designee) as collateral for, or then or at
any time thereafter applied (after payment of any amounts payable to the Collateral Agent pursuant to <U>Section 10</U>) in whole or in
part by the Collateral Agent against, all or any part of the Secured Obligations in such order as the Collateral Agent shall elect, consistent
with the provisions of the Purchase Agreement. Any surplus of such cash or Cash Proceeds held by the Collateral Agent (or its agent or
designee) and remaining after the date on which all of the Secured Obligations have been indefeasibly paid in full in cash, shall be paid
over to whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the proceeds of any such sale, collection or realization are insufficient to pay all amounts to which each Secured Party
is legally entitled, the Grantors shall be jointly and severally liable for the deficiency, together with interest thereon at the highest
rate specified in any applicable Transaction Document for interest on overdue principal thereof or such other rate as shall be fixed by
applicable Law, together with the costs of collection and the reasonable fees, costs, expenses and other client charges of any attorneys
employed by the Collateral Agent to collect such deficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor hereby acknowledges that if the Collateral Agent complies with any applicable Law in connection with a disposition of the Collateral,
such compliance will not adversely affect the commercial reasonableness of any sale or other disposition of the Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Collateral Agent shall not be required to marshal any present or future collateral security (including but not limited to, this Agreement
and the Collateral) for, or other assurances of payment of, the Secured Obligations or any of them or to resort to such collateral security
or other assurances of payment in any particular order, and all of the Collateral Agent&rsquo;s rights hereunder and in respect of such
collateral security and other assurances of payment shall be cumulative and in addition to all other rights, however existing or arising.
To the extent that any Grantor lawfully may, such Grantor hereby agrees that it will not invoke any Law relating to the marshalling of
collateral which might cause delay in or impede the enforcement of the Collateral Agent&rsquo;s rights under this Agreement or under any
other instrument creating or evidencing any of the Secured Obligations or under which any of the Secured Obligations is outstanding or
by which any of the Secured Obligations is secured or payment thereof is otherwise assured, and, to the extent that it lawfully may, each
Grantor hereby irrevocably waives the benefits of all such Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor irrevocably and unconditionally:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consents&nbsp;to
the appointment of pre-judgment or post-judgment receiver with all of the same powers that would otherwise be available to the Grantors,
including but not limited to the power to&nbsp;(A) hold, manage, control or dispose of the Collateral wherever located, (B) take any action
with respect to the Collateral to the maximum extent permitted by Law and (C) conduct a public or private sale of any or all of the Grantors&rsquo;
right, title and interest in and to such Collateral, including any disposition of the Collateral to the Secured Parties in exchange for
cancellation of all or a portion of the Obligations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consents
that any such receiver can be appointed without a hearing or prior notice to the Grantors, provided, however, that the Collateral Agent
shall provide prompt notice to the Grantors after such appointment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;agrees
not to oppose or otherwise interfere (directly or indirectly) with any effort by Collateral Agent to seek the appointment of a receiver;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;waives
any right to demand that a bond be posted in connection with the appointment of any such receiver, provided, however, that in the event
that no bond is posted, the Collateral Agent shall be responsible for ; and&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indemnity and Expenses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor jointly and severally agrees to defend, protect, indemnify and hold harmless the Collateral Agent and each other Indemnitee from
and against any and all claims, losses, damages, liabilities, obligations, penalties, fees, reasonable costs and expenses (including without
limitation, reasonable attorneys&rsquo; fees, costs, expenses and disbursements) incurred by the Collateral Agent or such Indemnitee to
the extent that they arise out of or otherwise result from or relate to or are in connection with this Agreement (including without limitation,
enforcement of this Agreement), except claims, losses or liabilities resulting solely and directly from the Collateral Agent&rsquo;s or
such Indemnitee&rsquo;s gross negligence or willful misconduct, as determined by a final judgment of a court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor jointly and severally agrees to pay to the Collateral Agent upon demand the amount of any and all costs and expenses, including
the reasonable fees, costs, expenses and disbursements of counsel for the Collateral Agent and of any experts and agents (including without
limitation, any collateral trustee which may act as agent of the Collateral Agent), which the Collateral Agent may incur in connection
with (i)&nbsp;the preparation, negotiation, execution, delivery, recordation, administration, amendment, waiver or other modification
or termination of this Agreement, (ii)&nbsp;the custody, preservation, use or operation of, or the sale of, collection from, or other
realization upon, any Collateral, (iii)&nbsp;the exercise or enforcement of any of the rights of the Collateral Agent hereunder, or (iv)&nbsp;the
failure by any Grantor to perform or observe any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
11.&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices, Etc.</U> All notices and other communications provided for hereunder shall be given in accordance with the notice
provision of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
12.&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Security Interest Absolute; Joint and Several Obligations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
rights of the Secured Parties, all Liens and all obligations of each of the Grantors hereunder shall be absolute and unconditional irrespective
of (i) any lack of validity or enforceability of the Purchase Agreement or the Notes, (ii) any change in the time, manner or place of
payment of, or in any other term in respect of, all or any of the Secured Obligations, or any other amendment or waiver of or consent
to any departure from the Purchase Agreement or the Notes, (iii) any exchange or release of, or non-perfection of any Lien on any Collateral,
or any release or amendment or waiver of or consent to departure from any guaranty, for all or any of the Secured Obligations, or (iv)
any other circumstance that might otherwise constitute a defense available to, or a discharge of, any of the Grantors in respect of the
Secured Obligations. All authorizations and agencies contained herein with respect to any of the Collateral are irrevocable and powers
coupled with an interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor hereby waives (i) promptness and diligence, and (ii) any requirement that the Collateral Agent or any Secured Party protect, secure,
perfect or insure any security interest or other lien on any property subject thereto or exhaust any right or take any action against
any Grantor or any other Person or any collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the obligations of the Grantors hereunder are joint and several. The Collateral Agent may, in its sole and absolute discretion, enforce
the provisions hereof against any of the Grantors and shall not be required to proceed against all Grantors jointly or seek payment from
the Grantors ratably. In addition, the Collateral Agent may, in its sole and absolute discretion, select the Collateral of any one or
more of the Grantors for sale or application to the Secured Obligations, without regard to the ownership of such Collateral, and shall
not be required to make such selection ratably from the Collateral owned by all of the Grantors. The release or discharge of any Grantor
by the Collateral Agent shall not release or discharge any other Grantor from the obligations of such Person hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
13.&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>The Collateral Agent</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>[Reserved]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers
and Duties</U>. Each Investor irrevocably authorizes the Collateral Agent to take such action on such Investor&rsquo;s behalf and to exercise
such powers, rights and remedies hereunder as are specifically delegated or granted to the Collateral Agent by the terms hereof and the
other Transaction Documents, together with such powers, rights and remedies as are reasonably incidental thereto. The Collateral Agent
shall have only those duties and responsibilities that are expressly specified herein or any other Transaction Documents. The Collateral
Agent may exercise such powers, rights and remedies and perform such duties by or through its agents or employees. The Collateral Agent
shall not have, by reason hereof or any of the other Transaction Documents, a fiduciary relationship in respect of, or any fiduciary duties
to, any Investor or any other Person; and nothing herein, expressed or implied, is intended to or shall be so construed as to impose upon
the Collateral Agent any obligations in respect hereof except as expressly set forth herein. The powers conferred on the Collateral Agent
hereunder are solely to protect its interest in the Collateral and shall not impose any duty upon it to exercise any such powers.&nbsp;
Except for the exercise of reasonable care in the accounting for moneys actually received by it hereunder, the Collateral Agent shall
have no duty as to any Collateral or as to the taking of any necessary steps to preserve rights against prior parties or any other rights
pertaining to any Collateral.&nbsp; The Collateral Agent shall be deemed to have exercised reasonable care in the custody and preservation
of Collateral in its possession if such Collateral is accorded treatment substantially equal to that which the Collateral Agent accords
its own property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Immunity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Responsibility for Certain Matters</U>. The Collateral Agent shall not be responsible to any Investor for the execution, effectiveness,
genuineness, validity, enforceability, collectability or sufficiency hereof or for any representations, warranties, recitals or statements
made herein or made in any written or oral statements or in any financial or other statements, instruments, reports or certificates or
any other documents furnished or made by the Collateral Agent to the Investors or by or on behalf of any Grantor to the Collateral Agent
and the transactions contemplated hereby or for the financial condition or business affairs of the Grantor, or any other Person liable
for the payment of any Secured Obligations, nor shall the Collateral Agent be required to ascertain or inquire as to the performance or
observance of any of the terms, conditions, provisions, covenants or agreements contained in any of the Transaction Documents or as to
the existence or possible existence of any Event of Default or to make any disclosures with respect to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exculpatory
Provisions</U>. Neither the Collateral Agent nor any of its officers, partners, directors, employees, attorneys or agents shall be liable
to the Investors for any action taken or omitted by the Collateral Agent under or in connection with any of the Transaction Documents
except to the extent caused by the Collateral Agent&rsquo;s gross negligence or willful misconduct, as determined by a final, non-appealable
judgment of a court of competent jurisdiction. The Collateral Agent shall be entitled to refrain from any act or the taking of any action
(including the failure to take an action) in connection herewith or any of the other Transaction Documents or from the exercise of any
power, discretion or authority vested in it hereunder unless and until the Collateral Agent shall have received instructions in respect
thereof from the Investors and, upon receipt of such instructions from the Investors, the Collateral Agent shall be entitled to act or
(where so instructed) refrain from acting, or to exercise such power, discretion or authority, in accordance with such instructions, including
for the avoidance of doubt refraining from any action that, in its opinion or the opinion of its counsel, may be in violation of the automatic
stay under any debtor relief Laws. Without prejudice to the generality of the foregoing, (A) the Collateral Agent shall be entitled to
rely, and shall be fully protected in relying, upon any communication, instrument or document believed by it to be genuine and correct
and to have been signed or sent by the proper Person, and shall be entitled to rely and shall be protected in relying on opinions and
judgments of attorneys (who may be attorneys for a Grantor), accountants, experts and other professional advisors selected by it; and
(B) no Investor shall have any right of action whatsoever against the Collateral Agent as a result of the Collateral Agent acting or (where
so instructed) refraining from acting hereunder or any of the other Transaction Documents in accordance with the instructions of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delegation
of Duties</U>. The Collateral Agent may perform any and all of its duties and exercise its rights and powers under this Agreement by or
through any one or more sub-agents appointed by the Collateral Agent. The Collateral Agent and any such sub-agent may perform any and
all of its duties and exercise its rights and powers by or through their respective Affiliates. The exculpatory, indemnification and other
provisions of this <U>Section 13</U> shall apply to any of the Affiliates of the Collateral Agent. All of the rights, benefits, and privileges
(including the exculpatory and indemnification provisions) of this <U>Section 13</U> shall apply to any such sub-agent and to the Affiliates
of any such sub-agent, and shall apply to their respective activities as sub-agent as if such sub-agent and Affiliates were named herein.
Notwithstanding anything herein to the contrary, with respect to each sub-agent appointed by the Collateral Agent, (i) such sub-agent
shall be a third party beneficiary under this Agreement with respect to all such rights, benefits and privileges (including exculpatory
rights and rights to indemnification) and shall have all of the rights and benefits of a third party beneficiary, including an independent
right of action to enforce such rights, benefits and privileges (including exculpatory rights and rights to indemnification) directly,
without the consent or joinder of any other Person, against the Grantors and the Investors, (ii) such rights, benefits and privileges
(including exculpatory rights and rights to indemnification) shall not be modified or amended without the consent of such sub-agent, and
(iii) such sub-agent shall only have obligations to the Collateral Agent and not to the Grantors, any Investor or any other Person and
no Grantor, Investor, or any other Person shall have any rights, directly or indirectly, as a third party beneficiary or otherwise, against
such sub-agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agent
Entitled to Act as Investor</U>. The agency hereby created shall in no way impair or affect any of the rights and powers of, or impose
any duties or obligations upon, Esousa in its individual capacity as an Investor. With respect to its financial advances to the Company,
the Collateral Agent shall have the same rights and powers hereunder as any other Investor and may exercise the same as if it were not
performing the duties and functions delegated to it hereunder, and the term &ldquo;Investor&rdquo; shall, unless the context clearly otherwise
indicates, include the Collateral Agent in its individual capacity. The Collateral Agent and its Affiliates may accept deposits from,
lend money to, own securities of, and generally engage in any kind of banking, trust, financial advisory or other business with any Grantor
or any of its Affiliates as if it were not performing the duties specified herein, and may accept fees and other consideration from such
Grantor for services in connection herewith and otherwise without having to account for the same to Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investors&rsquo;
Representations, Warranties and Acknowledgment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Investor represents and warrants that it has made its own independent investigation of the financial condition and affairs of the Company
and that it has made and shall continue to make its own appraisal of the creditworthiness of the Company. The Collateral Agent shall not
have any duty or responsibility, either initially or on a continuing basis, to make any such investigation or any such appraisal on behalf
of the Investors or to provide any Investor with any credit or other information with respect thereto, whether coming into its possession
before the execution of this Agreement or at any time or times thereafter, and the Collateral Agent shall not have any responsibility
with respect to the accuracy of or the completeness of any information produced by the Company and subsequently provided to the Investors
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Investor, by delivering its signature page to this Agreement, shall be deemed to have acknowledged receipt of, and consented to and approved,
each collateral document in existence on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right
to Indemnity</U>. Each Investor, according to its pro rata amount of Notes, severally agrees to indemnify the Collateral Agent, to the
extent that the Collateral Agent shall not have been reimbursed by the Grantors, for and against any and all liabilities, obligations,
losses, damages, penalties, actions, judgments, suits, costs, expenses (including counsel fees and disbursements) or disbursements of
any kind or nature whatsoever which may be imposed on, incurred by or asserted against the Collateral Agent in exercising its powers,
rights and remedies or performing its duties hereunder, or otherwise in its capacity as the Collateral Agent in any way relating to or
arising out of this Agreement; <U>provided</U>, no Investor shall be liable for any portion of such liabilities, obligations, losses,
damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from the Collateral Agent&rsquo;s gross negligence
or willful misconduct, as determined by a final, non-appealable judgment of a court of competent jurisdiction. If any indemnity furnished
to the Collateral Agent for any purpose shall, in the opinion of the Collateral Agent, be insufficient or become impaired, the Collateral
Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified against until such additional indemnity
is furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successor
Collateral Agent</U>. The Collateral Agent may resign at any time by giving prior written notice thereof to Investors and the Grantors,
and the Collateral Agent may be removed at any time with or without cause by an instrument or concurrent instruments in writing delivered
to the Grantors and the Collateral Agent signed by the Investors. The Collateral Agent shall have the right to appoint a financial institution
as Collateral Agent hereunder, subject to the reasonable satisfaction of the Grantors and the Investors and the Collateral Agent&rsquo;s
resignation shall become effective on the earliest of (i) 30 days after delivery of the notice of resignation (regardless of whether a
successor has been appointed or not), (ii) the acceptance of such successor Collateral Agent by the Grantors and the Investors or (iii)&nbsp;such
other date, if any, agreed to by the Investors. Upon any such notice of resignation or any such removal, the Investors shall have the
right, upon five Business Days&rsquo; notice to the Collateral Agent, to appoint a successor Collateral Agent. Until a successor Collateral
Agent is so appointed by the Investors or the Collateral Agent, any collateral security held by Collateral Agent on behalf of the Investors
under the Collateral Documents shall continue to be held by the retiring Collateral Agent as nominee until such time as a successor Collateral
Agent is appointed. Upon the acceptance of any appointment as Collateral Agent hereunder by a successor Collateral Agent, that successor
Collateral Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the retiring or removed
Collateral Agent under this Agreements, and the retiring or removed Collateral Agent under this Agreement shall promptly (i)&nbsp;transfer
to such successor Collateral Agent all sums and all of its right, title and interest in and to all other items of Collateral held hereunder,
together with all records and other documents necessary or appropriate in connection with the performance of the duties of the successor
Collateral Agent under this Agreements, and (ii)&nbsp;execute and deliver to such successor Collateral Agent or otherwise authorize the
filing of such amendments to financing statements, and take such other actions, as may be necessary or appropriate in connection with
the assignment to such successor Collateral Agent of the security interests created hereunder, whereupon such retiring or removed Collateral
Agent shall be discharged from its duties and obligations under this Agreement. After any retiring or removed Collateral Agent&rsquo;s
resignation or removal hereunder as the Collateral Agent, the provisions of this Agreement, shall inure to its benefit as to any actions
taken or omitted to be taken by it under this Agreement while it was the Collateral Agent hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding
Taxes</U>. To the extent required by any applicable law, the Collateral Agent may withhold from any payment to any Investor an amount
equivalent to any applicable withholding tax attributable to the amount paid to that Investor. If the Internal Revenue Service or any
other Governmental Entity asserts a claim that the Collateral Agent did not properly withhold tax from amounts paid to or for the account
of any Investor because the appropriate form was not delivered or was not properly executed or because such Investor failed to notify
the Collateral Agent of a change in circumstance which rendered the exemption from, or reduction of, withholding tax ineffective or for
any other reason, or if the Collateral Agent reasonably determines that a payment was made to a particular Investor pursuant to this Agreement
without deduction of applicable withholding tax from such payment, such Investor (and not the other Investors) shall indemnify the Collateral
Agent fully for all amounts paid, directly or indirectly, by the Collateral Agent as tax or otherwise, including any penalties or interest
and together with all expenses (including legal expenses, allocated internal costs and out-of-pocket expenses) incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Collateral
Agent May File Bankruptcy Disclosure and Proofs of Claim</U>. In case of the pendency of any proceeding under any debtor relief Laws relative
to the Grantors, the Collateral Agent (irrespective of whether the principal of any Secured Obligation shall then be due and payable as
herein expressed or by declaration or otherwise and irrespective of whether the Collateral Agent shall have made any demand on the Grantors)
shall be entitled and empowered (but not obligated) by intervention in such proceeding or otherwise:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
file a verified statement pursuant to rule 2019 of the Federal Rules of Bankruptcy Procedure that, in its sole opinion, complies with
such rule&rsquo;s disclosure requirements for entities representing more than one creditor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Secured Obligations that
are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Investors and
the Collateral Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Collateral Agent
and its respective agents and counsel and all other amounts due the Collateral Agent hereunder) allowed in such judicial proceeding; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.85in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and any custodian, receiver, assignee, trustee,
liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Investor to make such
payments to the Collateral Agent and, in the event that the Collateral Agent shall consent to the making of such payments directly to
the Investors, to pay to the Collateral Agent any amount due for the reasonable compensation, expenses, disbursements and advances of
the Collateral Agent and its agents and counsel, and any other amounts due the Collateral Agent hereunder. To the extent that the payment
of any such compensation, expenses, disbursements and advances of the Collateral Agent, its agents and counsel, and any other amounts
due the Collateral Agent hereunder out of the estate in any such proceeding, shall be denied for any reason, payment of the same shall
be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the
Investors may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Nothing contained herein shall
be deemed to authorize the Collateral Agent to authorize or consent to or accept or adopt on behalf of any Investor any plan of reorganization,
arrangement, adjustment or composition affecting the Secured Obligations or the rights of any Investor or to authorize the Collateral
Agent to vote in respect of the claim of any Investor in any such proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">Section
14.&nbsp;</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
amendment of any provision of this Agreement (including any Schedule attached hereto) shall be effective unless it is in writing and signed
by each Grantor affected thereby and the Collateral Agent, and no waiver of any provision of this Agreement, and no consent to any departure
by any Grantor therefrom, shall be effective unless it is in writing and signed by the Collateral Agent, and then such waiver or consent
shall be effective only in the specific instance and for the specific purpose for which given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
failure on the part of the Secured Parties to exercise, and no delay in exercising, any right hereunder or under any other Transaction
Document shall operate as a waiver thereof; nor shall any single or partial exercise of any such right preclude any other or further exercise
thereof or the exercise of any other right. The rights and remedies of the Secured Parties provided herein and in the other Transaction
Documents are cumulative and are in addition to, and not exclusive of, any rights or remedies provided by Law. The rights of the Secured
Parties under any Transaction Document against any party thereto are not conditional or contingent on any attempt by such Person to exercise
any of its rights under any other Transaction Document against such party or against any other Person, including but not limited to, any
Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall create a continuing security interest in the Collateral and shall (i) remain in full force and effect, subject to paragraph
(e) below, until the date on which all of the Secured Obligations have been indefeasibly paid in full in cash and (ii) be binding on each
Grantor and all other Persons who become bound as debtor to this Agreement in accordance with Section 9-203(d) of the Code, and shall
inure, together with all rights and remedies of the Secured Parties hereunder, to the benefit of the Secured Parties and their respective
successors, transferees and assigns. Without limiting the generality of clause (ii) of the immediately preceding sentence, the Secured
Parties may assign or otherwise transfer their respective rights and obligations under this Agreement and any other Transaction Document
to any other Person pursuant to the terms of the Purchase Agreement, and such other Person shall thereupon become vested with all of the
benefits in respect thereof granted to the Secured Parties herein or otherwise. Upon any such assignment or transfer, all references in
this Agreement to any Secured Party shall mean the assignee of any such Secured Party. None of the rights or obligations of any Grantor
hereunder may be assigned or otherwise transferred without the prior written consent of the Collateral Agent, and any such assignment
or transfer shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the date on which all of the Secured Obligations have been indefeasibly paid in full in cash, (i) subject to paragraph (e) below, this
Agreement and the security interests and licenses created hereby shall terminate and all rights to the Collateral shall revert to the
respective Grantor that granted such security interests hereunder and (ii) the Collateral Agent will, upon the Grantors&rsquo; request
and at the Grantors&rsquo; expense, without any representation, warranty or recourse whatsoever, (A) return to the Grantors (or whomsoever
shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct) such of the Collateral as shall not
have been sold or otherwise disposed of or applied pursuant to the terms hereof and (B) execute and deliver to the Grantors such documents
as the Grantors shall reasonably request to evidence such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall remain in full force and effect and continue to be effective should any petition be filed by or against any Grantor for
liquidation or reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors
or should a receiver or trustee be appointed for all or any significant part of any Grantor&rsquo;s assets, and shall continue to be effective
or be reinstated, as the case may be, if at any time payment or performance of the Secured Obligations, or any part thereof, is, pursuant
to applicable Law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Secured Obligations,
whether as a &ldquo;voidable preference,&rdquo; &ldquo;fraudulent conveyance,&rdquo; or otherwise, all as though such payment or performance
had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Secured Obligations
shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the execution and delivery, or authentication, by any Person of a security agreement supplement in substantially the form of <U>Exhibit
C</U> hereto (each a &ldquo;<B><U>Security Agreement Supplement</U></B>&rdquo;), (i) such Person shall be referred to as an &ldquo;<B><U>Additional
Grantor</U></B>&rdquo; and shall be and become a Grantor, and each reference in this Agreement to &ldquo;Grantor&rdquo; shall also mean
and be a reference to such Additional Grantor, and each reference in this Agreement and the other Transaction Documents to &ldquo;Collateral&rdquo;
shall also mean and be a reference to the Collateral of such Additional Grantor, and (ii) the supplemental <U>Schedules I-XI</U> attached
to each Security Agreement Supplement shall be incorporated into and become a part of and supplement <U>Schedules I-XI</U>, respectively,
hereto, and the Collateral Agent may attach such Schedules as supplements to such Schedules, and each reference to such Schedules shall
mean and be a reference to such Schedules, as supplemented pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THIS
AGREEMENT SHALL BE GOVERNED BY, CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, EXCEPT AS REQUIRED BY
MANDATORY PROVISIONS OF LAW AND EXCEPT TO THE EXTENT THAT THE VALIDITY AND PERFECTION OR THE PERFECTION AND THE EFFECT OF PERFECTION OR
NON-PERFECTION OF THE SECURITY INTEREST CREATED HEREBY, OR REMEDIES HEREUNDER, IN RESPECT OF ANY PARTICULAR COLLATERAL ARE GOVERNED BY
THE LAW OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>EACH
GRANTOR HEREBY IRREVOCABLY CONSENTS TO AND WAIVES ANY RIGHT TO OBJECT TO OR OTHERWISE CONTEST THE APPOINTMENT OF A RECEIVER AFTER THE
OCCURRENCE OF AN EVENT OF DEFAULT. EACH GRANTOR (i) GRANTS SUCH WAIVER AND CONSENTS KNOWINGLY AFTER HAVING DISCUSSED THE IMPLICATIONS
THEREOF WITH COUNSEL, (ii) ACKNOWLEDGES THAT (A) THE UNCONTESTED RIGHT TO HAVE A RECEIVER APPOINTED FOR THE FOREGOING PURPOSES IS CONSIDERED
ESSENTIAL BY THE SECURED PARTIES IN CONNECTION WITH THE ENFORCEMENT OF THEIR RIGHTS AND REMEDIES HEREUNDER AND UNDER THE OTHER DOCUMENTS
EXECUTED IN CONNECTION HEREWITH, AND (B) THE AVAILABILITY OF SUCH APPOINTMENT AS A REMEDY UNDER THE FOREGOING CIRCUMSTANCES WAS A MATERIAL
FACTOR IN INDUCING THE SECURED PARTIES TO MAKE (AND COMMIT TO MAKE) THE LOAN TO THE COMPANY, AND (iii) AGREES TO ENTER INTO ANY AND ALL
STIPULATIONS IN ANY LEGAL ACTIONS, OR AGREEMENTS OR OTHER INSTRUMENTS IN CONNECTION WITH THE FOREGOING AND TO COOPERATE FULLY WITH THE
AGENTS OR INVESTORS IN CONNECTION WITH THE ASSUMPTION AND EXERCISE OF CONTROL BY THE RECEIVER OVER ALL OR ANY PORTION OF THE COLLATERAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to and without limitation of any of the foregoing, this Agreement shall be deemed to be a Transaction Document and shall otherwise
be subject to all of terms and conditions contained in Sections 11.5 and 11.6 of the Purchase Agreement, <I>mutatis mutandi</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor irrevocably and unconditionally waives any right it may have to claim or recover in any legal action, suit or proceeding with
respect to this Agreement any special, exemplary, punitive or consequential damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to
the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or thereof or affecting the validity
or enforceability of such provision in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section
headings herein are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which shall
be deemed an original, but all of such counterparts taken together shall constitute one and the same agreement. Delivery of an executed
counterpart of this Agreement by facsimile or electronic mail shall be equally effective as delivery of an original executed counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, each Grantor
has caused this Agreement to be executed and delivered by its officer thereunto duly authorized, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><U>GRANTORS</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>BitNile Holdings, Inc. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>Ault Alliance, Inc. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>digital power lending, llc </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>alliance cloud services, llc </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><U>PLEDGOR</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>DIGITAL FARMS MANAGEMENT LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">ACCEPTED BY:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Esousa Holdings, LLC</B></FONT>,
    as Collateral Agent</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>&nbsp;Michael Wachs</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;Managing Member</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ex10_3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">GUARANTY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>GUARANTY</B> dated
as of December [___], 2021 (as amended, supplemented or otherwise modified from time to time, this &ldquo;<B><U>Guaranty</U></B>&rdquo;)
is made by the undersigned (together with each other Person that executes a joinder agreement and becomes a &ldquo;Guarantor&rdquo; hereunder,
each a &ldquo;<B><U>Guarantor</U></B>&rdquo;, and collectively, the &ldquo;<B><U>Guarantors</U></B>&rdquo;), in favor of the Agent (as
defined below) for the benefit of the Investors (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RECITALS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BitNile
Holdings, Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), each party listed as a &ldquo;Investor&rdquo; in the
Purchase Agreement referenced below (together with their respective successors and assigns, each a &ldquo;<B><U>Investor</U></B>&rdquo;),
and Esousa Holding LLC, a New York limited liability company, as agent for the Investors (the &ldquo;<B><U>Agent</U></B>&rdquo;) and as
an Investor, are parties to that certain Securities Purchase Agreement of even date herewith (as amended, supplemented or otherwise modified
from time to time, the &ldquo;<B><U>Purchase Agreement</U></B>&rdquo;), pursuant to which, among other things, the Company shall issue
certain Senior Secured Promissory Notes (as amended, supplemented or otherwise modified from time to time, and as replaced or refinanced
from time to time, the &ldquo;<B><U>Notes</U></B>&rdquo;) to the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Notes are secured by that certain Security Agreement dated as of the date hereof (as amended, supplemented or otherwise modified from
time to time, the &ldquo;<B><U>Issuer Security Agreement</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
the Investors have requested, and the Guarantors have agreed, that the Guarantors shall execute and deliver to the Investors, a guaranty
guaranteeing all of the obligations of the Company under the Purchase Agreement, the Notes and the other Transaction Documents until the
Notes have been indefeasibly paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to a Pledge and Security Agreement dated as of the date hereof (as amended, supplemented or otherwise modified from time to time, the
&ldquo;<B><U>Guarantor Security Agreement</U></B>&rdquo;), the Guarantors have granted to Agent, as Agent for the Investors, a security
interest in and lien on their assets to secure their respective obligations under this Guaranty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Guarantor has determined that the execution, delivery and performance of this Guaranty directly benefits, and is in the best interest
of, such Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the premises and the agreements herein and for other consideration, the sufficiency of which is hereby acknowledged,
each Guarantor hereby agrees with each Investor as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 1</B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Definitions.</U></B>
Reference is hereby made to the Purchase Agreement, the Notes and the other Transaction Documents for a statement of the terms thereof.
All terms used in this Guaranty, which are defined in the Purchase Agreement and not otherwise defined herein, shall have the same meanings
herein as set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 2</B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Guaranty.</U></B>
The Guarantors, jointly and severally, hereby unconditionally and irrevocably, guaranty the punctual payment, as and when due and payable,
by stated maturity or otherwise (after giving effect to any applicable grace or cure periods), of the Obligations and any other amounts
now or hereafter owing by the Company in respect of the Purchase Agreement, the Notes and the other Transaction Documents (such obligations,
to the extent not paid by the Company, being the &ldquo;<B><U>Guaranteed Obligations</U></B>&rdquo;; <U>provided that</U>, when the Notes
have been indefeasibly paid in full pursuant to their terms, the term &ldquo;Guaranteed Obligations&rdquo; shall not include any of the
foregoing obligations under the Purchase Agreement or any other Transaction Documents, and any remaining obligations under such Transaction
Documents shall no longer be guaranteed hereby). Without limiting the generality of the foregoing, each Guarantor's liability hereunder
shall extend to all amounts that constitute part of the Guaranteed Obligations and would be owed by the Company to the Investors under
the Purchase Agreement and the Notes but for the fact that they are unenforceable or not allowable due to the existence of any proceeding
commenced by or against the Company or any Guarantor under any provision of the Bankruptcy Code (Title 11 of the United States Code) or
under any other bankruptcy or insolvency law, assignments for the benefit of creditors, formal or informal moratoria, compositions, or
extensions generally with creditors, or proceedings seeking reorganization, arrangement, or other similar relief, and all fees, commissions,
expense reimbursements, indemnifications and all other amounts due or to become due under any of the Transaction Documents, and any and
all expenses (including reasonable counsel fees and expenses) reasonably incurred by the Investors or the Agent in enforcing any rights
under this Guaranty, involving the Company, any other Grantor under the Issuer Security Agreement or any Guarantor hereunder (the &ldquo;<B><U>Transaction
Parties</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Guaranty
Absolute; Continuing Guaranty; Assignments.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Guarantors, jointly and severally, guaranty that the Guaranteed Obligations will be paid strictly in accordance with the terms of the
Transaction Documents, regardless of any Law now or hereafter in effect in any jurisdiction affecting any of such terms or the rights
of the Investors with respect thereto. The obligations of each Guarantor under this Guaranty are independent of the Guaranteed Obligations,
and a separate action or actions may be brought and prosecuted against any Guarantor to enforce such obligations, irrespective of whether
any action is brought against any other Transaction Party or whether any Transaction Party is joined in any such action or actions. The
liability of any Guarantor under this Guaranty shall be irrevocable, absolute and unconditional irrespective of, and each Guarantor hereby
irrevocably waives, to the extent permitted by law, any defenses it may now or hereafter have in any way relating to, any or all of the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
lack of validity or enforceability of any Transaction Document or any agreement or instrument relating thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
change in the time, manner or place of payment of, or in any other term of, all or any of the Guaranteed Obligations, or any other amendment
or waiver of or any consent to departure from any Transaction Document, including without limitation, any increase in the Guaranteed Obligations
resulting from the extension of additional credit to any Transaction Party or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
taking, exchange, release or non-perfection of any collateral with respect to the Guaranteed Obligations, or any taking, release or amendment
or waiver of or consent to departure from any other guaranty, for all or any of the Guaranteed Obligations; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
change, restructuring or termination of the corporate, limited liability company or partnership structure or existence of any Transaction
Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Guaranty shall continue
to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or
must otherwise be returned by any Investor or any other Person upon the insolvency, bankruptcy or reorganization of any Transaction Party
or otherwise, all as though such payment had not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Guaranty is a continuing guaranty and shall (i) remain in full force and effect until the indefeasible payment in full in cash of all
Guaranteed Obligations (together with any matured indemnification obligations as of the date of such payment, but excluding any inchoate
or unmatured contingent indemnification obligations) and (ii) be binding upon each Guarantor and its respective successors and assigns.
This Guaranty shall inure to the benefit of and be enforceable by the Agent, on behalf of the Investors and their respective successors,
and permitted pledgees, transferees and assigns. Without limiting the generality of the foregoing sentence, the Agent and any Investor
may pledge, assign or otherwise transfer all or any portion of its rights and obligations under and subject to the terms of any Transaction
Document to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted to
the Agent and such Investor herein or otherwise, in each case as provided in the Transaction Documents. Notwithstanding the foregoing
and for the avoidance of doubt, this Guaranty will expire and each Guarantor will be automatically released from its obligation hereunder
without any further action by any Person upon the indefeasible payment in full in cash of all Guaranteed Obligations (together with any
matured indemnification obligations as of the date of such payment, but excluding any inchoate or unmatured contingent indemnification
obligations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waivers.</U></B>
To the extent permitted by applicable Law, each Guarantor hereby waives promptness, diligence, notice of acceptance and any other notice
with respect to any of the Guaranteed Obligations and this Guaranty and any requirement that the Agent exhaust any right or take any action
against any Transaction Party or any other Person or any Collateral (as defined in each of the Issuer Security Agreement and the Guarantor
Security Agreement). Each Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated
herein and that the waiver set forth in this <U>Section&nbsp;4</U> is knowingly made in contemplation of such benefits. The Guarantors
hereby waive any right to revoke this Guaranty, and acknowledge that this Guaranty is continuing in nature and applies to all Guaranteed
Obligations, whether existing now or in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subrogation.</U></B>
No Guarantor may exercise any rights that it may now or hereafter acquire against any Transaction Party or any other Guarantor that arise
from the existence, payment, performance or enforcement of any Guarantor's obligations under this Guaranty, including without limitation,
any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy
of the Investors or the Agent against any Transaction Party or any other guarantor or any Collateral, whether or not such claim, remedy
or right arises in equity or under contract, statute or common law, including without limitation, the right to take or receive from any
Transaction Party or any other guarantor, directly or indirectly, in cash or other property or by set-off or in any other manner, payment
or security solely on account of such claim, remedy or right, unless and until the indefeasible payment in full in cash of all Guaranteed
Obligations (together with any matured indemnification obligations as of the date of such payment, but excluding any inchoate or unmatured
contingent indemnification obligations). If any amount shall be paid to a Guarantor in violation of the immediately preceding sentence
at any time prior to the later of the payment in full in cash of the Guaranteed Obligations, such amount shall be held in trust for the
benefit of the Investors and shall forthwith be paid ratably to the Investors to be credited and applied to the Guaranteed Obligations,
whether matured or unmatured, in accordance with the terms of the Transaction Documents, or to be held as collateral for any Guaranteed
Obligations thereafter arising. If (a) any Guarantor shall make payment to the Investors of all or any part of the Guaranteed Obligations,
and (b) the Investors receive the indefeasible payment in full in cash of all Guaranteed Obligations (together with any matured indemnification
obligations as of the date of such payment, but excluding any inchoate or unmatured contingent indemnification obligations), the Agent
and the Investors will, at such Guarantor's request and expense, promptly execute and deliver to such Guarantor appropriate documents,
without recourse and without representation or warranty, necessary to evidence the transfer by subrogation to such Guarantor of an interest
in the Guaranteed Obligations resulting from such payment by such Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations,
Warranties and Covenants.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Guarantor hereby represents and warrants as of the date first written above as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor is (A) an individual with full capacity, who has knowledge and a complete understanding of the terms set forth in this Guaranty
and each other Transaction Document to which Guarantor is a party, and has had the opportunity to consult with counsel regarding the terms,
conditions, liabilities and obligations under this Guaranty; or (B)(1) a corporation, limited liability company or limited partnership
duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization as set forth on the signature
pages hereto, (2) has all requisite corporate, limited liability company or limited partnership power and authority to conduct its business
as now conducted and as presently contemplated and to execute and deliver this Guaranty and each other Transaction Document to which the
Guarantor is a party, and to consummate the transactions contemplated hereby and thereby and (3) is duly qualified to do business and
is in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the conduct of its
business makes such qualification necessary except where the failure to be so qualified would not reasonably be expected to result in
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
execution, delivery and performance by each Guarantor of this Guaranty and each other Transaction Document to which such Guarantor is
a party (A) in the case of a Guarantor that is an entity, have been duly authorized by all necessary corporate, limited liability company
or limited partnership action, (B) in the case of a Guarantor that is an entity, do not and will not contravene its Organization Documents,
or any applicable Law or any material contractual restriction binding on the Guarantor or its properties and will not result in or require
the creation of any Lien (other than pursuant to any Transaction Document) upon or with respect to any of its properties, and (C) do not
and will not result in any default, noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal of any material permit,
license, authorization or approval applicable to it or its operations or any of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required in connection with
the due execution, delivery and performance by the Guarantor of this Guaranty or any of the other Transaction Documents to which the Guarantor
is a party, other than expressly provided for in any of the Transaction Documents and the filing of any financing statements or similar
matters needed in connection with the perfection of the Liens granted under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
of this Guaranty and the other Transaction Documents to which the Guarantor is or will be a party, when delivered, will be, a legal, valid
and binding obligation of the Guarantor, enforceable against the Guarantor in accordance with its terms, except as may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, suretyship or other similar Laws and equitable principles (regardless
of whether enforcement is sought in equity or at law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>There
is no pending or, to the knowledge of the Guarantor, threatened in writing action, suit or proceeding against the Guarantor or to which
any of the properties of the Guarantor is subject, before any court or other Governmental Authority or any arbitrator that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>if
adversely determined, could reasonably be expected to have a Material Adverse Effect or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>relates
to this Guaranty or any of the other Transaction Documents to which the Guarantor is a party or any transactions contemplated hereby or
thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
Guarantor (A) has read and understands the terms and conditions of the Purchase Agreement, the Notes and the other Transaction Documents,
and (B) now has and will continue to have independent means of obtaining information concerning the affairs, financial condition and business
of the Company and the other Transaction Parties, and has no need of, or right to obtain from the Agent or any Investor, any credit or
other information concerning the affairs, financial condition or business of the Company or the other Transaction Parties that may come
under the control of the Agent or any Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right
of Set-off.</U></B> Upon the occurrence and during the continuance of any Event of Default, the Agent may, and is hereby authorized to,
at any time and from time to time, without notice to the Guarantors (any such notice being expressly waived by each Guarantor) and to
the fullest extent permitted by law, set-off and apply any and all deposits (general or special, time or demand, provisional or final)
at any time held and other indebtedness at any time owing by any Investor to or for the credit or the account of any Guarantor against
any and all obligations of the Guarantors now or hereafter existing under this Guaranty or any other Transaction Documents, irrespective
of whether or not Agent shall have made any demand under this Guaranty or any other Transaction Document and although such obligations
may be contingent or unmatured. Agent agrees to notify in writing the relevant Guarantor promptly after any such set-off and application
made by such Investor, provided that the failure to give such notice shall not affect the validity of such set-off and application. The
rights of the Agent under this <U>Section&nbsp;7</U> are in addition to other rights and remedies (including without limitation, other
rights of set-off) which the Agent or any Investor may have under this Guaranty or any other Transaction Document in law or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 8.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Notices,
Etc.</U></B> All notices and other communications provided for hereunder shall be in writing and shall be mailed (by overnight mail or
by certified mail, postage prepaid and return receipt requested), telecopied or delivered, if to any Guarantor, to the address for such
Guarantor set forth on the signature page hereto, or if to any Investor, to it at its respective address set forth in the Purchase Agreement;
or as to any Person at such other address as shall be designated by such Person in a written notice to such other Person complying as
to delivery with the terms of this <U>Section&nbsp;8</U>. All such notices and other communications shall be effective (i) if mailed (by
certified mail, postage prepaid and return receipt requested), when received or three Business Days after deposited in the mails, whichever
occurs first; (ii) if telecopied, when transmitted and confirmation is received, provided same is on a Business Day and, if not, on the
next Business Day; or (iii) if delivered by hand, upon delivery, provided same is on a Business Day and, if not, on the next Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CONSENT
TO JURISDICTION; SERVICE OF PROCESS AND VENUE.</U></B> ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS GUARANTY OR ANY OTHER TRANSACTION
DOCUMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK IN THE COUNTY OF NEW YORK OR OF THE UNITED STATES DISTRICT COURT FOR THE
SOUTHERN DISTRICT OF NEW YORK, AND, BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH GUARANTOR HEREBY IRREVOCABLY ACCEPTS IN RESPECT
OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS. NOTHING HEREIN SHALL AFFECT THE RIGHT OF THE
INVESTORS TO SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS OR OTHERWISE PROCEED AGAINST EACH
GUARANTOR IN ANY OTHER JURISDICTION. ANY GUARANTOR HEREBY EXPRESSLY AND IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY
OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE JURISDICTION OR LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED
TO ABOVE AND ANY CLAIM THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. TO THE EXTENT THAT ANY GUARANTOR HAS OR HEREAFTER
MAY ACQUIRE ANY IMMUNITY FROM JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS (WHETHER THROUGH SERVICE OR NOTICE, ATTACHMENT PRIOR
TO JUDGMENT, ATTACHMENT IN AID OF EXECUTION OR OTHERWISE) WITH RESPECT TO ITSELF OR ITS PROPERTY, EACH GUARANTOR HEREBY IRREVOCABLY WAIVES
SUCH IMMUNITY IN RESPECT OF ITS OBLIGATIONS UNDER THIS GUARANTY AND THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>WAIVER
OF JURY TRIAL, ETC.</U></B> EACH GUARANTOR HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM CONCERNING
ANY RIGHTS UNDER THIS GUARANTY OR THE OTHER TRANSACTION DOCUMENTS, OR UNDER ANY AMENDMENT, WAIVER, CONSENT, INSTRUMENT, DOCUMENT OR OTHER
AGREEMENT DELIVERED OR WHICH IN THE FUTURE MAY BE DELIVERED IN CONNECTION HEREWITH OR THEREWITH, OR ARISING FROM ANY FINANCING RELATIONSHIP
EXISTING IN CONNECTION WITH THIS GUARANTY OR THE OTHER TRANSACTION DOCUMENTS, AND AGREES THAT ANY SUCH ACTION, PROCEEDING OR COUNTERCLAIM
SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH GUARANTOR CERTIFIES THAT NO OFFICER, REPRESENTATIVE, AGENT OR ATTORNEY OF ANY
INVESTOR HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY INVESTOR WOULD NOT, IN THE EVENT OF ANY ACTION, PROCEEDING OR COUNTERCLAIM,
SEEK TO ENFORCE THE FOREGOING WAIVERS. EACH GUARANTOR HEREBY ACKNOWLEDGES THAT THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE INVESTORS
ENTERING INTO THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
payments made by any Guarantor hereunder or under any other Transaction Document shall be made in accordance with the terms of the respective
Transaction Document and shall be made without set-off, counterclaim, deduction or other defense. All such payments shall be made free
and clear of and without deduction for any present or future Taxes, deductions, charges or withholdings and all liabilities with respect
thereto, other than Excluded Taxes. If any Guarantor shall be required to deduct or to withhold any Taxes from or in respect of any amount
payable hereunder or under any other Transaction Document:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>the
amount so payable shall be increased to the extent necessary so that after making all required deductions and withholdings (including
Taxes on amounts payable to any Investor pursuant to this sentence) each Investor receives an amount equal to the sum it would have received
had no such deduction or withholding been made,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>such
Guarantor shall make such deduction or withholding,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>such
Guarantor shall pay the full amount deducted or withheld to the relevant taxation authority in accordance with applicable law, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>as
promptly as possible thereafter, such Guarantor shall send the Agent an official receipt (or, if an official receipt is not available,
such other documentation as shall be satisfactory to the Agent, as the case may be) showing payment. In addition, each Guarantor agrees
to pay any Other Taxes<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor hereby indemnifies and agrees to hold the Agent and each Investor (each an &ldquo;<B><U>Indemnified Party</U></B>&rdquo;) harmless
from and against Taxes or Other Taxes (including, without limitation, any Taxes or Other Taxes imposed by any jurisdiction on amounts
payable under this <U>Section&nbsp;11</U>, but excluding Excluded Taxes) paid by any Indemnified Party as a result of any payment made
hereunder or from the execution, delivery, registration or enforcement of, or otherwise with respect to, this Agreement or any other Transaction
Document, and any liability (including penalties, interest and expenses for nonpayment, late payment or otherwise) arising therefrom or
with respect thereto, whether or not such Taxes or Other Taxes were correctly or legally asserted, except to the extent that such Taxes
or Other Taxes are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross
negligence or willful misconduct of such Indemnified Party. This indemnification shall be paid within 30 days from the date on which the
Agent makes written demand therefor, which demand shall identify the nature and amount of such Taxes or Other Taxes and shall include
a certification as to the amount of any such Taxes or Other Taxes by the Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
any Guarantor fails to perform any of its obligations under this <U>Section&nbsp;11</U>, such Guarantor shall indemnify the Agent and
each Investor for any taxes, interest or penalties that may become payable as a result of any such failure. The obligations of the Guarantors
under this <U>Section&nbsp;11</U> shall survive the termination of this Guaranty and the payment of the Guaranteed Obligations and all
other amounts payable hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
Investor that is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Transaction Document
shall deliver to the Company, at the time or times reasonably requested by the Company, such properly completed and executed documentation
reasonably requested by the Company as will permit such payments to be made without withholding or at a reduced rate of withholding. In
addition, any Investor, if reasonably requested by the Company, shall deliver such other documentation prescribed by applicable law or
reasonably requested by the Company as will enable the Company to determine whether or not such Investor is subject to backup withholding
or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution
and submission of such documentation shall not be required if in the Investor's reasonable judgment such completion, execution or submission
would subject such Investor to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position
of such, Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
any party determines, in its sole discretion exercised in good faith, that it has received a refund of any taxes as to which it has been
indemnified pursuant to this <U>Section&nbsp;11</U> (including by the payment of additional amounts pursuant to this <U>Section&nbsp;11</U>),
it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this <U>Section&nbsp;11</U>
with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and
without interest (other than any interest paid by the relevant governmental refunding party with respect to such refund). Such indemnifying
party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this paragraph
(e) (plus any penalties, interest or other charges imposed by the relevant governmental refunding party) in the event that such indemnified
party is required to repay such refund to such governmental refunding party. Notwithstanding anything to the contrary in this paragraph
(e), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraph (e) the
payment of which would place the indemnified party in a less favorable net after-tax position than the indemnified party would have been
in if the tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification
payments or additional amounts with respect to such tax had never been paid. This paragraph shall not be construed to require any indemnified
party to make available its tax returns (or any other information that it deems confidential) to the indemnifying party or any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 12.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Miscellaneous.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor will make each payment hereunder in Dollars and in immediately available funds to each Investor, at such address specified by
such Investor from time to time by notice to the Guarantors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
amendment or waiver of any provision of this Guaranty and no consent to any departure by any Guarantor therefrom shall in any event be
effective unless the same shall be in writing and signed by each Guarantor and the Agent, on behalf of the Investors, and then such waiver
or consent shall be effective only in the specific instance and for the specific purpose for which given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
failure on the part of the Agent or any Investor to exercise, and no delay in exercising, any right hereunder or under any other Transaction
Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder or under any Transaction Document
preclude any other or further exercise thereof or the exercise of any other right. The rights and remedies of the Agent and the Investors
provided herein and in the other Transaction Documents are cumulative and are in addition to, and not exclusive of, any rights or remedies
provided by Law. The rights of the Agent and the Investors under any Transaction Document against any party thereto are not conditional
or contingent on any attempt by the Agent or any Investor to exercise any of their respective rights under any other Transaction Document
against such party or against any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
provision of this Guaranty that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the
extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability
of such provision in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty shall (i) be binding on each Guarantor and Investor and their respective successors and assigns, and (ii) inure, together with
all rights and remedies of the Agent and the Investors hereunder, to the benefit of the Agent and the Investors and their respective successors,
transferees and assigns. Without limiting the generality of clause (ii) of the immediately preceding sentence, the Agent and any Investor
may assign or otherwise transfer its rights and obligations under the Purchase Agreement, the Notes or any other Transaction Document
to any other Person in accordance with the terms thereof, and such other Person shall thereupon become vested with all of the benefits
in respect thereof granted to the Agent or such Investor, as the case may be, herein or otherwise. None of the rights or obligations of
any Guarantor hereunder may be assigned or otherwise transferred without the prior written consent of the Agent on behalf of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
subsidiary (whether by acquisition or formation) of any Guarantor shall execute and deliver to the Agent and the Investors a joinder to
this Guaranty in form and substance reasonably satisfactory to the Agent and the Investors. Upon the execution and delivery of such a
joinder by any such subsidiary, such subsidiary shall become a Guarantor hereunder with the same force and effect as if originally named
a Guarantor herein. The execution and delivery of any agreement or instrument adding an additional Guarantor as a party to this Guaranty
shall not require the consent of any Guarantor hereunder. The rights and obligations of each Guarantor hereunder shall remain in full
force and effect, and shall be joint and several with each other Guarantor hereunder, notwithstanding the addition of any new Guarantor
hereunder, as though such new Guarantor had originally been named a Guarantor hereunder on the date of this Guaranty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty reflects the entire understanding of the transactions contemplated hereby and shall not be contradicted or qualified by any other
agreement, oral or written, entered into before the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Section
headings herein are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty may be executed by each party hereto on a separate counterpart, each of which when so executed and delivered shall be an original,
but all of which together shall constitute one agreement. Delivery of an executed counterpart by facsimile or other method of electronic
transmission shall be equally effective as delivery of an original executed counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>THIS
GUARANTY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE
PERFORMED THEREIN WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Receipt
of Payments.</U></B> Without limiting the obligations of the Guarantors under <U>Section&nbsp;2</U> of this Guaranty, if the Agent or
any Investor receives from or on behalf of any Guarantor any amount under this Guaranty or any other Transaction Document in a currency
other than the currency in which the Guaranteed Obligations are denominated (the &ldquo;<B>Obligation Currency</B>&rdquo;), including
without limitation, by way of enforcement upon Collateral, the Agent and each Investor is hereby authorized to, and at its sole discretion
may, convert such currency into the Obligation Currency for application to the Guaranteed Obligations in accordance with the Transaction
Documents. The Guaranteed Obligations shall be satisfied only to the extent of the amount of the Obligation Currency received by the Agent
or any Investor from such conversion of the Guaranteed Obligations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Currency;
Judgment.</U></B> Without limiting and in addition to <U>Section&nbsp;13</U> of this Guaranty, if for the purposes of obtaining judgment
in any court in any jurisdiction with respect to this Guaranty it becomes necessary to convert into the currency of such jurisdiction
(herein called the &ldquo;<B><U>Judgment Currency</U></B>&rdquo;) any amount due hereunder in any currency other than the Judgment Currency,
then conversion shall be made at the Exchange Rate prevailing on the Business Day before the day on which (a) the date of actual payment
of the amount due, in case of any proceeding in the courts of any jurisdictions that could give effect to such conversion being made on
such date, or (b) judgment is given in the case of any proceeding in the courts of any other jurisdiction. In the event that there is
a change in the Exchange Rate prevailing between the Business Day before the day on which the judgment is given and the date of payment
of the amount due, the Guarantors will, on the date of payment, pay such additional amounts (if any) as may be necessary to ensure that
the amount paid on such date is the amount in the Judgment Currency which when converted at the exchange rate prevailing on the date of
payment is the amount then due under this Guaranty. Any additional amount due from the Guarantors under this <U>Section&nbsp;14</U> will
be due as a separate debt and shall not be affected by judgment being obtained for any other sums due under or in respect of any of the
Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[</FONT>The
remainder of this page intentionally left blank<FONT STYLE="text-transform: uppercase">]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Guarantor
has caused this Guaranty to be executed by its respective duly authorized officer, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>MILTON AULT</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 49%"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;Milton Ault</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Address for Notices:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">[_______________________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Attn: [______________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Tel.: [______________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Email.: [______________]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page to Guaranty)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Guarantor
has caused this Guaranty to be executed by its respective duly authorized officer, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>KRISTY AULT</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 49%"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;Kristy Ault</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Address for Notices:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">[_______________________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Attn: [______________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Tel.: [______________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Email.: [______________]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature page to</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Guaranty</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Guarantor
has caused this Guaranty to be executed by its respective duly authorized officer, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><B>AULT AND COMPANY, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; width: 1%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; width: 49%"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;Milton Ault</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Address for Notices:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">[_______________________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Attn: [______________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Tel.: [______________]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Email.: [______________]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature page to</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Guaranty</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>ex10_4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">GUARANTY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>GUARANTY</B> dated
as of December 30, 2021 (as amended, supplemented or otherwise modified from time to time, this &ldquo;<B><U>Guaranty</U></B>&rdquo;)
is made by the undersigned (together with each other Person that executes a joinder agreement and becomes a &ldquo;Guarantor&rdquo; hereunder,
each a &ldquo;<B><U>Guarantor</U></B>&rdquo;, and collectively, the &ldquo;<B><U>Guarantors</U></B>&rdquo;), in favor of the Agent (as
defined below) for the benefit of the Investors (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RECITALS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BitNile Holdings, Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), each party listed as a &ldquo;Investor&rdquo;
in the Purchase Agreement referenced below (together with their respective successors and assigns, each a &ldquo;<B><U>Investor</U></B>&rdquo;),
and Esousa Holdings LLC, a New York limited liability company, as agent for the Investors (the &ldquo;<B><U>Agent</U></B>&rdquo;) and
as an Investor, are parties to that certain Securities Purchase Agreement of even date herewith (as amended, supplemented or otherwise
modified from time to time, the &ldquo;<B><U>Purchase Agreement</U></B>&rdquo;), pursuant to which, among other things, the Company shall
issue certain Senior Secured Promissory Notes (as amended, supplemented or otherwise modified from time to time, and as replaced or refinanced
from time to time, the &ldquo;<B><U>Notes</U></B>&rdquo;) to the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Notes are secured by that certain Security Agreement dated as of the date hereof (as amended, supplemented or otherwise modified
from time to time, the &ldquo;<B><U>Security Agreement</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Additionally, the Investors have requested, and the Guarantors have agreed, that the Guarantors shall execute and deliver to the
Investors, a guaranty guaranteeing all of the obligations of the Company under the Purchase Agreement, the Notes and the other Transaction
Documents until the Notes have been indefeasibly paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Pursuant to the Security Agreement, the Guarantors have granted to Agent, as agent for the Investors, a security interest in and
lien on their assets to secure their respective obligations under this Guaranty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Guarantor has determined that the execution, delivery and performance of this Guaranty directly benefits, and is in the best interest
of, such Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the premises and the agreements herein and for other consideration, the sufficiency of which is hereby acknowledged,
each Guarantor hereby agrees with each Investor as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 1</B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Definitions.</U></B>
Reference is hereby made to the Purchase Agreement, the Notes and the other Transaction Documents for a statement of the terms thereof.
All terms used in this Guaranty, which are defined in the Purchase Agreement and not otherwise defined herein, shall have the same meanings
herein as set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 2</B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Guaranty.</U></B>
The Guarantors hereby unconditionally and irrevocably, guaranty the punctual payment, as and when due and payable, by stated maturity
or otherwise (after giving effect to any applicable grace or cure periods), of the Obligations and any other amounts now or hereafter
owing by the Company in respect of the Purchase Agreement, the Notes and the other Transaction Documents (such obligations, to the extent
not paid by the Company, being the &ldquo;<B><U>Guaranteed Obligations</U></B>&rdquo;; <U>provided that</U>, when the Notes have been
indefeasibly paid in full pursuant to their terms, the term &ldquo;Guaranteed Obligations&rdquo; shall not include any of the foregoing
obligations under the Purchase Agreement or any other Transaction Documents, and any remaining obligations under such Transaction Documents
shall no longer be guaranteed hereby). Without limiting the generality of the foregoing, each Guarantor's liability hereunder shall extend
to all amounts that constitute part of the Guaranteed Obligations and would be owed by the Company to the Investors under the Purchase
Agreement and the Notes but for the fact that they are unenforceable or not allowable due to the existence of any proceeding commenced
by or against the Company or any Guarantor under any provision of the Bankruptcy Code (Title 11 of the United States Code) or under any
other bankruptcy or insolvency law, assignments for the benefit of creditors, formal or informal moratoria, compositions, or extensions
generally with creditors, or proceedings seeking reorganization, arrangement, or other similar relief, and all fees, commissions, expense
reimbursements, indemnifications and all other amounts due or to become due under any of the Transaction Documents, and any and all expenses
(including reasonable counsel fees and expenses) reasonably incurred by the Investors or the Agent in enforcing any rights under this
Guaranty, involving the Company, any other Grantor under the Security Agreement or any Guarantor hereunder (the &ldquo;<B><U>Transaction
Parties</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Guaranty
Absolute; Continuing Guaranty; Assignments.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Guarantors guaranty that the Guaranteed Obligations will be paid strictly in accordance with the terms of the Transaction Documents, regardless
of any Law now or hereafter in effect in any jurisdiction affecting any of such terms or the rights of the Investors with respect thereto.
The obligations of each Guarantor under this Guaranty are independent of the Guaranteed Obligations, and a separate action or actions
may be brought and prosecuted against any Guarantor to enforce such obligations, irrespective of whether any action is brought against
any other Transaction Party or whether any Transaction Party is joined in any such action or actions. The liability of any Guarantor under
this Guaranty shall be irrevocable, absolute and unconditional irrespective of, and each Guarantor hereby irrevocably waives, to the extent
permitted by law, any defenses it may now or hereafter have in any way relating to, any or all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
lack of validity or enforceability of any Transaction Document or any agreement or instrument relating thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
change in the time, manner or place of payment of, or in any other term of, all or any of the Guaranteed Obligations, or any other amendment
or waiver of or any consent to departure from any Transaction Document, including without limitation, any increase in the Guaranteed Obligations
resulting from the extension of additional credit to any Transaction Party or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
taking, exchange, release or non-perfection of any collateral with respect to the Guaranteed Obligations, or any taking, release or amendment
or waiver of or consent to departure from any other guaranty, for all or any of the Guaranteed Obligations; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
change, restructuring or termination of the corporate, limited liability company or partnership structure or existence of any Transaction
Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Guaranty shall continue
to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or
must otherwise be returned by any Investor or any other Person upon the insolvency, bankruptcy or reorganization of any Transaction Party
or otherwise, all as though such payment had not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Guaranty is a continuing guaranty and shall (i) remain in full force and effect until the indefeasible payment in full in cash of all
Guaranteed Obligations (together with any matured indemnification obligations as of the date of such payment, but excluding any inchoate
or unmatured contingent indemnification obligations) and (ii) be binding upon each Guarantor and its respective successors and assigns.
This Guaranty shall inure to the benefit of and be enforceable by the Agent, on behalf of the Investors and their respective successors,
and permitted pledgees, transferees and assigns. Without limiting the generality of the foregoing sentence, the Agent and any Investor
may pledge, assign or otherwise transfer all or any portion of its rights and obligations under and subject to the terms of any Transaction
Document to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted to
the Agent and such Investor herein or otherwise, in each case as provided in the Transaction Documents. Notwithstanding the foregoing
and for the avoidance of doubt, this Guaranty will expire and each Guarantor will be automatically released from its obligation hereunder
without any further action by any Person upon the indefeasible payment in full in cash of all Guaranteed Obligations (together with any
matured indemnification obligations as of the date of such payment, but excluding any inchoate or unmatured contingent indemnification
obligations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waivers.</U></B>
To the extent permitted by applicable Law, each Guarantor hereby waives promptness, diligence, notice of acceptance and any other notice
with respect to any of the Guaranteed Obligations and this Guaranty and any requirement that the Agent exhaust any right or take any action
against any Transaction Party or any other Person or any Collateral (as defined in the Security Agreement). Each Guarantor acknowledges
that it will receive direct and indirect benefits from the financing arrangements contemplated herein and that the waiver set forth in
this <U>Section&nbsp;4</U> is knowingly made in contemplation of such benefits. The Guarantors hereby waive any right to revoke this Guaranty,
and acknowledge that this Guaranty is continuing in nature and applies to all Guaranteed Obligations, whether existing now or in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subrogation.</U></B>
No Guarantor may exercise any rights that it may now or hereafter acquire against any Transaction Party or any other Guarantor that arise
from the existence, payment, performance or enforcement of any Guarantor's obligations under this Guaranty, including without limitation,
any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy
of the Investors or the Agent against any Transaction Party or any other guarantor or any Collateral, whether or not such claim, remedy
or right arises in equity or under contract, statute or common law, including without limitation, the right to take or receive from any
Transaction Party or any other guarantor, directly or indirectly, in cash or other property or by set-off or in any other manner, payment
or security solely on account of such claim, remedy or right, unless and until the indefeasible payment in full in cash of all Guaranteed
Obligations (together with any matured indemnification obligations as of the date of such payment, but excluding any inchoate or unmatured
contingent indemnification obligations). If any amount shall be paid to a Guarantor in violation of the immediately preceding sentence
at any time prior to the later of the payment in full in cash of the Guaranteed Obligations, such amount shall be held in trust for the
benefit of the Investors and shall forthwith be paid ratably to the Investors to be credited and applied to the Guaranteed Obligations,
whether matured or unmatured, in accordance with the terms of the Transaction Documents, or to be held as collateral for any Guaranteed
Obligations thereafter arising. If (a) any Guarantor shall make payment to the Investors of all or any part of the Guaranteed Obligations,
and (b) the Investors receive the indefeasible payment in full in cash of all Guaranteed Obligations (together with any matured indemnification
obligations as of the date of such payment, but excluding any inchoate or unmatured contingent indemnification obligations), the Agent
and the Investors will, at such Guarantor's request and expense, promptly execute and deliver to such Guarantor appropriate documents,
without recourse and without representation or warranty, necessary to evidence the transfer by subrogation to such Guarantor of an interest
in the Guaranteed Obligations resulting from such payment by such Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations,
Warranties and Covenants.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Guarantor hereby represents and warrants as of the date first written above as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor is (A) an individual with full capacity, who has knowledge and a complete understanding of the terms set forth in this Guaranty
and each other Transaction Document to which Guarantor is a party, and has had the opportunity to consult with counsel regarding the terms,
conditions, liabilities and obligations under this Guaranty; or (B)(1) a corporation, limited liability company or limited partnership
duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization as set forth on the signature
pages hereto, (2) has all requisite corporate, limited liability company or limited partnership power and authority to conduct its business
as now conducted and as presently contemplated and to execute and deliver this Guaranty and each other Transaction Document to which the
Guarantor is a party, and to consummate the transactions contemplated hereby and thereby and (3) is duly qualified to do business and
is in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the conduct of its
business makes such qualification necessary except where the failure to be so qualified would not reasonably be expected to result in
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
execution, delivery and performance by each Guarantor of this Guaranty and each other Transaction Document to which such Guarantor is
a party (A) in the case of a Guarantor that is an entity, have been duly authorized by all necessary corporate, limited liability company
or limited partnership action, (B) in the case of a Guarantor that is an entity, do not and will not contravene its Organization Documents,
or any applicable Law or any material contractual restriction binding on the Guarantor or its properties and will not result in or require
the creation of any Lien (other than pursuant to any Transaction Document) upon or with respect to any of its properties, and (C) do not
and will not result in any default, noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal of any material permit,
license, authorization or approval applicable to it or its operations or any of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required in connection with
the due execution, delivery and performance by the Guarantor of this Guaranty or any of the other Transaction Documents to which the Guarantor
is a party, other than expressly provided for in any of the Transaction Documents and the filing of any financing statements or similar
matters needed in connection with the perfection of the Liens granted under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
of this Guaranty and the other Transaction Documents to which the Guarantor is or will be a party, when delivered, will be, a legal, valid
and binding obligation of the Guarantor, enforceable against the Guarantor in accordance with its terms, except as may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, suretyship or other similar Laws and equitable principles (regardless
of whether enforcement is sought in equity or at law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>There
is no pending or, to the knowledge of the Guarantor, threatened in writing action, suit or proceeding against the Guarantor or to which
any of the properties of the Guarantor is subject, before any court or other Governmental Authority or any arbitrator that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>if
adversely determined, could reasonably be expected to have a Material Adverse Effect or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT>relates
to this Guaranty or any of the other Transaction Documents to which the Guarantor is a party or any transactions contemplated hereby or
thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
Guarantor (A) has read and understands the terms and conditions of the Purchase Agreement, the Notes and the other Transaction Documents,
and (B) now has and will continue to have independent means of obtaining information concerning the affairs, financial condition and business
of the Company and the other Transaction Parties, and has no need of, or right to obtain from the Agent or any Investor, any credit or
other information concerning the affairs, financial condition or business of the Company or the other Transaction Parties that may come
under the control of the Agent or any Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right
of Set-off.</U></B> Upon the occurrence and during the continuance of any Event of Default, the Agent may, and is hereby authorized to,
at any time and from time to time, without notice to the Guarantors (any such notice being expressly waived by each Guarantor) and to
the fullest extent permitted by law, set-off and apply any and all deposits (general or special, time or demand, provisional or final)
at any time held and other indebtedness at any time owing by any Investor to or for the credit or the account of any Guarantor against
any and all obligations of the Guarantors now or hereafter existing under this Guaranty or any other Transaction Documents, irrespective
of whether or not Agent shall have made any demand under this Guaranty or any other Transaction Document and although such obligations
may be contingent or unmatured. Agent agrees to notify in writing the relevant Guarantor promptly after any such set-off and application
made by such Investor, provided that the failure to give such notice shall not affect the validity of such set-off and application. The
rights of the Agent under this <U>Section&nbsp;7</U> are in addition to other rights and remedies (including without limitation, other
rights of set-off) which the Agent or any Investor may have under this Guaranty or any other Transaction Document in law or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 8.</B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Notices,
Etc.</U></B> All notices and other communications provided for hereunder shall be in writing and shall be mailed (by overnight mail or
by certified mail, postage prepaid and return receipt requested), telecopied or delivered, if to any Guarantor, to the address for such
Guarantor set forth on the signature page hereto, or if to any Investor, to it at its respective address set forth in the Purchase Agreement;
or as to any Person at such other address as shall be designated by such Person in a written notice to such other Person complying as
to delivery with the terms of this <U>Section&nbsp;8</U>. All such notices and other communications shall be effective (i) if mailed (by
certified mail, postage prepaid and return receipt requested), when received or three Business Days after deposited in the mails, whichever
occurs first; (ii) if telecopied, when transmitted and confirmation is received, provided same is on a Business Day and, if not, on the
next Business Day; or (iii) if delivered by hand, upon delivery, provided same is on a Business Day and, if not, on the next Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CONSENT
TO JURISDICTION; SERVICE OF PROCESS AND VENUE.</U></B> ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS GUARANTY OR ANY OTHER TRANSACTION
DOCUMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK IN THE COUNTY OF NEW YORK OR OF THE UNITED STATES DISTRICT COURT FOR THE
SOUTHERN DISTRICT OF NEW YORK, AND, BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH GUARANTOR HEREBY IRREVOCABLY ACCEPTS IN RESPECT
OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS. NOTHING HEREIN SHALL AFFECT THE RIGHT OF THE
INVESTORS TO SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS OR OTHERWISE PROCEED AGAINST EACH
GUARANTOR IN ANY OTHER JURISDICTION. ANY GUARANTOR HEREBY EXPRESSLY AND IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY
OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE JURISDICTION OR LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED
TO ABOVE AND ANY CLAIM THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. TO THE EXTENT THAT ANY GUARANTOR HAS OR HEREAFTER
MAY ACQUIRE ANY IMMUNITY FROM JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS (WHETHER THROUGH SERVICE OR NOTICE, ATTACHMENT PRIOR
TO JUDGMENT, ATTACHMENT IN AID OF EXECUTION OR OTHERWISE) WITH RESPECT TO ITSELF OR ITS PROPERTY, EACH GUARANTOR HEREBY IRREVOCABLY WAIVES
SUCH IMMUNITY IN RESPECT OF ITS OBLIGATIONS UNDER THIS GUARANTY AND THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>WAIVER
OF JURY TRIAL, ETC.</U></B> EACH GUARANTOR HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM CONCERNING
ANY RIGHTS UNDER THIS GUARANTY OR THE OTHER TRANSACTION DOCUMENTS, OR UNDER ANY AMENDMENT, WAIVER, CONSENT, INSTRUMENT, DOCUMENT OR OTHER
AGREEMENT DELIVERED OR WHICH IN THE FUTURE MAY BE DELIVERED IN CONNECTION HEREWITH OR THEREWITH, OR ARISING FROM ANY FINANCING RELATIONSHIP
EXISTING IN CONNECTION WITH THIS GUARANTY OR THE OTHER TRANSACTION DOCUMENTS, AND AGREES THAT ANY SUCH ACTION, PROCEEDING OR COUNTERCLAIM
SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH GUARANTOR CERTIFIES THAT NO OFFICER, REPRESENTATIVE, AGENT OR ATTORNEY OF ANY
INVESTOR HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY INVESTOR WOULD NOT, IN THE EVENT OF ANY ACTION, PROCEEDING OR COUNTERCLAIM,
SEEK TO ENFORCE THE FOREGOING WAIVERS. EACH GUARANTOR HEREBY ACKNOWLEDGES THAT THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE INVESTORS
ENTERING INTO THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
payments made by any Guarantor hereunder or under any other Transaction Document shall be made in accordance with the terms of the respective
Transaction Document and shall be made without set-off, counterclaim, deduction or other defense. All such payments shall be made free
and clear of and without deduction for any present or future Taxes, deductions, charges or withholdings and all liabilities with respect
thereto, other than Excluded Taxes. If any Guarantor shall be required to deduct or to withhold any Taxes from or in respect of any amount
payable hereunder or under any other Transaction Document:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>the
amount so payable shall be increased to the extent necessary so that after making all required deductions and withholdings (including
Taxes on amounts payable to any Investor pursuant to this sentence) each Investor receives an amount equal to the sum it would have received
had no such deduction or withholding been made,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>such
Guarantor shall make such deduction or withholding,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>such
Guarantor shall pay the full amount deducted or withheld to the relevant taxation authority in accordance with applicable law, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>as
promptly as possible thereafter, such Guarantor shall send the Agent an official receipt (or, if an official receipt is not available,
such other documentation as shall be satisfactory to the Agent, as the case may be) showing payment. In addition, each Guarantor agrees
to pay any Other Taxes<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor hereby indemnifies and agrees to hold the Agent and each Investor (each an &ldquo;<B><U>Indemnified Party</U></B>&rdquo;) harmless
from and against Taxes or Other Taxes (including, without limitation, any Taxes or Other Taxes imposed by any jurisdiction on amounts
payable under this <U>Section&nbsp;11</U>, but excluding Excluded Taxes) paid by any Indemnified Party as a result of any payment made
hereunder or from the execution, delivery, registration or enforcement of, or otherwise with respect to, this Agreement or any other Transaction
Document, and any liability (including penalties, interest and expenses for nonpayment, late payment or otherwise) arising therefrom or
with respect thereto, whether or not such Taxes or Other Taxes were correctly or legally asserted, except to the extent that such Taxes
or Other Taxes are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross
negligence or willful misconduct of such Indemnified Party. This indemnification shall be paid within 30 days from the date on which the
Agent makes written demand therefor, which demand shall identify the nature and amount of such Taxes or Other Taxes and shall include
a certification as to the amount of any such Taxes or Other Taxes by the Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
any Guarantor fails to perform any of its obligations under this <U>Section&nbsp;11</U>, such Guarantor shall indemnify the Agent and
each Investor for any taxes, interest or penalties that may become payable as a result of any such failure. The obligations of the Guarantors
under this <U>Section&nbsp;11</U> shall survive the termination of this Guaranty and the payment of the Guaranteed Obligations and all
other amounts payable hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
Investor that is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Transaction Document
shall deliver to the Company, at the time or times reasonably requested by the Company, such properly completed and executed documentation
reasonably requested by the Company as will permit such payments to be made without withholding or at a reduced rate of withholding. In
addition, any Investor, if reasonably requested by the Company, shall deliver such other documentation prescribed by applicable law or
reasonably requested by the Company as will enable the Company to determine whether or not such Investor is subject to backup withholding
or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution
and submission of such documentation shall not be required if in the Investor's reasonable judgment such completion, execution or submission
would subject such Investor to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position
of such, Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
any party determines, in its sole discretion exercised in good faith, that it has received a refund of any taxes as to which it has been
indemnified pursuant to this <U>Section&nbsp;11</U> (including by the payment of additional amounts pursuant to this <U>Section&nbsp;11</U>),
it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this <U>Section&nbsp;11</U>
with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and
without interest (other than any interest paid by the relevant governmental refunding party with respect to such refund). Such indemnifying
party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this paragraph
(e) (plus any penalties, interest or other charges imposed by the relevant governmental refunding party) in the event that such indemnified
party is required to repay such refund to such governmental refunding party. Notwithstanding anything to the contrary in this paragraph
(e), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraph (e) the
payment of which would place the indemnified party in a less favorable net after-tax position than the indemnified party would have been
in if the tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification
payments or additional amounts with respect to such tax had never been paid. This paragraph shall not be construed to require any indemnified
party to make available its tax returns (or any other information that it deems confidential) to the indemnifying party or any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 12.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Miscellaneous.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor will make each payment hereunder in Dollars and in immediately available funds to each Investor, at such address specified by
such Investor from time to time by notice to the Guarantors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
amendment or waiver of any provision of this Guaranty and no consent to any departure by any Guarantor therefrom shall in any event be
effective unless the same shall be in writing and signed by each Guarantor and the Agent, on behalf of the Investors, and then such waiver
or consent shall be effective only in the specific instance and for the specific purpose for which given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
failure on the part of the Agent or any Investor to exercise, and no delay in exercising, any right hereunder or under any other Transaction
Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder or under any Transaction Document
preclude any other or further exercise thereof or the exercise of any other right. The rights and remedies of the Agent and the Investors
provided herein and in the other Transaction Documents are cumulative and are in addition to, and not exclusive of, any rights or remedies
provided by Law. The rights of the Agent and the Investors under any Transaction Document against any party thereto are not conditional
or contingent on any attempt by the Agent or any Investor to exercise any of their respective rights under any other Transaction Document
against such party or against any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
provision of this Guaranty that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the
extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability
of such provision in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty shall (i) be binding on each Guarantor and Investor and their respective successors and assigns, and (ii) inure, together with
all rights and remedies of the Agent and the Investors hereunder, to the benefit of the Agent and the Investors and their respective successors,
transferees and assigns. Without limiting the generality of clause (ii) of the immediately preceding sentence, the Agent and any Investor
may assign or otherwise transfer its rights and obligations under the Purchase Agreement, the Notes or any other Transaction Document
to any other Person in accordance with the terms thereof, and such other Person shall thereupon become vested with all of the benefits
in respect thereof granted to the Agent or such Investor, as the case may be, herein or otherwise. None of the rights or obligations of
any Guarantor hereunder may be assigned or otherwise transferred without the prior written consent of the Agent on behalf of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
subsidiary (whether by acquisition or formation) of any Guarantor shall execute and deliver to the Agent and the Investors a joinder to
this Guaranty in form and substance reasonably satisfactory to the Agent and the Investors. Upon the execution and delivery of such a
joinder by any such subsidiary, such subsidiary shall become a Guarantor hereunder with the same force and effect as if originally named
a Guarantor herein. The execution and delivery of any agreement or instrument adding an additional Guarantor as a party to this Guaranty
shall not require the consent of any Guarantor hereunder. The rights and obligations of each Guarantor hereunder shall remain in full
force and effect notwithstanding the addition of any new Guarantor hereunder, as though such new Guarantor had originally been named a
Guarantor hereunder on the date of this Guaranty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty reflects the entire understanding of the transactions contemplated hereby and shall not be contradicted or qualified by any other
agreement, oral or written, entered into before the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Section
headings herein are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty may be executed by each party hereto on a separate counterpart, each of which when so executed and delivered shall be an original,
but all of which together shall constitute one agreement. Delivery of an executed counterpart by facsimile or other method of electronic
transmission shall be equally effective as delivery of an original executed counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>THIS
GUARANTY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE
PERFORMED THEREIN WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Receipt
of Payments.</U></B> Without limiting the obligations of the Guarantors under <U>Section&nbsp;2</U> of this Guaranty, if the Agent or
any Investor receives from or on behalf of any Guarantor any amount under this Guaranty or any other Transaction Document in a currency
other than the currency in which the Guaranteed Obligations are denominated (the &ldquo;<B>Obligation Currency</B>&rdquo;), including
without limitation, by way of enforcement upon Collateral, the Agent and each Investor is hereby authorized to, and at its sole discretion
may, convert such currency into the Obligation Currency for application to the Guaranteed Obligations in accordance with the Transaction
Documents. The Guaranteed Obligations shall be satisfied only to the extent of the amount of the Obligation Currency received by the Agent
or any Investor from such conversion of the Guaranteed Obligations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Currency;
Judgment.</U></B> Without limiting and in addition to <U>Section&nbsp;13</U> of this Guaranty, if for the purposes of obtaining judgment
in any court in any jurisdiction with respect to this Guaranty it becomes necessary to convert into the currency of such jurisdiction
(herein called the &ldquo;<B><U>Judgment Currency</U></B>&rdquo;) any amount due hereunder in any currency other than the Judgment Currency,
then conversion shall be made at the Exchange Rate prevailing on the Business Day before the day on which (a) the date of actual payment
of the amount due, in case of any proceeding in the courts of any jurisdictions that could give effect to such conversion being made on
such date, or (b) judgment is given in the case of any proceeding in the courts of any other jurisdiction. In the event that there is
a change in the Exchange Rate prevailing between the Business Day before the day on which the judgment is given and the date of payment
of the amount due, the Guarantors will, on the date of payment, pay such additional amounts (if any) as may be necessary to ensure that
the amount paid on such date is the amount in the Judgment Currency which when converted at the exchange rate prevailing on the date of
payment is the amount then due under this Guaranty. Any additional amount due from the Guarantors under this <U>Section&nbsp;14</U> will
be due as a separate debt and shall not be affected by judgment being obtained for any other sums due under or in respect of any of the
Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[</FONT>The
remainder of this page intentionally left blank<FONT STYLE="text-transform: uppercase">]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Guarantor
has caused this Guaranty to be executed by its respective duly authorized officer, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>GUARANTORS</B>:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Ault
Alliance, Inc. &nbsp;</B></FONT></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 3%">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: top; width: 37%">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="width: 10%; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&nbsp;</P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>digital
power lending, llc &nbsp;</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&nbsp;</P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>alliance
cloud services, llc &nbsp;</B></FONT></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: top">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&nbsp;</P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notices to all Guarantors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Milton C. Ault, III</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email.: todd@aultglobal.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Park Avenue, Suite 1658A, New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Henry Nisser</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email.: henry@aultglobal.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page to Guaranty)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="bitnile_logo.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BitNile Holdings Obtains $52.2 Million in Secured
Debt Financing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Las Vegas, NV, December 31, 2021 &ndash; BitNile
Holdings, Inc (NYSE American: NILE), a diversified holding company (&ldquo;<B>BitNile</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;)
announced today that it has sold $58.4 million of principal face amount 10% Original Issuance Discount Promissory Notes (the &ldquo;<B>Notes</B>&rdquo;)
to sophisticated investors for $52.2 million (the &ldquo;<B>Financing</B>&rdquo;). The Notes are due and payable on March 31, 2022, accrue
interest at the rate of 8% per annum and are secured by a majority of the assets of the Company, as well as a pledge of the equity interests
in the Company&rsquo;s subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The investors who participated in the Financing
received warrants to purchase approximately 12.4 million shares of the Company&rsquo;s common stock (&ldquo;<B>Common Stock</B>&rdquo;),
exercisable for five years at $2.50 per share on a cashless basis, subject to adjustment. Further, the investors received a different
kind of warrant that entitles them to purchase approximately 1.7 million shares of Common Stock, exercisable for five years at $2.50 per
share on a cashless basis, subject to adjustment, with certain Black-Scholes valuation terms, including a $1.25 floor price on the closing
bid price of the Company&rsquo;s common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The repayment terms of the Notes provide that
while the Notes are outstanding, to the extent that the Company raises additional funds from future financing transactions or the sale
of any Bitcoin, the Company will make a payment on the Notes equal to 65% of the net proceeds from such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purchase agreement for the Notes provides
for registrations rights related to the warrants issued in conjunction with the Notes. The Company agreed to file a resale registration
statement on Form S-3 registering all of the shares of Common Stock underlying the warrants as well as any other shares of common stock
issuable to certain of the investors underlying previously issued warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notes are guaranteed by the Company&rsquo;s
Founder and Executive Chairman, Milton &ldquo;Todd&rdquo; Ault, III and by Ault &amp; Company, Inc., a related party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proceeds from the Note offering will be used
for the purchase of commercial real estate, the purchase of Bitcoin mining equipment and general working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information on BitNile and its subsidiaries,
BitNile recommends that stockholders, investors, and any other interested parties read BitNile&rsquo;s public filings and press releases
available under the Investor Relations section at www.BitNile.com or available at <FONT STYLE="color: blue">www.sec.gov</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About BitNile Holdings,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">BitNile Holdings, Inc.
is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.
Through its wholly and majority-owned subsidiaries and strategic investments, BitNile owns and operates a data center at which it mines
Bitcoin and provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, automotive,
telecommunications, medical/biopharma, and textiles. In addition, BitNile extends credit to select entrepreneurial businesses through
a licensed lending subsidiary. BitNile Holdings&rsquo; headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas,
NV 89141; www.BitNile.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="bitnile_logo.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">This press release
contains &ldquo;forward-looking statements&rdquo; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and
Section&nbsp;21E of the Securities Exchange Act of 1934, as amended.&nbsp;These forward-looking statements generally include statements
that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &ldquo;believes,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;opportunity,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;could,&rdquo; &ldquo;potential,&rdquo; or similar expressions. Statements that are not historical facts are forward-looking statements.
Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements
speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information
or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various
factors.&nbsp;More information, including potential risk factors, that could affect the Company&rsquo;s business and financial results
are included in the Company&rsquo;s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company&rsquo;s
Forms 10-K, 10-Q and 8-K. All filings are available at&nbsp;<FONT STYLE="color: blue">www.sec.gov</FONT> and on the Company&rsquo;s website
at www.BitNile.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>BitNile Holdings Investor Contact: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IR@BitNile.com or 1-888-753-2235</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>bitnile_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bitnile_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( #$
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /[^**_ [_@Y<U_7?#/_  23^-6K^&];U?P]JT'COX-)#JFAZE>Z
M3J,*3?$718IDBO;">WN8TEC9HY524+(A*N"I(K^#W]C?]A#_ (*E_M\^!_$_
MQ'_9;F^(/C[PCX-\5?\ "%^(-3N_CG-X9>R\1C2=/US[$EKKGB6UN+A1INJ6
M4YN(4:(&7R]V]2!];D_#%+-,MJ9GB,VP^6T*>*EA6\123AS*%*49.K*O2BN9
MU5%1:W6[O9>1C<TGA<3'"T\'4Q,Y4U42IR:E9N2:4%3FW;EO>_7;0_T-_P!A
M[_@JYIG[9VH?\% +"T^#>J> S^PIXNN_"M[)>>*++6!\0VM;7XBW)O+);>QM
M_P"Q%?\ X5_(HBN3<LO]I1DL?(?=Z=_P2D_X**V'_!3W]EO_ (:6T[X7W_PD
MM_\ A8'BKP)_PBFH^(+7Q+<%_#(T\MJ/]HV=G8Q;+O[>-L'D;HO+.6;/'\"^
ME_\ !OK_ ,%N]#;5VT3X1:GH[>()&EUYM*^/GAC3FUN5EG5I-7-GXEA.I2,M
MS<J7O?/8K<3@G$LFZ*R_X(:?\%VO@[H,LW@/X1_$O1M/TR6;58]$^%?Q_P##
MVG7?VL*))KK3])TOQOHT<VHR"-<&V/VNX=41/,DV*?>K\,\-58XB.&S_ "RC
M4JSPKPTGB8S5"-.CR8F#3QEJGUFLU54I).DER1NMO/IYIF<'3=7+\7.,8U54
M7LG'VCE-2I235'W?9T[Q:5^>ZDW??_4;HK_.B_X(S?\ !;S]MC]GG]L7X=_L
M=?MF>//B'\4OA-\0/B1I_P %?$&E_&^ZU75OBK\#O'FL:JGAS1]4M_%/B0R^
M+6T;3/$$UI9>*O"WB2\U*UM]&>6_T :?<V:PZC^[W_!V5XH\3>$_^"<'POU+
MPKXBUWPSJ,O[7GPXLY;_ ,/:OJ&BWLEI)\,?C-+):R7>FW%M.]M)+##(\#2&
M)Y(HG92T:$?.XCA7%X7.<#E->O2Y<P<?J^,I)U*4H.]Y<C<)<T6K2AS=8N,I
M1:;]*GFU*M@J^,ITYWP]_:49M1DI*VG,E)6:>CMT::31_3_17\;7_!(_P;\>
M_P!IS_@VZ_:8^''PRU7Q)XQ^./C[QS^T%X7\ W&I>,+NSUJ?5SJO@^2QM(?%
M6K:@LNF)%$EQY,KWL,4(+*A7?S^%_P#PXB_X+S?]"5XU_P#$E]*_^:ZMJ'#.
M#GB,PPV+S_!8"I@<94PB6(A"$JZIJ/[Z,9XFFXQ;;C;WK-/WC.IFE>-/#5*6
M75\1'$48UFZ3E)4W)_ W&E*[6COINM#_ $]:*_QS_P!KCX5_MR_L,_%G_A2'
M[2WBWXC^!OB1_P (CHGCG^Q+3XN:OXCA_P"$:\17.KVFDWW]HZ+KUS9;[BXT
M/4XVMO-\Z$V^9%4.F?TVL?\ @A5_P7>U&RL]0M/"7B^2TO[6WO;5V_:8T]&>
MWNH4GA=D;Q5N1FBD4E& 92=I&0:]*KP1@J%*C6K<38"E1Q,7+#U:E*$(5XKE
M;E2E+&)324HMN+:2DF]SFAGM>I*<*>5XB<Z;2J1C-N4&W9*:5&\6VFK.VS[,
M_P!/JD#*2P!!*':P!!*L55MK ?=.UE;!P=K*>A%?R1_\$&/V$/\ @HM^P<_[
M9WC;]L+2]8T*WU_X.Z>_PUN=6^)]E\28QXB\-?V_JMU)'9)JNJQV1A7[+([3
M1)'<J!$V\96OXZ_V0/\ @J%^UC^PY^UIKW[2W@+XA>(O&&K>)_&>M77QC\&^
M-/$&KZMX<^,NC7NNW=SJNF^+TN[JX:35#YDT^A>)$!U70-0\NYLIA$9X)N'"
M<'RS"OFE#+\TPN+_ +/IX:5&K"'[K%U,13E4]FJD:LXT>1QE!S;J7G9.,5=Q
MWK9TL/3PD\1A:M+ZS*JI1D_>HQIRC'F<7"+FWS*7+:.FS;T/]?&BOAK_ ()]
M_P#!03X _P#!1WX!Z-\<_@5K@8K]FTOX@^ -3F@7QE\,/&#6_FW7AGQ3I\;;
MX]Q2:;1=8B3^S=?T]/MNGRMLN8;;[EKY&O0K8:M4P^(ISHUJ,W"I3J1<9PDM
MTT_O3V:::;33/8IU(581J4Y*<)I2C*+NI)[-/^K;/4**_P _3_@\4U+4;+]I
M[]E);+4+^S5_V=_%3.MI>7-LKL/B!K(#.L$L89@. 6!...E?T._MJ:OJVD?\
M&Z'B/6=)U34M+UBT_P"">OP-N;75M.OKJRU.VN3X&^&H-Q;W]M+'=PSG>V9H
MY5D.YLM\QS[T^'W'!Y%BUB[O.\2\.J;H6^K6K1I<_/[9^V^+FMR4MK7>YP1S
M&]?'T?8V^HT_:<WM+^U]SGM;D]S:U[R[^1^]U%?Q%_\ !GYXW\:^,-0_;A'B
M[Q?XI\4BQA^#ALAXD\0:MK@L_.'C'SOLO]IW=U]G\W8GF^3L\S8N[.T8_+7_
M (*E_$SXD:7_ ,'$OBOP[IGQ!\<:;X?3]JW]DBT30;#Q9K]GHRVMWI'P3-W;
M+I=OJ$=B+>Z,\QN81!Y<YFE,JL9'SW4^$9U,ZS')_KT5++\&L8\1]7;55..'
ME[-4_;7@_P#:+<W/+X?AUTPEFZC@</C?8-K$5O9>S]HKPUJ+FYN2TO@VLM]]
M#_2^HI!T'T%+7QQ[(445_D>_%W0_VK_VE?\ @IA\=_V>/@3XW^(.M?$/QU^T
MU\8]!\$>&/\ A9NM>'=-FFL_%OB"Z%FM[>:S;:9IEM!9VLIC\QHH(TC$:@<"
MOH>'\A_MV>,4L;3P,,'1C7J5:E+VD.1N2DY/VM)04%%R<FVK=K'FYCF#P"H6
MH2KRKS<(QC+E?,N6R2Y)\SDY622O?N?ZX5%?YA__  X=_P""\W_0G^+O_$FM
M._\ FJH_X<._\%YO^A/\7?\ B36G?_-57L_ZIY3_ -%?E7W4O_FW^ODSC_M?
M&?\ 0GQ?WS\O^G'FC_3PHK^,S_@@)_P3'_X*=_L??MO^)?BK^V'H&O:9\*;[
M]GSQ[X-L;C4OC):>/K<^,]7\8_#74](B&B0:WJ+QRMIFAZZ5U P!8%5X3(IN
M0K?V9U\QFV!H9=B_J^'Q]#,J?LX3^LX?E]FY3O>'NU*JYH6U]Z^NR/4PF(J8
MFC[6IAZF&ES->RJ7YK*UI:Q@[.^FG0AN+BWL[>>[NYX;6UM89;BYN;B5(+>W
MMX$:6:>>:5ECAAAC5I)99&5(T5G=@H)K^>+]LS_@YH_X)S_LJ>(=7\"^"M8\
M5?M2^/M#N);/5-/^"<6F7/@RQOK>1HI[*7XDZU=V?AF^GB90S2: VMV3QMF*
M[DD5HA^$'_!RI_P6<\;>/_BAXR_X)X?LU^,+WPY\)OA[<-H/[1OB[PWJ#VU_
M\3/&RHDE_P##./4[*195\$>$P\=MXELK>98O$'B+[3I^I>=9Z2+8_P GGP3^
M"_Q"_:"^)OA3X1?"S0I=>\8^+M02SL+5 8[.PM5(;4-:UBZ"M'IVB:1;%[S4
M[^;"0PILC$MS-;P2_8Y3PGEV&RFMQ!Q1C(8#+</A*N85O:UHX2AA<!0I.O5Q
M>/Q4[*C2C0C*K)*4/9TESSJ)WA'Q<7F^)J8N&7951>(Q-2M##PY(.M4JXBI-
M0A1P]*-W.;FU!74N:3M&-K2?]MEA_P 'DGPU.K@:I^PY\14T S$-)IWQ4\)S
MZTL!/RL+:ZTFVL'F Y:,WJ(3P)0#N'[:?L'?\%[?^">W[>VN:3\/O!OQ"U#X
M2_&36#%!IOPH^,]I:^$M8U[4)!G^S_"&NB\NO#/BJ\+%8H+"QU.+5[R8LEGI
MDXC9A_))^TC_ ,$9/ASX>_9B\&^!/A1)%=?M!^"=(U'Q'?>.[HFU'Q3\0W8A
MDUKPYJ*2N8[#1V,*VO@M6V?V2T2&[=FU+4)#_+[J.G:YX5UV[TO5+34O#_B3
MPYJLUI>V=PEQIVK:+K.E731312*?*N;*_L+R%E)'ES031Y4JR@U\EX:\5^%/
MC3@,[K<#XK&87%9'F-? XG#8J4Z>,^KJK4AE^;K!8BK5G/*\UI4W5PTVZ%:$
ME5PV(A0Q%*4#V.)LHXMX(KX".>T:-6CF&&IUZ56DE*C[3DB\3@W7IQC&.+PD
MY<E6*YZ<DXU:;J4YJ1_N!45_)'_P;7?\%EO%_P"UCHU[^P_^U!XHG\2_'7X;
M^&'UWX0_$;6KDSZ]\5/ASHJ1Q:KX?\37<KF?5O&_@:W:"Y&M2^9>>(O#&^\U
M>635M(O=0U;^MRL<URS$Y1C:V!Q27M*;3C.-W"K3EK"K3;WC)?.,E*$K2BTK
MPF*I8RA"O2;Y9:.+^*$U\4)6ZK\4TUHT?S\?\'.__*(/XW_]C[\%?_5D:)7Y
MZ_\ !IOXVT+X:_\ !.S]L[XB^*)+F'PUX#^/'B'QCXAFL[=KN[BT3PS\%/!F
MLZI);6J%7N;A+&RG:&!6#32!8P06S7Z%?\'._P#RB#^-_P#V/OP5_P#5D:)7
MY\?\&F7@W0?B-_P3Q_;*^'WBJVEO/#'CGX^:_P"$/$5I#/+:S76A^(_@MX+T
M?5;>*ZA*S6TDUC>3QI/$RR0LPD0AE!KZO"<O^H6+Y[\G]N4^?E^+EM@^;EOI
M>U[7ZGDU;_V_0M:_U*=K[7M5M?RN?;,7_!T__P $E)8XY4\<?&G9*B2+GX-:
MT#M=0RY'V_@X(R.U5[__ (.I/^"3=G975U!XK^.6I36\$DL6GV7P;U,7=Y(H
MREO;FZU:VMA+(<*IGGBB7J[J 37;Q_\ !L5_P2&BCCB3X(^.@D:+&H/Q@\=D
M[44*N3_:7)P!S4-Y_P &PW_!(N[M+FUC^#OQ"L)+B"6%+ZR^,'C07EH\B%5N
M+4W5W=6WGPD[XOM%M<0[P/,AD7*GEOP)?X>(+76_U3;3>TO7;MIYZVS_ /FR
M[[JWEY>O]6M_*M^Q9\!OB9_P6G_X+3^+?VQ/AW\-[SP%^SEHW[2OAWXZ?$_7
M-6NK%!X9\+>&+[3=3T#PC--;L&U;X@>/4\/06VS3;6>UTUKZ\U._FCMM/ NO
MZ&?^#NO_ )1I_"O_ +/$^&O_ *J[XUU_*K\:-%\=?\$*/^"R5WX2_9J^*'B#
M7-&^%OC?X=7]DMYJ6V7QG\*OB5;Z+K&I?"_XE0Z<MIINNE]'OWTC5W^Q6X6_
MMK+7-/@TW5;.RGM?ZI?^#N.9;C_@F9\);A ZI/\ M?\ PPF02*4<++\*_C2Z
MAT/*N P#*>5.1VKZC'1E+B/A"O1G">5U:-&.6149QJ0I0IP<E6<Y2<IN,Z34
M_=O%*+CS0E.?E8=I99G-.<9+%0G-XIMIQE.3DER<J224HS]W776]FDO2/^#4
M'_E$_9?]G)_'+_TJ\-U_2S7\TW_!J#_RB?LO^SD_CE_Z5>&Z_I9KX#B3_D?Y
MO_V'XC_TXSZ'+/\ D7X/_L'I_P#I*/\ ,Y_X.Q?^4K#?]FH_!C_U(_BO7^D[
MX&_Y$GP?_P!BMX?_ /33:5_FQ?\ !V+_ ,I6&_[-1^#'_J1_%>O])WP-_P B
M3X/_ .Q6\/\ _IIM*]_B;_DG>#_^P/$_^D8(\_*_^1EG/_7ZE^=8QOBY_P D
MI^)W_9/?&G_J-ZE7^8-_P0I_8G^"?_!0']L#]H3]G#X[:3<77AKQ%^S]\4-1
MT#Q#I<GV?Q'X"\9V'C;PVN@>-?#-T3LCU71Y;B3=;7*R6&J64MUIFH0RVEU(
MM?Z?/Q<_Y)3\3O\ LGOC3_U&]2K_ #PO^#4;_E*3\4_^R ?%/_U//"=/A:M5
MP^1\4UZ%25*M2P^%J4ZD&XSA.+KN,HM;-,G-X1J8_**<XJ<)U*T91DKJ46Z*
M::?='R#K^@_M_?\ !MS^WO;W^G7,MYHU^TQTC5A'?I\'?VIO@[%J$37.FZE
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MF*TB>&PMHHY)$0-,X,CDL37S/_Q#$?\ !(K_ *(SX_\ _#O^-O\ Y-K@PO\
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M& 5DUH7"7(BC*8,I@6^MXF91^X1-Z5^P>(G@2_''A7_5['^)4>!>&JU23QF
MRQ*IF>=8C#NE4PBS)T<#FM2AP]AIN-:K1GA<'2Q6(A3G/&\F'C3/P^7CM/PD
MXEA_9_A9Q5QYF\,/1K_VAAL-E^$R3+*&)E5A.E@<PSW.<@P>9<0UXTYQI8#+
M<3F&-I4I.,L+3=92?]?_ ,<_'7@GP[I>E^-]>\8>&-'\&+HS7_\ PEFHZ[IE
MKX<DLIY$DM[F#69;I=/N(KI2#:-;SR_:MRBW$K,H/\RW_!0SP3^RU^U!<ZC\
M8/V9?BY\/=>^-NA6Q_X3KP'IU[+I-[\2M'TZ$*-3\/PZQ9Z7#KGC+1K6+:;?
M2Y+RZUW2X5@C6:YLK8-\IKH?[ &F^1K%U\6_BQX_\/VLCW.A_!_[+JRW$5S<
MMN2PDN!:VD1621A%,;2XM)FR&$[LOSZ5]X@_8X\0PKI/Q%_9D^)GP TJYQ%X
M=^(=C!KR2(<8@>Y^UAX;C>,/)(;;4F9<JA5B7'XQX1_0)J>%&?0XKPGCOET>
M(L+5J4\%0P.'H_V!F&4UJD?:9=Q-3PL\ZHSPF/C"/*Z^<Y)4H8F-'$471Q&&
MI5X>]QG]-BGQ;@:>3T_ +Q+Q>2580EF&*QF2T\KSG!8Z"NZF099GN/R+.LVQ
M6 YI/$+(\ESRC*ASPC4Q5.LZ,_'O^";OQMU_]G3]OC]D?XM>'[BXM+WP_P#'
MKX>:1J$<;R0B\T'QCXBLO!GB'3KQ 5,MI/I>NW)N+:3B0Q*&7<HQ_L? YY'(
M/(([U_CL?L7_  -M?C-_P4;_ &;/@K\)=5N_%^AZU^TQ\//[!\02V<EK-?\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>nile-20220103_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://NILE/role/Cover" xlink:href="nile-20220103.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://NILE/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>nile-20220103.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /KQpo7xRiXhun8uCaXssSaWO2aPty5hyGZkxvGt2fQka3yooXq2ThCc/ZooGYVwF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:NILE="http://NILE/20220103" elementFormDefault="qualified" targetNamespace="http://NILE/20220103">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://NILE/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nile-20220103_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nile-20220103_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>nile-20220103_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140575746146120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  03,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BITNILE HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000896493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-1721931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11411 Southern Highlands Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Las Vegas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">444-5464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NILE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>bn123121128k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nile-20220103.xsd" xlink:type="simple"/>
    <context id="From2022-01-03to2022-01-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000896493</identifier>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2022-01-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-03to2022-01-03">0000896493</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-03to2022-01-03">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-01-03to2022-01-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-03to2022-01-03">2022-01-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-01-03to2022-01-03">BITNILE HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-03to2022-01-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-01-03to2022-01-03">001-12711</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-03to2022-01-03">94-1721931</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-03to2022-01-03">11411 Southern Highlands Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-03to2022-01-03">Suite 240</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-03to2022-01-03">Las Vegas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-03to2022-01-03">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-03to2022-01-03">89141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-03to2022-01-03">(949)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-03to2022-01-03">444-5464</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-01-03to2022-01-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-01-03to2022-01-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-01-03to2022-01-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-01-03to2022-01-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-01-03to2022-01-03">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-03to2022-01-03">NILE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-03to2022-01-03">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-03to2022-01-03">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ S30C5)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ S30C5 =!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #-
M-"-4@JZ%S.T    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " #--"-4F5R<(Q &  "<)P  $P
M@ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,TT(U21:')G
M5@0  -H0   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " #--"-4GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="bn123121128k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://NILE/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bn123121128k.htm">bn123121128k.htm</File>
    <File>ex10_1.htm</File>
    <File>ex10_2.htm</File>
    <File>ex10_3.htm</File>
    <File>ex10_4.htm</File>
    <File>ex4_1.htm</File>
    <File>ex4_2.htm</File>
    <File>ex4_3.htm</File>
    <File>ex99_1.htm</File>
    <File>nile-20220103.xsd</File>
    <File>nile-20220103_lab.xml</File>
    <File>nile-20220103_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bn123121128k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "bn123121128k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nile-20220103_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nile-20220103_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nile-20220103.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "NILE",
   "nsuri": "http://NILE/20220103",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "bn123121128k.htm",
      "contextRef": "From2022-01-03to2022-01-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://NILE/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "bn123121128k.htm",
      "contextRef": "From2022-01-03to2022-01-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001214659-22-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001214659-22-000010-xbrl.zip
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MU[:4;KMU<]WI==I=TKPX(>W;UOOFQ;LV:5U^_-CI=CN7%W_+^BKK6M]GZH[
MF?8LZ']2;!5)I5RO-=:ZINRQ[W[BWQK1G50A<P#WUH7GT\OKC^30M:G)]QDT
M;QOE&K?:"X432_71U$(_Z4X-'8S(U?CNGN]T=-;J5L[V -S/VIKQ\7)'>X6S
MM&%W6,*9'OTMK+T>]H*Q0'"OVQ<]<MV^NKSNK7DMC_#->A9QY3NN3TV/>!;T
M4C'P090JL1RBU+>T;6(-B#=B^,AW=$]G[N9&>ZJ.J G[15/U\+G2J-9^84E^
M<8%>SY+19$;L7C/;<CRR%7QF%,PAYGJ$/4!+XO#'3-O>%[.2<TMI 26E!:ZX
MZ=T6AGFV.GCH7$TK/39L:_2'U4'<"=1@I#'T&VET-H-%,#-+720FECOZ0$V?
M.K/-C6J>(."%2N2%:%M9VZ:_2$\+'_V:#747PY$>QBRR">1[RNEN=?*P6_VZ
M!GV=-6[NZ+C3PS 6>7]Y?M*Y>-?-D\Y%J_@2JCP;<5OM*06E@]-&67#"Z1+J
M$M=F*CK &M$!LYY+0$V!:#C;S\<>'NT;#&9G&( !E9\8E'/\LTTU+?B\\J Q
MOR T]U7+,*CM@E$?_"7<QT//"09X8(ZGJ]0(L ;N0^!B'GI:T$H"KU;?+&!.
MSIFR,6^@,=5R>$Q\G_@F3 8CYKDY%MY+L'#'A$ZV[-?U0)Q;(F[<LK0%''W[
MKM\=W$^_7^SHZU Y&/+'B(7';,=Z0)Y)ZIPGS!/4,#/H!+350IZ7OSQM(::5
M!8@.>&E)UVIEW42J)(ATJAL,5M1G3C9%OGVK*=?:7W9/JZU-QT1C8AA+*2B5
M747YF]"[=AE(HK='IQT9EE-YWV6X?K@<?;BJ_/EU;*X/UPLFD#MJU K*;@4L
MMZ=@'GXX/Z9K,G4X%S*T,"VP+!WR%0Q+5].%Z0E*_;#O\&"L'A=,WMP94E/_
MSC]O9]-U53[(G%_+&H]U%X^#"?(J$3A[SA$[Q>MBMTC:8]NP9H"2),W(A57<
M3A&BQ'>>HW^..?O#$G6:D*BFICG,=>6O<^BA9$O3U9?*Z8E);[O=ZMJD*6/P
MW)&BU!2%="T?F=DD[_7AR*"FYI(KZMQ/Z&R!?.7G//7J(PNM9"_TP\GH=CI6
MZL8[]1D76LD==7T=Q+92*R]:$?#.4HM @FO!GY=.SYJ8"Q:D[E3W;KZ.WL_N
MU[V@:.C<T3E8C)_8D+I/)E M:S5<F5TZ5V!A@,):8-@T1I_/?38<3F=KIU%J
M_-S1Q:<%"YI;3S-K/5<66$S&7[J]V$R[_/K0GW7'$[?=6/=J$J/GCO8:(%R/
M;5#/ZW#(B>'&9#N 8=VF!F%3IOJ>_H!."&AIYFZ3+9@TP5D_H[?QBVGF8\D_
M*%5-A]'%'$/_JCE77]K*_8=U*./X>$"A1JVQ_526#^(@YQ:8+E<CRUQJ_=;L
MR]N/G^_O.YW!&J:='C-W5*O5"O7:3NWOY?#(Y_\?%UH8S,8Y$I-/,@^^M&KX
MZ,H2\(+HYH;Z3^+QK[X+=M0L=]0:,?6>1S*I#=X@B#+:H'UK2OK,L"9$%V'.
M4_ >R5[A;'-CH!NX9MT%!'@,A$##"*FKCWW#HR:S?->8$1>$Q!W,>%?9P>K#
MR#2P9?%!+$C!A8E0<Q8\&X K;TVP'[JH.MJ<[OYSX^)E,)Y0*_Q(<D#'NC';
M)Y]AO<A0[F*5\MG1/< Z6N*^*<U@-UM(IW5U=Z+4Z\?*C^N6IR2K9$XI=V0M
M%]YX4';^IX2)0A6'2NQ84!Z/9TFM4I?,DPS&\Q#\EK)+6J?7I%(M%Z'A^H1S
MG90M2\IV+4-78>[F\"-(((BAD4U6P^JP;T[C]MS[<6_X*62=G\]/TC0"N+DQ
MEB#G":K4:$&IQ&B:.%0)*5HK%T7+7Y.HP79ZY3"4"TR9XF=^J"^=R\%@T<:J
M3\_LX:[5;JB[STK<Q?/Z22(#X((:@_RX!"LUK5#9ZF\_C>2B[:])]+ULHG=<
MUV?.HZ2??3^OU>N]MOVY_I*DGYO=RS- E15J6^K3&$"V?78&>!E3(+9?"6.(
M.6!.V5DGS\CVFQO2.@*TK-,8ZE/U?NA8@'\\3+&<?3(9Z7C*^'<<ZF3/Y6=.
M>T0^6$80-I4OUD_GB_&1"[A6AIG($X?:X6RKM041\AYFY(OS:'5$5(.Z[H)0
M^Q+HRIOEP=*?F;E2?Q/BXGD\IYY#D1L$WSSC.-W9N&\96R[7!K\6DFN-!>QQ
M(4]H.7>P0,^!A ,T^"92 PL/&.8EY#^M5KM]>IK!X1F'$<MB'?/^AM10,Z72
MYXR=O7<-W^W=-JWWUDV#K2$>D!X3G%380@!%7<]2[_/DCW*Q7%:(31WR0 U_
M\0ED%E$7*8=EC/##6 P"B5(@!+\NB 2=[?0NU3^_MM@ZDLP2 P+3=<[;OSZ6
M KH'N__B# _6^[-^HP]/O?Z/1\+3Y^$HB_-'X5ES GQ^Z;9)DX]'S66(?8YS
MJ4Q;XH LW;F?R7[IF!K:=8ST9T3E@23H=0]S8/P ,QGDV=S070*$![,0(0\)
M*+&)!UND-;8Q\D-=HK&!;HHT%>'=E^OS>7:Q[+HJV<*%[AYP#S]HK/,$%QL3
M7/!T5!B9E7ZA(F%M;L2 9>7LA5#1XHPZQN 67X?]V<XF13Q5;D4?*'E6%\!_
MQ\&W!/1LD=[M.=</WZS[*_7'MY"GN#]+)O:HY_,ZB-X9+)%"#&NG9!JC-2#4
M^ES0=@02RPQP4$!B38N[*[[+>"L85X:&L7)8YRZ,J&I"(O'!C!F./M%A;)1^
M$Y8$3QSVH+O0#_0 -56,$%&5E]7RL!'6;6O4T5P1%=86.4O5+1HFZ,8%O+@"
M9ULOG4+Y,]4DJU;>5#,*;T0US@J5-S%3.+/R)E:9\[.5-\]4M10?%(<[@%[?
M? Q= ' Q-C=RYM&07NDT6&D<RWL96-[!Y<<\Z;CGG/:L5U[L0A\Y3=>EZ4I)
MO6&P 9]Q1HI8PA[,:+'(15[>*YUZYNC#D9?LA%958%$%96USA'(8O2_T&>@;
M0(3-J1LGSDX&<?9^E#A/*%5Y2=H(2$_"6%SL7JK6;8W9Q6L5GT0@*LXKY0Q>
M*0M>>2SO;YXX'#.9K*_H)D^![WAL3)1B61&)XZ(M/FAC^BV>NUJ$DN!8AIR@
MU:SSK(OFT&$\[!KUC%/^U]S'%C@T"Z.2ER8L665X"D^J95[_H&QN;.%F_]__
M[(%!>8 %2(;EHH&!Y1*(#/Y$.=C.DV/=N\#LQ?>6P;?Z/.F8:C$/& U2FDD\
MOS(-5]A)<9"$JS7NMGC6Y@:-^RI7O@/FAQNC3!I@]ZJ9 ,8M(A68B8(7Y%HV
MN!T>-\@0_@-S/<MQTS ZP8,XI,T-820A%M#HPBZZB\:2RB-06_JVF"E O@*K
M&IY9P%T7E@?SWD(S$#K[U#!FB)MH,&P0&P>L-XWK,C2^'ABV3DZ. TQ.3%I]
MA X!*T,T-J,4H@&%Z=$QVGPX2YZ5,-7QP-"8D3]V=O+E<AG_.X YP@H&,&8!
MRV8(4 [-4A<M03M >V(0=.]J^7*CGJ_6RT149?.8>@NCM*1)DG&F,, 41ISP
M_@'LE<$48;\$,:4-*IEFKIL<]K.8.?BELE \!H%ZW%J?,D<%PQCQ)*CW1Z58
M!]YW_?Y70#RNF6HH.EDLEAHG,8"@'Z RCDN@T).0F6_4*OEZ>4_B$K^+HR)[
M'L?!/,C<<OE<.'-PK&'SS8UFJGV:OQ9">P1Y$3E70>/FQG$6'OG,/6LH A_)
M)<0POV#NB5D_<VSAZ<<]+SW\393'<=7,QP4'/+\1*"*LZ:,SXH)_/RL@LR()
M54ZIG?J;4-I 8:B,@9.H>S"A&?12&33.XSB&\$^%DG/8&)6LY7O<L01%F2<#
MT(1<-:*\2B\4%*AJF9J/GB[H=R$OVQR02\5A#[:&C46U !X'@6568]B6,?/)
M9F(O<7];TL:+:0,";V[$52/%_9&GD@V02#0,-/!-F!<K<9G$V@/,1>L6JM@X
M."_A4).:0&Q,<B,5%15238G4S9G(+F,/.L]9P_"DZ\,4XJH/\_TD5X5[+)=N
M .DQ, Z4\C;1Z,P--7W,["B2WORD)CKP,49+^BQ03-R8Q1"'(:*3 4H$SX\H
M9M/V<14P.;X=PJ84C)>(1.?)^7DKK;6"^$=",0;V #I'0TOD\PG+8,ZV"/J#
M(I9C)Y05R2 MQ[R.58C??!W-B_XL$8I)R/8\Y7'#G\5(CG3H"W,(=Y41V&T,
MMJ@0%4L6\Z_ +1:XN'0,N+Z"7= %>Y$Z^CP;=&//DGLLP&F[($(T9E$#'^8Q
MH(\PN)\+(HJQO"'/" $9[C-@[L&\;*5&;0ZE+Y-I:P.ON/)\1G!1IGT=M$CX
M1J$[ %9R#%7B$#9ALH&BMPVF#9%%,;()+.UQ'PRFX7J8!<OQ!AN(IZ.Q3%!H
M)4)OL'@)+S[4DK@-MY AJ@;._((X$2)B2PO&@C_R:!GCEL+5&5!Z[.:SAX^M
M =>J[![@\8H-VLD+0JK8-?)4PB\W-T!*/3"WP0"V,=%9DR7HT!Y7;^/?>0*4
MX32%V8%,ZZ##7 P>@\H6C842,+$6']R*//^(<PMW9UP"$]MMBNBNRY(F$<P)
MRYB9AS(.IA5JW^A,*$;:(F"08$@ =XU\(CB<W4&HHCASQVA"%I$$:_!"FG!*
MBSGC(I.CT@CVC+SS*<*>\P,RFB1=UJ^@U3Q#R*S+'A#O1J X@7$L,A3=&!-H
M5D79-[AV,%B@'M/<$$O(YALIFE:A;?3;*LY>:!VBGS?P'613L#^EHPP[&0VP
M/4?'YG_IV#YH91(Q.K$ $$W?\ AO'%!%!"'PX#$%+"T&P-X#S*B7+EB,L%SA
M3AB(&/R&03[JA@>T;17Y</E,'FB']3JM$=6=,8(WA:)KC70VB#6XY 4]#@XJ
MIY87MC">B[HV; #LV4]%#_60/?1G/XV#P4Z8JSJZ'2]:6!0Q>?X9_1-DAANK
M-(KF;&X\-9S#^:Z/<9Q0M8+WOO>&>^G4-/VQ,*>AIU#A6DP"Q.# AQ^I _MW
M51&7HH@>_"&FH9K2AA1GB,( @K4!.H"(_-(8;L9K;$!1/L/ZGCSI^QZWV0U]
MK(NM 1Q%JAO ":@[Q_0>O$XZ$_O>9 2.@>:S6#XK3B'LP16V. %-!OM4"^;
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M5%YX!P#$M.35VR)Q ?O&AM[<$&/[O+Q#A@7!E[0M5QA9H(=5L(8\Z1Z0#!4
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M*UQDM]?)B%_2&S:-TCXZB. O7R?\O["[\R&(/^)U5(/0"[K@$GY31B,2EQV
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MF"KK(1J#)3O >5V %1B-ITF6D-E *)HKI&1 ]QGM!TE<Y>,Y!B]@P]5AX.Y
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M.%O,#!ZV="3C#R9)45;KO>V?UM'D#U%WN S&=-0+MJER_'.>M 5@@E 8#5[
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MLUE*WTC9-[4'LS=U7[=Z0 HN6!-GY9B3)"^54RR"$UO =3C*F4Y_..?#O'O
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M!VK _(5Y8/DW&:YD(X_%SK(129*-)=53U6+PH$X)LF\1:D$D\"(-4CEX<(T
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M-&%Y]50>:;9$Y$A9T^G_V#QF?,VXC,9[SG[KVBV;2RV (E1 2#Q,GY6: >;
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MG,F&&-(74&@>@:&^&(Z6<.;Z:XR!A3!78$FZ,^P_,4!C',U^^Y*#S^]DL<&
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MY1-%M+A;M)KYKJC^BV.EC=@']VEZG%A/?9@'0Q1GT-,1WI$9O#QV!BTB?(^
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MBG#2Z 9T(MGA<[R^;FJIX1:6,\'0/SOG72A>/1[ JW75;)WCT $69'- @5L
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M"KSS-0QX_H_-XH(%V3;\I?QAS7^<[UM &,:!*YB][P7D+J%[5S"[0^V"CM'
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MUGW@71NR-%0MV!@Y<.O')DJP&XZRKK*;&U?[HK)H9P5Z%])'% W%H6Z8EG/
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M)2* G.YD?N!+<_/0X5W4?:*"<V&&';ZS-D8@&3;4<8/\?W2<:*"**9+UI]3
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MX$'#B9. &.(6%=UF]D"LJ<!-,6&C3(R?QNL9)O5^J=?B?FQ'OU><^NFI;T7
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M?CA%%7MR$;NFX!,4O*!-@=QL(XJ:V302=1VMQ+NIKJ_!\O%L;'^)O+ZQ$["
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M=HSL;"G\'%#UV3.GJ%T6A3D*\B5UNK"P.M3K")/#\BNT8:06GEXLRN&0O=,
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MN-K_-N(TON/A;HOB+K(4CEF+BZ.:"BP2H?0W9E*G>385WFF)O6&*T=EM7-I
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MRDXX*=5269;:JI229MELBHVZZ@E*WGJ-]$2DTXBN>GGM'R&T:J;>_=>3-T\
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MW PBM);*"=,!.JCQPY#1M01H_QH$:(B7G@\*,3N74R0.7<7L2P>=2;H(6+A
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MWR18OW^U$C6E-P[U&S+TLV=_L@<P/*Q[XJ<_U9NCUK_U[$^U!G+WI4?#/OY
M6,'_< @UYS'*5/3IX4@!\L&^%W2([AG]4G-&OS)PKG,&#J )KNZ.RF#TCJ5D
M/:^<D=ZOF,W7;MO!UD>(KHRA=_&*?1G9?GH#LNV(?YIF#SVQ-23K-DHR2/5R
M!3>"-#M-S9=SX,!6XV,I)\O4>3J.1OB<5L"8O</CQ3)* .,N9UK\Q5<NSM :
MM611'[Z$=Q4P9YB 2/L$X%2PP.V)[SO1%.Y,<!J?HU*GIE,0NI"WH/(6@<P?
MXR)(ZD8A#:0%%(U!<(O320X2NC"+GB,:DWT'WF:>$\U2T-N 9(/$$(ATP%.F
M%SBC> ^TO@A$721N/?3-&=P.B86.]!Z2;L22:8'L"%D1:8W^:D*0,7&-JSP#
MH&"[.R_I+R\">'*1I><@7+$PC ^$?%!F!\#+KM9B/?,>ZR7$BD/#J4L>DM+*
MM%V8F2KN-IZ/D^5$\4%-65%#2G::XH;K-)U:/HZB@SGJ6NB'!A] +HWB>?WP
M=$+.^\V&/3Z]Z"!)YZ?P[$@%IW:7?(EV]X(/(&BFRX*MR/K40"W$VT98S^AD
M-BD6;'-/_Y([AF?C5VHVM+$$$(643OQ+D%JL:K"-(B[0E(*F9#U1_4GP54V7
M"9K?X0JH,LY53#"!K&.-)&6OPVAIM>!IA#=9=+!+$LR6<S6'K\>*[C0\AZ@0
MH2A.'R#U,!<#O0RBF.&R )''L!< '.H=LYFX$(B:1*=PL'GA;4,PPZH%?- R
MU'F<.RK+?C3_E"T7!6@;!RD@Y<XP+F Y3Y[H!T[FY!@8("'+Z9E=F*#9L&,R
M!H[L0# CK"E-SDF)2:*+4%P75N@M>>7&&6R/"39II0F/(;_/T&F39G$4DE<B
MS5E2#VD=A!TYG:]@'%Q@TGR<06$T"T047-4G1%,0K[-3D&O_*_I7E ' 3H70
M&24M!ZQ.(C1')+&:RJ4"3)PJY(1X('&>"VU3GQ>P&K02QK,1$ XE%Q')RVP>
M@V;G4FHTX[F4FK @)5,@^U_I P?2?"177';XO]G@BT.+ 2K,)(>W'.7 [!#E
MQC!GKG@?]+)^?M<^A5P!V$YF[XJ]''*,;/\!:LGX3?9))#DHVN4:3TKZ2CP_
M!_30E,*0?(M-;SS,I7E7&:VKZ&XH2(V#RB-TQ^Q^NI]F;T?&>G9]^<H*5Z!^
MCN R XU] 2<U!_J^Q(/37[\(6O9N[]TK_S- <"?:)<RX)OA6N(<V$$P=@=-W
M'I29V44,-WRD6%;)BRPF@QTJYN,QZ(YDV-->93$>:&%C!?T YAQEDT3EN68\
M1]%%4)$=\::SJ$KFK$N 81;GDYC'B^@K301@'!(O9'Z^R9HR5*(Q:+E:!"63
M0I'N!<.JEZ-D]:HA,<1R\3@7BLYTO60@/G(T6(,8@79X@0Z2EC%/.XO0'!J,
MLG0)RV=)/TMS\N-,#!OV"1'0<6'Z044.)CW#VK?1TD>A +B42ST_[,A,Z,Q0
ME?F.*3P!II11Z+'J S >XAW;A\@1C<NJ;): WFQ8F4SP83W(65H#&%D-"EW.
M0CP(8IZ^588 <[!:BV:SX6AEP44$+Z  [BD2"[1]%P5S*A8Z8,DHU1,/!$$#
MC[""SJ0""#0N(A25DXAEV%084N;XVU!21YD-'OC!#:A/-(6+=V].W?3Z]U\!
MQ !QT/0% #N'%4Q$[372KX=1=:1(,_3(Y?"(^]E2PFCT"3&)N$TCX7<]B)N=
MA($^J"D@Q&H+,'L#8:%SU/M!#DXBUBS$B$$7CP#LD!92:^E&)HE1--=24%\=
M)=\EC@Y4/N/[2N%Z\A"J;8HUZ@E2W (-&^3#7(4386!%V M7V]22.]DOQBBW
MFIW7K[39 **S3 B!V&VJ28A6BR(3 R JA+;)U!)<8\ZYPVBXF?'[Z8N@MR 8
M/<=Q!XIV^B)X'R5+_'IK&[^A;=P%O@;[BV!XN8 %MC*@C.,701>N#A]--T6
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MS?#&0:!/]ZX7_LCNVG<@O2NX67.5+N]E3.AM^\U))B%60_9-+2Q8WVV,]B*
MJ#3=0Q[N= ^T_ DY,^DZGIW4]CPSN?!8+(FD!$SQ]C7F2ETH% ]7582ZP]SI
MFT=#4!5L.+B)]D!+5W+ME]=UJ.JMOG/N&J-L"X6)0J$ '9B5@&'KR-;V<GJ
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M>QG5XKJY\J06$VOFT!BNT@LW+D:&'I]B5#5L;0Z/80N=TF QU^A=LP>27-W
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MM3O!TO)7W39,EH#K/^26#R[2<EP%9Y\@J*SO:M5"[R[UV<P(\.3QU@KP':P
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M9[1K,T7CG , S?S76%U-K 76""O\!"?RU@:HM4>! %U&6WD((U5<H&=AXY/
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MVN\=?L2K\^CM\-W1J_\/4$L#!!0    ( ,TT(U3)%[V-@C(  " 4 0 *
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M&D4$>]2-T.]8? #Y,XB03S>H371"C>^W6V;1*DZ34WAVHIU1()1+M+VC/H%
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MN#<<?^ZH=[U!;]@]Q,=API,!G.-!'Q> WU%WOM)QFDUWL6/?J-L_$!#NJ %
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M*0*'!IG ?8W(L%/%(SCO<?]MW\P_. )&_!;D"#B>80]%15@G[/XC"A;OY%A
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MB#E7QM2D]&MN<BQ8DB:V0"AF<;F6:-Y:MTVU599"1&^NMN0P>GM3A>A&3+C
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M*<&L#(D:'K\;6\(?B^QG&R'[$"2YDE1<DJ]B./-%3-@ #>Z3%GFP.\$3;(D
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MQ%XG%:)IK*U%TR"WV6"S<LX'N7!@BG"VC9B/C&D7338,[&P!,ECL#R5T0J)
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MK*J:N60,SO7C"%T.MZ';N]GX^EK ?1,%]0849G;5W;MD[KUD')DT=D37F&7
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MX>ZEUU^6$BH\W\K: B3E*ZID;8M?V\3^KLEZIS8#ZSC.ZHES<4OQ,+_4?DW
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ME;OK5-"A-GY\EL516"##!-4NV4AZ,M=T4K'LL=ML#%:5TMMHH@ZV1>DWH6?
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MZY$FQ HF)G..+2>V<7=5LV1KG(;ZJ0^7G@TGN-#6UM\UT9X3^"T3EZFKRAL
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MOQX?G!Y^1'P^/AJ\/W[S_P%02P,$%     @ S30C5 T7<(R+0@  07 !  D
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MM]-X#,V0J1_$!$@30($>CS25=&Z1H^&Y,KI#K#7 /&,"7D^\WG15?;;@0=E
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MNS\\]NSM:]VGW\D)3+8[@<!<TNV\BI)TQ<(KK@@(UI$H"-;/RN=TD8L\6R%
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M_NS)OLR6KI$L?+Z3^#)[H;]/07Y!*;7UI&XOU1#;;A5-//]GX+[67E#YVO>
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M+3F%I<5=]08N1TZ,<PT@5 @'Y(DR_)RSUY$%)KEEIE\$/J14NWK>!OA,0'A
MLC/U,H#:8'/'D+PIC?(K&FWC[8RV1TFY7%7B4N]VCC/1V$M)M)GR[Y)Q16<7
M.TY9+1Z&UD)&QJ@ F7P1 XL,;0!K3;X8-FH5JW5>LJ9X9I.UR\Y]7R];/R_>
M+?31H_E)-H[4R 1J2*:S3K#@,!OM5(6)=$0_?J\!9^-BT>QTQ<0EC!0P=^GI
M7<=^P<+9=EAX8M-9NYW<YDMP\*_.0Y6XCX9X._97!X%URD;>!4G^_2#:WTW
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MNR6W#*=VH+!N51);/ZORRB2T60:T:BTZ6"W5(Y1)0YO6F<X#.1/0#2@;UZM
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M9;S\ !Q7K#.D(\,UN$QTX / %(TGVE^ =A($'V +M\]ZF,\>TA.8THX%)=A
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M9>@NUMR/.BA6)JLMI3Q>P/]A$-_&+_0E=A53,L7ED7 %<'S$]G:4KK[_"%R
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ME>]?L83\*AQF)P?4/QKV!@<(-_%N<# @QY4=TW?H5S!Z?@U4#5+6CEEEHR5
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MWI]>O;T95=:.=*+-"QHGA=P[XYT@U)GJ^],#7G7VC:/@!&@QNIL:KBCM4A2
M%"<_&1Z]+V;_*"=@_O,Q8!!MCD 0!UR,OOVL89=P?[WJ\[\_)D\^*L"667R)
MYI/T$[,,E!);\ ,0G@- </,<H0CY,N>CF2$_GS0%(#S"7H84B)4U1>Y/%2>C
M609YIIQ"'H4(FB9ZC$*EP"1RD&,T@]S3F4]CM),)3FJF4G7I;3W/P*.>X/Z]
MQR; 'U&9QEP9H5NE+7:%=1J=CO#'(\7"B7)FYA-MIB)FRP664[6JMR&- P0C
M'I$@,=L19%$1%UBCXR)R54$I\EP;M[0DSR&R,"A EP?O^()4:X5B.9&9E0="
M&FUA =E:+A0)ZE#A=*K9=HA>-'R^?A49CUNX3K0HE3&+<3!6.@=$2D6H71P4
M4!O8;I M ?[*&KXC0!&,#+;[ILXR;=]VH@%!7RH+%J#N2A?\@A)&*'(L=$R)
M])W&RAN+SE;:E=619JB8P/H&U@[8)-%A: 2S=;M/NUT:(FM1;C-Z#5";"!;P
MG3!W<P$8,2R0W-1[>MBBU2"OV;AY3\?/L?EDLTS^#RK=GR?%EZS_TF[3E9))
M_ *6G,H3T/^]D%DD(0:UV^4T__1R\'Y]5-UV.G]!Q[FK1&F/M4,DOJ"?^-E8
M&V3[\IGO^ZF7/_ X4L7@/SI_==VGB_[U];OSR\O!S2\O]P[W_.?AN_.+ZG/)
MLJ0&)1*16XA6_06GJMC-V&2'^R?$YFM;]6\9;,AL;BL:R#6?CI65(/^ZV1(Y
M\3LNJQTEZ:.C_97#1I>[5CS=WSUE__BNH_V=%Q/U30>C6_[!ML)O.&&'/\8
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M$2 YM'U0WR@$QE#13!>=(U\W]H!['VWQC?OEWKEJC_P/4$L! A0#%     @
MS30C5%6V1DJF(   ;;0  !               ( !     &)N,3(S,3(Q,3(X
M:RYH=&U02P$"% ,4    " #--"-4E,.7.?:A  #+V0, "@
M@ '4(   97@Q,%\Q+FAT;5!+ 0(4 Q0    ( ,TT(U2%I]-58Y<  ,%. P *
M              "  ?+"  !E>#$P7S(N:'1M4$L! A0#%     @ S30C5*K:
M*F)4,@  CAT!  H              ( !?5H! &5X,3!?,RYH=&U02P$"% ,4
M    " #--"-4R1>]C8(R   @% $ "@              @ 'YC $ 97@Q,%\T
M+FAT;5!+ 0(4 Q0    ( ,TT(U2'.RJ0,S0  +P' 0 )              "
M :._ 0!E>#1?,2YH=&U02P$"% ,4    " #--"-4#1=PC(M"  !!< $ "0
M            @ ']\P$ 97@T7S(N:'1M4$L! A0#%     @ S30C5*,N?Q0E
M2   /H\!  D              ( !KS8" &5X-%\S+FAT;5!+ 0(4 Q0    (
M ,TT(U1:X$-3? L  &DG   *              "  ?M^ @!E>#DY7S$N:'1M
M4$L! A0#%     @ S30C5 "?NI(H P  U0L  !$              ( !GXH"
M &YI;&4M,C R,C Q,#,N>'-D4$L! A0#%     @ S30C5%60,'S]"@  @(8
M !4              ( !]HT" &YI;&4M,C R,C Q,#-?;&%B+GAM;%!+ 0(4
M Q0    ( ,TT(U0SL!,:4@<  ,57   5              "  2:9 @!N:6QE
G+3(P,C(P,3 S7W!R92YX;6Q02P4&      P # #  @  JZ "

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
